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Abstract 
Abstract 
Allergic and autoimmune diseases have been rising at epidemic proportions in recent years. 
This coincides with reduced exposure to infectious agents, alterations in commensal bacteria 
and additional lifestyle changes in the developed world. In response to this, the original 
hygiene hypothesis was proposed, correlating reduced Thi-inducing infections with elevated 
Th2-associated allergic diseases. This founded the early Thl-Th2 hygiene hypothesis. 
Paradoxical observations have been reported in developing regions of the world, where the 
exposure to Th2 inducing helminths is higher, yet the level of Th2 associated allergic disease 
is lower. To account for these findings the original hygiene hypothesis has been revised, 
suggesting that deficient regulatory mechanisms are responsible for the rising trends in 
inflammatory disorders. Helminths establish long-lived chronic infections in their definitive 
host, with avoidance and manipulation of host effector responses. Throughout helminth 
infections, immunoregulatory networks are generated, limiting immunopathology and 
permitting survival of parasites. I propose that helminth induced regulatory networks extend to 
regulate damaging allergic and autoimmune inflammatory responses. 
This thesis aimed to experimentally dissect the relationship between helminth infections and 
allergic diseases. We show here that cellular populations generated during a helminth 
infection can control both Thi-mediated autoimmune, and Th2-associated allergic 
inflammation. CD4CD25 T cells or CD19 B-cells from mesenteric lymph nodes (MLN) of 
mice chronically infected with Heligmosomoides polygyrus were transferred to allergen 
sensitive or myelin oligodendrocyte glycoprotein (MOG) (p355)  immunised recipients. 
Allergen-sensitive mice receiving cells from infected donors had significantly reduced airway 
eosinophilia, broncho-alveolar lavage (BAL) fluid IL-5 and eotaxin secretions upon airway 
challenge in a model of allergic airway inflammation. Similarly, MOG(355) immunised mice 
receiving CD19 B-cells from infected mice, had a significantly delayed onset and reduced 
severity of disease with fewer CD4iFN-y cells in the central nervous system (CNS) during 
experimental allergic encephalomyelitis (EAE), a murine model of multiple sclerosis (MS). I 
propose a testable regulatory model encompassing multidimensional infectious tolerance with 
an array of regulatory cells. 
Taken together, these, data highlight the immunoregulatory potential of chronic helminth 
infections, explaining the inverse relationship between helminth infections and dysregulated 
inflammatory events. 
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Chapter 1. Introduction 
Medical conditions such as allergic asthma, inflammatory bowel disease and diabetes have 
risen sharply in recent years stimulating the attention of the medical world. Asthma, in 
particular, has been the focus of much research with a greater understanding of the 
immunological processes involved in airway pathologies. Many thought-provoking 
explanations have been proposed for the rising prevalence of asthma, with the hygiene 
hypothesis gaining much favour. This hypothesis is breaking new ground in allergic and other 
dysregulated inflammatory disorders and proposes that some aspects of infectious agents 
can be beneficial, maintaining immunological homeostasis. The recently observed inverse 
association between helminth infections and allergic diseases have helped to shape the 
hygiene hypothesis from a simple Thl-Th2 dichotomy into a multilateral regulatory model, 
and may explain rising trends of a wide range of inflammatory disorders. The following 
introduction highlights key events in this exciting area, summarising the complex disease 
state of asthma with a cellular-based model of airway allergy. The influence of genetic pre-
dispositions and environmental risk factors are discussed, with a detailed analysis of the 
hygiene hypothesis and the influence of infectious pathogens on allergic disease outcome. 
Attention is focused on helminth infections and their exceptional ability to modify responses to 
third party pathogens, allergens and autoantigens. This introduction concludes with proposed 
mechanisms of helm inth-associated protection from allergies and highlights the need and 
justification for this thesis. 
1.1 Escalating Allergic and Inflammatory diseases. 
Asthma exerts a global burden of 300 million sufferers (Masoli, M. et al. 2004) affecting I in 5 
individuals in developed countries (Umetsu, D. T. et al. 2002), accounting for almost I in 
every 250 deaths worldwide; It is predicted to rise by a further 100 million cases by 2025 
(Masoli, M. et al. 2004) posing one of the most common chronic diseases in the world. Since 
the 1950's, allergic symptoms in general have progressively increased (Isolauri, E. et al. 
2004). Childhood asthma symptoms in the USA are now the major cause of school 
absenteeism, are the most common cause of hospitalisation, and have resulted in a doubling 
of asthma-related deaths from 1980 to 1992 (O'Connell, E. J. 2004). Within the UK, an 
approximate threefold increase in allergy-related visits to hospitals has been observed over 
the past 20 years, burdening the NHS by £900 million per annum. These numbers are 
expected to rise to a third of UK residents (Johnson, C. C. et al. 2002; 2004). Furthermore, 
multi-system-allergic diseases are more common, with patients presenting multiple 
sensitivities culminating in airway, food borne and skin allergies within the same individual 
(2004). 
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Several reports have assessed the global burden of asthma and other atopic diseases. 
Namely, the 'The International Study of Asthma and Allergies in Childhood (ISAAC), which 
exposed a peak prevalence of asthma symptoms in the United Kingdom (35%), New 
Zealand, Australia and Republic of Ireland, compared to lower prevalence in non-
industrialised countries, Indonesia (2%), Albania, Romania, and Georgia (lSAACSubject 
1998). Similarly, the European Community Respiratory Health Survey (ECRHS) identified a 
higher prevalence of allergic diseases in developed countries than in lesser developed 
eastern Europe, North Africa and India (1996). Combining these and other reports, the Global 
Initiative for Asthma (GINA) made an effort to raise awareness among public health bodies, 
government officials, health care workers and the general public that asthma is on the 
increase (Masoli, M. et al. 2004). These epidemiological data sets paint a convincing picture 
of elevating asthma symptoms; however thankfully, several reports also describe a plateau 
and even decline in asthmatic episodes in the UK (Anderson, H. R. et al. 2004; Sunderland, 
R. S. and Fleming, D. M. 2004), Australia (Robertson, C. F. et al. 2004; Toelle, B. G. et al. 
2004) and Italy (Ronchetti, R. et al. 2001). Improved disease management and allergen 
avoidance may contribute to these findings, however explanations for these reductions are as 
elusive as explanations for the initial increase. 
Interestingly, a considerable disparity in the prevalence of allergic symptoms between 
developed and developing countries of the world has been unearthed. The many differences 
between these regions may highlight factors protecting individuals from allergic diseases in 
developing countries. 
Upon further investigation, the disparity in asthma symptoms is also found between rural and 
urban areas within both industrial and non-industrial countries (Yemaneberhan, H. et al. 1997; 
Beasley, R. 1998; Beasley, R. et al. 2000; Leynaert, B. et al. 2001; Dagoye, D. et al. 2003; 
Masoli, M. et al. 2004). In particular, within African countries allergies are more common in 
the upper socioeconomic bracket of urban residents (Weinberg, E. G. 2000), suggesting that 
urbanisation and the adoption of a 'western lifestyle' correlate with allergic symptoms. Other 
immune-mediated diseases are also rising in similar geographical regions. Autoimmunity, 
such as type 1 diabetes (IDDM) (2000; Simpson, C. R. et al. 2002) multiple sclerosis (MS) 
(Rosati, G. et al. 1988) and coeliac disease (CD) (Farrokhyar, F. et al. 2001) are increasing in 
a manner similar to allergic disorders (Stene, L. C. and Nafstad, P. 2001; Bach, J. F. 2002) 
(Fig.1.1). Most significantly, allergy and autoimmunity can coincide in the same individuals, 
indeed children with ThI associated CD or RA have a higher incidence of Th2 associated 
allergies (Kero, J. et al. 2001; Simpson, C. R. et al. 2002). 
Many potential factors underlying the rise in immune-reactive disorders have been suggested. 
Asthma genetics has progressed significantly with genome wide screens to identify previously 
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unrecognised genes, while candidate gene approaches have revealed several asthma 
susceptibility genes (Wills-Karp, M. and Ewart, S. L. 2004), as highlighted below. 
Environmental risk factors, such as changes in lifestyle and behavioural patterns, the 
influence of viral infections during childhood and changes in allergen exposure are all 
uncovering potential risk factors associated with the increased allergy epidemic, and will be 
discussed further below. 
A 
Rheumatic 
loo- ,fever 	HappatitisA 
Mumps 
. Measles\ \ 
CD 
1950 1960 1970 1980 1990 2000 
B 




6  300 	
ads rosis/ 
i:::
200- 	 Type I 
 diabetes 
1950 1960 1970 19B0 1990 200 
Fig 1.1 Inverse Relation between the Incidence of Infectious Diseases (A) and the 
Incidence of Immune Disorders (B) from 1950 to 2000 (Bach, J. F. 2002) 
1.1.1 Asthma - Polygenic inheritance combined with 
Environmental allergen exposure. 
Allergic diseases are thought to result from multigenic predispositions combined with specific 
environmental interactions. The most characteristic feature of allergic responses is the 
generation of allergen-specific-IgE. The production of IgE appears to be protective against 
pathological parasitic infections (Jankovic, D. et al. 1997). The production of IgE may have 
provided an evolutionary advantage, limiting helminth infections. However, an aberration from 
our helminth burdened past and relative freedom from parasitic infections may have resulted 
in the development of IgE associated allergic diseases. The connotations of reduced helminth 
infections, beyond IgE, will be discussed in more detail below. 
A 'genotype of susceptibility' identifying those at a higher risk of developing allergies has yet 
to be resolved. The task is obstructed because asthma, for example, includes several 
different phenotypes, likely reflecting different pathogenic mechanisms with aetiological 
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heterogeneity. The association with environmental factors further complicates the 
identification of a 'genotype of susceptibility' as environmental factors, such as diet and 
housing, are themselves clustered within families. Nevertheless, efforts are being made to 
identify genes, alleles and chromosomal regions, which confer susceptibility to asthma. 
Familial aggregation, parent-of-origin (most predominantly maternal linkage, suggesting 
immune interactions through placenta and breast milk) and genomic imprinting are the 
strongest risk factors for asthma susceptibility (Geha, R. S. 2003). Th2 cytokines within the 
5q31 region (Cookson, W. 0. and Moffatt, M. F. S. 2000), cluster of differentiation 14 (CD14), 
and several other chromosomal regions (Ober, C. et al. 1998; Howard, T. D. et al. 1999) 
associate with a number of intermediate phenotypes of asthma. Of interest, ADAM33 (Van 
Eerdewegh, P. et al. 2002), Timi (McIntire, J. J. et al. 2001), and complement factor 5 (C5) 
(Karp, C. L. et al. 2000) are some of the most recent and exciting genes identified in humans 
and mice. These will be discussed later. An inspiring review of this topic, beyond the 
requirements of this thesis can be seen in (Wills-Karp, M. and Ewart, S. L. 2004). 
Approximately 40% of allergic diseases can be attributed to genetically variable factors 
(Holgate, S. T. S. 1998) such as atopy and IgE (Pearce, N. et al. 1999); however, for disease 
to manifest there is an absolute requirement for environmental interactions with the insulting 
allergen. The most important environmental allergens derive from invertebrates, such as 
house dust mites (Dermatophagoides pteronyssinus and D. farinae) and cockroaches, 
domestic animals, fungi, pollen and grasses. In utero sensitisation to aeroallergens, such as 
Der p1, via maternal inhalation might represent the earliest environmental exposure (Piccinni, 
M. P. et al. 1993), with further sensitisation and allergen-specific IgE responses developing 
and progressing throughout life. The relatively rapid rise in allergic diseases over a short 
period of time suggests environmental factors, not changes in genotype, are causes of the 
allergy epidemic. How might environmental factors, beyond allergens themselves, influence 
the tendency to become sensitised or responsive to innocuous antigens? To address this, we 
must first appreciate how allergic responses unfold and then examine possible environmental 
risk factors. 
1.1.2 Immunology and pathogenesis of Asthma. 
Allergic asthma represents an immune disorder, characterised by a state of immune 
hypersensitivity with elevated levels of allergen-specific IgE. Subsequent allergen encounters 
and cross linking of two or more mast cell bound IgE molecules provoke an accumulation of 
mast cells and eosinophils into air spaces and tissues of the lung, instigated by Th2 cells 
(Fig.1.2). Mechanisms associated with allergic asthma are described below in terms of 
cellular induction and soluble mediators, which play a direct role in allergic inflammation. 
8 
Chapter 1. Introduction 
Immunological surveillance in the airways depends on dendritic cells (DC's) in the sub-
epithelial layers and intercellular spaces between epithelial cells lining the alveolar walls of 
the lung (Gong, J. L. et al. 1992; Moller, G. M. et al. 1996; Lambrecht, B. N. S. 2001; Julia, V. 
et al. 2002). 
Allergen encounter, possibly by disruption of epithelial tight junctions (Wan, H. et al. 1999) or 
contact with the probing' dendrites of airway DC's (Rescigno, M. et al. 2001), accompanied by 
appropriate pathogen associated molecular pattern (PAMP) stimulation (Eisenbarth, S. C. et 
al. 2002), activates DCs and triggers a migration to the draining lymph nodes (Vermaelen, K. 
Y. et al. 2001). 
Once DCs reach the thoracic lymph nodes (Holt, P. G. et al. 1993; Vermaelen, K. Y. et al. 
2001), they mature and express high levels of peptide-loaded MHC and co-stimulatory 
molecules; CD80, CD86, OX40L, and ICOSL and migrate to the T-cell zones. MHC-TCR 
engagement (Mempel, T. R. et al. 2004) with appropriate co-stimulation and Interleukin (IL) 4 
signalling, generates allergen-reactive Th2 cells. Th2 cells then egress from lymph nodes 
back to the site of initial allergen encounter (Herrick, C. A. and Bottomly, K. 2003), following 
chemotactic gradients of chemokines such as RANTES (regulated on activation, normal T-
cell expressed and secreted), TARC (Thymus-associated and regulated chemokine) and 
MDC (macrophage derived chemokine) (Bonecchi, R. et al. 1998; Soumelis, V. et al. 2002) 
and most recently PGD2 (Nagata, K. et al. 1999; Hirai, H. et al. 2001; Honda, K. et al. 2003). 
Allergen re-encounter by DCs and activation of antigen-specific Th2 cells, results in a barrage 
of Th2 cell derived cytokine secretion. 
The central role for Th2 cells in asthma is apparent in both specific IgE production and the 
Th2-cytokine milieu found in the allergic response (Tournoy, K. G. et al. 2001). Animal models 
of allergic airway inflammation have shown that GATA-3 and STAT-6 disruption, inhibiting 
Th2 cell signalling, severely attenuates all key features of allergic airway inflammation 
(Tomkinson, A. et al. 1999; Zhang, D. H. et al. 1999). Alternative studies have depleted CD4 
Th2 cells or knocked out IL-4 and found similar inhibitions of allergen induced airway 
inflammation (Brusselle, G. G. et al. 1994; Gavett, S. H. et al. 1994). The allergic airway 
inflammatory response can be induced by the transfer of CD4 T-cell receptor transgenic Th2, 
but not ThI, cells (Cohn, L. et al. 1998). Thus, CD4 Th2 cells, recognising allergen peptides 
via their TCR and releasing interleukins orchestrating the allergic inflammatory response, are 
absolutely essential in the aetiology of allergic asthma. 
Allergen-specific IgE responses define allergic patients. However, it was not until the Thl-Th2 
dichotomy was classified (Mosmann, T. R. and Coffman, R. L. 1989) based on cytokine 
profiles, that the basis for IgE induction was understood. Th2-cell derived IL-4 induced 
transcription of CE (Corry, D. B. and Kheradmand, F. S. 1999) and CD40-CD40L interactions 
Chapter 1. Introduction 
between B- and 1-cells (de Lafaille, M. A. et al. 2001) induce B cell migration into lymphoid 
follicles, or bronchial associated lymphoid tissue (BALT) (Chvatchko, Y. et al. 1996), 
culminating in allergen specific lgE production (Burrows, B. et al. 1989; Saini, S. S. and 
MacGlashan, D. 2002). Allergen-specific-lgE represents a very small fraction of the total 
serum immunoglobulin (Burrows, B. et al. 1989). 
Due to the low concentrations of IgE, its function is related to the cell-bound high affinity 
receptor, FccRl, found on mast cells, basophils and human eosinophils (Yamaguchi, M. et al. 
1999). Allergen re-encounter and cross linking of two FctRl bound IgE molecules on tissue 
mast cells or blood basophils, in addition to activation of Th2 cells, results in phosphorylation 
and dephosphorylation of a series of proteins triggering activation and degranulation 
(Holgate, S. T. S. 1998; Gould, H. J. et al. 2003). Mast cells abound with inflammatory 
mediators including; histamine, proteolytic enzymes, complex carbohydrate cleaving 
enzymes, cytokines and chemokines, prostanoids and leukotrienes (Bradding, P. H., S.T.; 
Bradding, P. and Holgate, S. T. 1999; Miller, H. R; et al. 1999 (MC); Kobayashi, T. et al. 2000; 
Kobayashi, H. et al. 2000 (MC); Wedemeyer, J. and Galli, S. J. S. 2000 (MC); Hart, P. H. S. 
2001). Mast cells and their products are undoubtedly important components of the allergic 
inflammatory cascade (Kobayashi, T. et al. 2000; Mayr, S. I. et al. 2002; Taube, C. et al. 
2004), however, their importance in animal models of allergic airway inflammation is 
debatable. Comparable airway inflammation, airway hype rresponsiveness (AHR) or 
anaphylaxis (Oettgen, H. C. et al. 1994) has been achieved in the absence of IgE (Mehlhop, 
P. D. et al. 1997; Hamelmann, E. et al. 1999), B-cells (Hamelmann, E. et al. 1997; MacLean, 
J. A. et al. 1999), CD23 (Haczku, A. et al. 1997) or mast cells (Takeda, K. et al. 1997) but not 
T-cells (Gavett, S. H. et al. 1994). 
Th2 cytokines; IL-4, IL-5, IL-9 and IL-13 can be attributed to almost all intermediate stages of 
airway inflammation and pathophysiological asthma (Romagnani, S. S. 2001). Firstly, the 
archetypal Th2 cytokine IL-4, plays essential roles in Th2 generation, however, interestingly 
once Th2 priming is initiated, IL-5 takes centre stage. Beyond Th2 polarisation, IL-4 is not 
necessary for airway inflammation (Coyle, A. J. et al. 1995; Ying, S. et al. 1997; Hamelmann, 
E. et al. 1999). Thus, very early sources of IL-4, possibly from NKT cells (Akbari, 0. et al. 
2003) and basophils (Mm, B. et al. 2004) are fundamental for Th2 differentiation. 
IL-13, although sharing many properties, and even receptor complexes, with IL-4, has greater 
functional properties at the effector cell level. Mucus hypersecretion due to mucus cell 
metaplasia and goblet cell hyperplasia (Zhu, Z. et al. 1999) have been closely associated with 
IL-13 (Zhu, Z. et al. 2001) and IL-9 (Longphre, M. et al. 1999) secretions. IL-13 also promotes 
cellular recruitment by upregulating chemokine expression (Hart, P. H. S. 2001) and is critical 
for the development of AHR (Walter, D. M. et al. 2001). Furthermore, initial IgE class 
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switching (Finkelman, F. D. et al. 1988), airway eosinophilia (Cohn, L. et al. 2001) and pro-
fibrotic developments in chronic asthma (Postlethwaite, A. E. et al. 1992) are promoted by IL-
4 and / or IL-13. The recently discovered cytokine IL-25, is also secreted by Th2 cells and 
accentuates IL-4, IL-5 and IL-13 gene expression, amplifying the Th2 environment (Fort, M. 
M. et al. 2001 (2001)).ln allergic asthma, .IL-5 works in close collaboration with the 
predominant eosinophil chemoattractant, eotaxin (Jose, P. J. et al. 1994) (Rankin, S. M. et al. 
2000). 
Th2 cell derived IL-4 and IL-13, along with TNF-a released from macrophages, stimulate 
eotaxin release from lung fibroblasts, epithelial cells, and smooth muscle cells (Rankin, S. M. 
et al. 2000). Additional to the cheomotactic properties of eotaxin, local eotaxin production 
enhances; intracellular calcium levels- increasing respiratory burst activity (Tenscher, K. et al. 
1996), eosinophil adhesion to endothelial cells, via VCAM-1 on endothelial cells (Burke-
Gaffney, A. and Hellewell, P. G. 1996), corroborating eosinophil extravasation and 
degranulation in local tissues (Rankin, S. M. et al. 2000). In the periphery, eotaxin and IL-5 
enter the blood stream and act synergistically to mobilise the large reserve of mature 
eosinophils within bone marrow (Sklar, L. A. et al. 2004). IL-5, in addition to its chemotactic 
attributes is a priming agent and growth factor for eosinophils, increases eosinophil 
responsiveness and differentiation (Hamblin, S. 1993) and promotes T-cell dependent airway 
mucus production (Justice, J. P. et al. 2002), AHR and tissue damage. IL-5 is a potential 
therapeutic target, but although depleting >70% of circulating and sputum eosinophils with 
anti-IL-5 treatment, clinical asthma such as AHR was found not to be altered (Leckie, M. J. et 
al. 2000). 
The recruitment of eosinophils into the allergic lung and draining lymph nodes (van Rijt, L. S. 
et al. 2003) is a hallmark of allergic airway inflammation. Allergen induced degranulation of 
eosinophils, releasing major basic protein (MBP) (Lefort, J. et al. 1996), eosinophil cationic 
protein (ECP) and eosinophil peroxidase (EPO) is most likely responsible for lung tissue 
damage and AHR (Rankin, S. M. et al. 2000). Mucus hypersecretion and goblet cell 
hyperplasia, following allergen provocation, is another pathophysiological feature of asthma 
(Rogers, D. F. 2003). Cytokines IL-4, IL-9 and most importantly IL-13 (Zhu, Z. et al. 2001) as 
Well as oxidants from Th2 cells upregulate mucin production and epidermal growth factor 
(EGF). These pathophysiological changes can be easily observed in biopsies or paraffin 
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Collectively, a considerable cellular influx into the airways following allergen provocation, 
accompanied by tissue damage and excessive secretion of mediators, cytokines, chemokines 
and mucus ultimately lead to airway remodelling. Airway remodelling refers to the non-
inflammatory alterations in airway cells and tissues following chronic inflammation and is a 
major component of clinical asthma. Briefly, thickening of the airway wall smooth muscle, 
oedema, inflammatory cell infiltrates, glandular hypertrophy and connective tissue deposition 
result in airway narrowing, leading to reduced baseline airway calibre and 
hyperresponsiveness (Elias, J. A. et al. 1999; Chiappara, G. et al. 2001; Zhu, Z. et al. 2001). 
Allergen 
* 











Fig.1.2. Key events in the Allergic Cascade. Airway dendritic cells capture antigen and migrate to 
local lymph nodes, where 1h2 polarisation and differentiation occurs. Th2 cells egress to the site of 
allergen contact secreting IL-4, IL-5, IL-9 and IL-13, recruiting mast cells and eosinophils. Th2 cells 
promote B cell maturation and lgE class switching, with soluble IgE binding to its Fc receptor on 
mast cells. Cross linking of two IgE molecules triggers mast cell degranulation with a plethora of 
inflammatory mediators. - 
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1.1.3 The Hygiene Hypothesis - Risk factors and the pliancy of 
allergic diseases to environmental factors. 
Numerous risk factors in industrialised and urban living have been suggested by a number of 
investigators to be potential origins of the allergy epidemic. One credible theory for the recent 
rise in allergic diseases that takes into account the changes in pathogen exposure, accounts 
for our evolutionary past and genetic predispositions, which dissects the pathogenesis of 
allergic diseases and proposes tangible mechanisms, is the hygiene hypothesis. 
1.1.3.1 Genetic pre-dispositions 
Asthma manifests from complex gene-by-environment interactions (Barnes, K. C. 1999). 
Therefore, the allergy epidemic may possibly reflect an increase in susceptibility to allergic 
diseases, as well as changes in environmental patterns. The hygiene hypothesis integrates 
epidemiology with genetics, recognising that gene-environment interactions can also 
influence disease. Although there may not have been enough time for genetic factors to 
change enough to cause the current rise in allergies, epigenetic changes, as a result of 
environmental cues (Jaenisch, R. and Bird, A. 2003) may certainly contribute to the present 
epidemic. 
Umetsu and co-workers unravelled an enticing scenario in which Tim 1, a recently identified 
asthma susceptibility gene in mice, may provide evidence for a role of hepatitis A virus (HAV) 
and protection from allergic manifestations in humans. The gene product of Timi has been 
shown to regulate Th2 cell development and AHR in mice (McIntire, J. J. et al. 2001) with 
polymorphisms in Timi associated with varying development of AHR. The human homologue 
of Timi encodes for the receptor for HAy. Thus, interaction of HAV with its receptor (huTiml) 
may directly modify the Th2 cell pool, inhibiting excessive Th2 cellular development and 
proliferation and prevent the development of allergic asthma (Umetsu, D. T. et al. 2002). 
A single nucleotide polymorphism (SNP) in the CDI4 promoter region, C-159T, associated 
with increased soluble CDI4 (sCD14) and decreased total serum IgE (Baldini, M. et al. 1999); 
(Hubacek, J. A. et al. 1999), was Initially proposed as an LPS-related mechanism regulating 
IgE levels and subsequent allergen sensitisation. However, elevated sCD14 has also been 
observed in the BAL fluid of asthmatic patients (Vercelli, D. et al. 2001) possibly enhancing 
allergic inflammation (Kusunoki, T. et al. 2002). Thus, the complex interactions between 
CDI4, LIDS and lgE, although unresolved, highlight another gene-environment interaction, 
which may regulate allergic reactivity. 
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Finally, children born and raised on a farm have been reported to develop fewer allergies than 
non-farm dwelling children (described in more detail below). The protective effect of farm 
lifestyles, however, is only observed in children with a T allele for TLR2/-16934, with those 
children homozygous for the A allele displaying similar levels of atopy and allergic 
responsiveness as non-farm dwelling children (Eder, W. et al. 2004). Thus, exposure to a 
farm environment may modify an individual's genotype enough to alter their susceptibility to 
allergies. These studies help to identify candidate genes for allergy and the roles they play in 
the immunological development of allergic inflammation. 
1.1.3.2 Environmental Risk Factors 
Environmental exposures or lifestyle changes, such as diet and nutrition, have changed 
dramatically over the past several decades, with more processed and sterile packaged foods 
available. Consequences of diet changes are vast. The 'Barker hypothesis'- which associates 
foetal programming, particularly undernourished development, with chronic diseases (Barker, 
D. J. 1998) may dissect the allergy epidemic. Indeed, children with lower birth weights and 
smoking parents are at a greater risk of developing asthma (Magnus, P. et al. 1985). 
However, enhanced maternal nutrition has also been described as a risk factor (Beasley, R. 
et al. 2000). Thus nutritional status may only bear relevance in combination with other risk 
factors such as sterile food use and poor diets (Sears, M. R. 1997). 
Atmospheric changes have also been profound. Assaulting the airways with tobacco smoke 
during pregnancy or exposing infants to smoke increases wheezing and bronchial 
hyperreactivity during childhood (Chilmonczyk, B. A. et al. 1993; Stein, R. T. et al. 1999). 
Experimental systems addressing smoke exposure have ascribed adjuvant-like properties to 
tobacco smoke (Seymour, B. W. et al. 1997; Rumold, R. et al. 2001) and diesel exhaust 
particles (Diaz-Sanchez, D. et al. 1997), enhancing specific-IgE production. Reports of lower 
rates of asthma amongst smokers (Beasley, R. 1998) are most likely the "healthy smoker 
syndrome" (The tendency of those with asthma not to smoke), rather than any actual 
protection from allergy. Therefore, smoking and carbon-based air pollutants may certainly 
exacerbate existing airway allergy but there is no evidence that smoking or pollution creates 
new cases. Increased allergen release from pollen grains and longer-lasting pollen counts by 
some, but not all (Behrendt, H. and Becker, W. M. S. 2001), air pollutants may represent 
changes in the composition of allergens encountered, resulting in increased exposure. 
However, air pollution can not solely account for the rise in prevalence, as regions such as 
China and Eastern Europe, where some of the highest levels of particulate matter and SO2 
are found (Jones, A. P. 1998), have lower allergy rates than less polluted regions such as 
New Zealand and the UK (Beasley, R. 1998; lSAACSubject 1998). 
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We are exposed to more indoor allergens, such as HDM and mould spores, than in past 
decades, following the desire to insulate homes with wall-to-wall carpeting and installing 
central heating systems. Increased allergen exposure during the pollen season or after 
thunderstorms (Jarvis, D. and Burney, P. 1998) results in bouts of patients presenting allergy-
related symptoms. However, the annual pattern of allergen release, at least in Japan, has not 
changed significantly (Sato, K. et al. 1997). More contentiously, pet ownership has also 
increased (Custovic, A. et al. 2003), contributing to increased allergen levels (Wahn, U. et al. 
1997). Interestingly, pet ownership may pose as a protective factor rather than a risk factor for 
some individuals. This will be discussed below. 
Therefore, increased allergen exposure is unquestionably the biggest risk factor faced for 
allergic patients, however the effeôts of increased exposure on new allergy cases remains to 
be elucidated. 
The paradoxical effect of dog and cat ownership (a major source of allergens themselves) 
protecting from allergic diseases has been highlighted by Thomas Platts-Mills and others. 
Reports of exposure to domestic cats and dogs during infancy (Hesselmar, B. et al. 1999; 
Roost, H. P. et al. 1999) and preteen years (Perzanowski, M. S. et al. 2002) providing 
protection from allergic diseases and allergen sensitisations (Ownby, D. R. et al. 2002) added 
another dimension to the hygiene hypothesis. Individuals exposed to animals, whether farm 
animals or domestic cats and dogs, are exposed to significantly more environmental 
endotoxins (Platts-Mills, T. A. 2002), suggesting that similar immunological mechanisms, 
such as ThI immune deviation, govern animal-exposed-protection from allergy. However, the 
fact that cats and dogs are major sources of allergens, Eel dl, and Can fl, respectively, 
suggests multifaceted mechanisms. Indeed, children who did not respond to Fel dl, with skin 
prick tests had significant levels of Eel dl-specifc-lgG4 (Platts-Mills, T. et al. 2001) and IL-10  
secretions from peripheral T-cells (Reefer, A. J. et al. 2004). As lgG4 production requires IL-
4, similar to IgE, the occurrence of lgG4 and IL-la without IgE has been described as a 
'Modified Th2' response (Platts-Mills, T. et al. 2001). Furthermore, exposure to cats can also 
prevent sensitisations to other allergens such as dog allergens (Custovic, A. et al. 2003). 
Recent studies have found further evidence of a modified Th2 response, with higher IL-10  
and IL-13 cytokine secretion profiles after 1 year, and reduced allergic sensitization and 
atopic dermatitis in children exposed to dogs during the first year of life (Gem, J. E. et al. 
2004). Polymorphisms in genes encoding CD14 were also observed in this study, however, 
which may have confounding or additive protection from allergy when combined with dog 
exposure. The 'Modified T112 response' can conceivably provide protection from allergic 
reactivity by competing for allergen binding, lgG4 vs. IgE of similar specificities, and also by 
suppressing T-cell proliferation via IL-b, however the exact mechanism is still unresolved. 
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1.1.3.3 The Influence of Infection on Allergic Disease 
In search of an environmental aetiology of the allergy epidemic, the decline in common 
infectious diseases, highlighted by the inverse relationship between the prevalence of 
infectious pathogens and that of allergic disease (Shirakawa, T. et al. 1997; Matricardi, P. M. 
and Bonini, S. S. 2000; Matricardi, P. M. and Bonini, S. S. 2000; Bach, J. F. 2002) is one of 
the most attractive. Conceivably, if changes in our lifestyle with the introduction of air 
pollutants, smoking, changes in diet and increased allergen exposure may affect the 
incidence of asthma, then the inverse is also plausible, namely the loss of protective 
environmental exposures. 
It is generally thought that diseases reduce, rather than increase, our reproductive fitness. 
However, the hygiene hypothesis approaches this concept from the reverse, assessing our 
immunologically burdened past and appraising the benefit rather than the burden of infection. 
1.1.3.4 Hygiene Hypothesis 
Increased allergic diseases accompanied with reduced childhood infections through 
vaccination programmes, antibiotic development and general improved hygiene, contrast with 
a lower prevalence of allergic diseases in areas where childhood infections are more common 
(Strachan, D. P. 1989; Wills-Karp, M. et al. 2001; Yazdanbakhsh, M. et al. 2002; Romagnani, 
S. 2004). These observations helped shape the early hygiene hypothesis. 
Original observations almost 30 years ago, indicating that infections might protect from 
allergy, set the stage for later studies (Gerrard, J. W. et al. 1976). Despite higher levels of 
serum IgE (275.4 u/mI compared to 81.3 u/mI) with evidence of helminth, viral and bacterial 
infections, Métis residents of Saskatchewan, Canada, had relatively fewer cases of asthma, 
eczema and urticaria, compared to their relatively uninfected, white countrymen (Gerrard, J. 
W. et al. 1976). Helminth infected populations in the Gambia (Godfrey, R. C. 1975) and 
Zimbabwe (formerly Rhodesia) (Godfrey, R. C. 1975) with fewer allergies were reported 
during the mid 1970's, with self experimentation using hookworm alleviating hay fever 
symptoms (Turton, J. A. 1976). Thirteen years later, the hygiene hypothesis was coined from 
observations made by Strachan (Strachan, D. P. 1989), relating large household sizes with 
reduced hay fever. Strachan proposed that increased transmission of viral infections between 
siblings could protect from the development of allergic rhinitis. Immunological interpretation of 
smaller family sizes and reduced bacterial and viral infection, as impaired Thi responses and 
thus impaired counter regulation of Th2- pro-allergic responses, was the founding of the Thl- 
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Th2 hygiene hypothesis (Rook, C. A. and Stanford, J. L. 1998) (Matricardi, P. M. and Bonini, 
S. S. 2000). 
Although stimulating much new thinking on allergy, this position did not account for the 
parallel increase in Thi-mediated autoimmune diseases during a similar time frame (Stene, L. 
C. and Nafstad, P. 2001; Bach, J. F. 2002) and even within the same individuals (Kero, J. et 
al. 2001; Simpson, C. R. et al. 2002). Moreover, in developed countries, Th2-inducing 
helminth infections (such as Ascaris and the once ubiquitous pinworm) diminished in 
prevalence alongside Mycobacterium tuberculosis and other Thi-driving pathogens (Mao, X. 
Q. et al. 2000; Gale, E. A. 2002). Most importantly, the paradox emerged that allergies are 
less prevalent in helminth-infected populations, who show strong Th2 responses. 
Newer studies described below began to imply that ongoing, chronic infections may be as 
important as early-life experience in determining the mode of an immune response to 
allergenic substances. 
Furthermore, the spotlight is moving firmly into infection per so, rather than the Thi- or Th2-
stimulating nature of different microbes, and the questions now centre more on the generic 
response to infection rather than the consequence of any one pathogen. In these ways, the 
Hygiene Hypothesis has evolved and is often discussed in the context of disordered 
immunoregulation, rather than a dysfunctional ThlITh2 balance (Wills-Karp, M. et al. 2001; 
Yazdanbakhsh, M. et al. 2001) (Gale, E. A. 2002) (Umetsu, D. T. et al. 2002; Yazdanbakhsh, 
M. et al. 2002). 
Whether the hygiene hypothesis is posed in its original (imprinting) or later (regulatory) 
context, it has provoked a barrage of fascinating epidemiological studies. Traditional lifestyles 
associated with farming (Von Ehrenstein, 0. S. et al. 2000; Leynaert, B. et al. 2001; Riedler, 
J. et al. 2001) or anthroposophic communities, where a diet rich in lactobacilli and a limited 
use of antibiotics and vaccinations is common (Matricardi, P. M. and Bonini, S. S. 2000) 
appear to be protected from allergies. More akin with the developed world lifestyle, those 
attending childcare in early months of life (Kramer, U. et al. 1999) (Ball, T. M. et al. 2000) or 
from larger families (Matricardi, P. M. et al. 1998; Cooper, P. J. et al. 2004; Stabell Benn, C. 
et al. 2004) also appear to be protected from allergies. Presumably these lifestyles and 
environments provide an arena where infections are transmitted more readily. Infectious 
burden in the developing world due to problems of sanitation, access to clean drinking water, 
inadequate nutrition and crowding, where allergies are less common, far out weighs that of 
the developed world, further suggest that infections maybe protective. Indeed, migrants from 
Albania with relatively high levels of present or previous infection (covering Toxoplasma 
gondii, herpes simplex virus, hepatitis A virus (HAV) and Helicobacter pylon) and low allergic 
symptoms, manifest with time an increasing prevalence of sensitisation to local allergens 
(Ventura, M. T. et al. 2004). 
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Thus, rather ironically, the medical endeavour to eradicate may of these infections and the 
lifestyle changes associated with more affluent living may have left us at greater risk of 
developing allergic diseases. However, 'unhygienic' living is not a simple resolution to 
alleviate allergic diseases, indeed, poor and unhygienic inner city dwellings have seen an 
increase in severe asthma cases (Platts-Mills, T. A. 1997). Therefore, an understanding of 
specific bacterial, viral or helminth pathogens is required to piece together how particular 
pathogens and their products can protect us from allergies. 
1.1.3.5 Bacterial infections and Allergic disease 
Bacteria and bacterial products have received much attention for their allergy-preventing 
effects, presumably due to the wealth of stimuli for the developing immune system and our 
close association with commensal gut flora. A further extension of the hygiene hypothesis 
indicated that antibiotic 'over-use' has resulted in a general reduction of bacterial colonisation 
and bacterial turnover rate, conditions observed in developed countries, and may have 
removed the beneficial effects of these 'old bacterial friends' (Rook, G. A. and Stanford, J. L. 
1998; Bjorksten, B. et al. 2001). Indeed, a positive correlation with increased antibiotic use 
and allergic reactivity can be observed, at the epidemiological level (Farooqi, I. S. and 
Hopkin, J. M. 1998; Wickens, K. et al. 1999). 
Approximately a third of the developing world carry Mycobacterium tuberculosis, however 90-
95% do not develop disease, presumably due to efficient anti-bacterial responses of a Thi 
nature (Rook, G. A. and Stanford, J. L. 1998). Japanese school children have indeed shown 
an inverse association between reactivity to tuberculin and allergic responsiveness, with 
greater Th1:Th2 cytokine ratios (Shirakawa, T. et al. 1997). Vaccinations with Bacilli 
Calmette-Guérin (BCG), resulting in tuberculin conversion, reduces allergic symptoms in 
atopic individuals (Shirakawa, T. et al. 1997) and significantly reduces the development of 
allergic diseases (Romagnani, S. 2004). However, several studies contest the allergy-
protecting nature of BCG vaccination, indicating that vaccination per se does not prevent the 
development of allergy and asthma (Alm, J. S. et al. 1998). 
Bjorksten proposed that bacteria colonising the gastrointestinal tract provide persistent 
pressure on the developing immune system, in a manner protective to the host (Bjorksten, B. 
et al. 2001). A model involving the mucosal associated lymphoid tissue (MALT) network 
linking the gastric MALT (GALT) and bronchial MALT (BALT) allowing T cells to migrate 
between the two MALT sites, has been proposed. 
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Prospective studies found atopic patients had lower Bifidobacterium colonisation relative to 
allergy-free patients (Watanabe, S. et al. 2003). Other colonising bacteria, however, 
measured by seropositivity were associated with a higher prevalence of allergic disease 
(Linneberg, A. et al. 2003), suggesting that only specific bacterial exposures harbour anti-
allergy properties with the balance of protective: pathogenic explaining the variable 
epidemiological data. Attempts to restore or modulate bacteria colonisation with probiotics 
have uncovered some encouraging results with reduced allergic symptoms following 
lyophilised Bifidobacteria treatment (Hattori, K. et al. 2003) and Lactobacillus ingestion 
(Kalliomaki, M. et al. 2001), presumably shifting the balance towards the protective species. 
Endotoxins, such as lipopolysacharides (LPS) comprised of an antigenic 0-specific side 
chain, a core oligosacharide and a toxic lipid component, are derived from the outer-
membrane of Gram-negative bacteria and are a major source of bacterial stimulus. Lower 
levels of endotoxin exposure, resulting in reduced IFN-y secretions from peripheral T-cells, 
have been associated with increased skin reactivity to house dust mite (Gereda, J. E. et al. 
2000) and Alternaria, a common fungal allergen in Arizona (Martinez, F. D. and Holt, P. G. 
1999). Endotoxin levels in unpasteurised milk and exposure patterns of pregnant mothers 
and newborns may be responsible for the observed protection from allergy seen in children 
raised on farms (Leynaert, B. et al. 2001; Waser, M. et al. 2004). 
Endotoxins can trigger significant IL-12 secretions from DC's and Th2 cells, upon ligation with 
its receptor, CD14 (Triantafilou, M. and Triantafilou, K. 2002). As described earlier, the 
potential gene-environment interactions with LPS and CDI4, extend the protective effect of 
LIPS exposure. 
So, do bacteria and their products protect from allergy by simply deviating responses towards 
aThi nature? 
Bacterial products harbour some of the most potent Thi-inducing immunogens, acting via 
TLRs on DC's (Matricardi, P. M. and Bonini, S. S. 2000; Akdis, C. A. et al. 2003). Such 
bacterial encounter during allergen sensitisation and T-cell priming may be enough to deviate 
responses away from a pro-allergic Th2 response (Matricardi, P. M. and Bonini, S. S. 2000). 
Active bacterial infections with Mycobacterium (Waizi, G. et al. 2003) (Yang, X. et al. 1999), 
Chiamydia trachomafis (Bilenki, L. et al. 2002) or Mycoplasm pneumoniae (Chu, H. W. et al. 
2003), inducing a systemic Thi response prior to allergen sensitisation, reduce subsequent 
allergic airway inflammation in animal models, suggesting that an 'educated' or polarised 
immune response protects from allergy. Supporting this notion, crude endotoxin or LPS 
(Tulic, M. K. et al. 2000; Gerhold, K. et al. 2002), bacterial bNA containing many CpG motifs 
(Kim, Y. S. et al. 2004) or a bacterial-derived lipopeptide exposure, prevented subsequent 
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sensitisations (Tulic, M. K. et at. 2000), IgE responses and airway eosinophilia (Erb, K. J. et 
al. 1998; Hopfenspirger, M. T. and Agrawal, D. K. 2002; Zuany-Amorim, C. et at. 2002). 
Similarly, the inhibition of airway allergy has been observed following treatment with killed 
Listeria monocytogenes, M. vaccae and Lactobacillus plantarum, implying that live bacteria 
and active infections are not necessary, but rather signature molecules or potent Thl 
inducing agents are sufficient (Wang, C. C. and Rook, G. A. W. 1998; Herz, U. et al. 2000; 
Zuany-Amorim, C. et al. 2002). Animal studies have conclusively shown that in wild type, but 
not IFN-y receptor deficient mice, Thi clones can suppress Th2 clones when co-transferred, 
inhibiting airway eosinophilia upon airway challenge (Cohn, L. et at. 1999). Presumably, 
bacterial infections may protect from allergy in a similar manner, by deviating immune 
responses towards a Thi profile, fitting with the original hygiene hypothesis. 
Bacterial infections, however, invoke more than an anti-bacterial Thi response. An anti-
inflammatory, regulatory response is also induced, with the capacity to regulate allergic 
reactivity. Treatment of mice with SRP299, a killed Mycobacterium vaccae-suspension, 
induced allergen-specific CD4FCD45RBI0W  regulatory T cells (Treg), capable of protecting 
recipient mice from allergen provoked airway inflammation, in an IL-10 and TGF-13 dependent 
manner (Zuany-Amorim, C. et al. 2002). 
Furthermore, work form the same group has now shown that CD11c DCs isolated from mice 
treated with M.vaccae express elevated TGF-3 and IFN-a mRNA, suggesting that upstream 
mechanisms involving DCs may be responsible for protection from airway inflammation 
(Adams, V. C. et al. 2004) Similarly, Lactobacillus treatment of atopic children increased 
serum IL-10 and mitogen-stimulated PBMC IL-10 secretion in association with reduced 
allergic reactivity (Pessi, T. et al. 2000). Taken together, these studies suggest that in 
addition to immune deviation during bacterial infection / treatment, a regulatory compartment 
is expanded, providing an additional mechanism of protection from allergic reactivity. Possible 
mechanisms governing deviation and regulation will be discussed below. 
1.1.3.6 Viral Infections and Allergic disease 
Immune responses to viral infections characteristically involve NK cells, CD8 T-cells and 
CD4 T-cells secreting IFN-y and IL-12 resulting in a polarised Thi profile. As described 
above the counter-regulatory capacity of Thl responses can provide a possible mechanism of 
bacterial-induced protection and thus presumably viral protection from allergic disease. 
However, viral infections in relation to allergic disease, work both ways. Early childhood viral 
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infections increase wheezing and airway irritation with positive associations with the 
development of allergic diseases, whereas later viral infections and positive serology from 
prospective studies indicate a negative association with allergic disease. 
For example, children with evidence of respiratory infections, such respiratory syncytial virus 
(RSV) infections, bronchitis, or pneumonia, during infancy were found to have a higher risk of 
developing bronchial obstruction during the first 2 years of life and of having asthma at 4 
years of age (Nafstad, P. et al. 2000) (Sigurs, N. et al. 2000). Prospective studies conducted 
in Australia (Ponsonby, A. L. et al. 1999) or Germany (Illi, S. et al. 2001) have also confirmed 
that respiratory tract infections during the first 6 weeks of life (Illi, S. et al. 2001), or within the 
first year of life (Ponsonby, A. L. et al. 1999), increase the risk of asthma. The most common 
form of virally-exacerbated asthma is caused by rhinovirus (RV). Although these viruses can 
induce asthma like responses themselves, most virally-related asthma symptoms are lost by 
the age of 13 (Herz, U. et al. 2000), suggesting that the viral-associated-asthmatic phenotype 
observed in childhood, may not actually lead to asthma in the long run. 
Experimental models, however, support an exacerbation of airway allergy following viral 
infection; including increased allergen-specific IgE production and AHR (Suzuki, S. et al. 
1998) and even anaphylactic shock (O'Donnell, D. R. and Openshaw, P. J. 1998) with 
influenza A virus or RSV infection (Schwarze, J. et al. 1997; Barends, M. et al. 2002). 
Culley and colleagues have elegantly shown that the timing of RSV infection in a juvenile 
mouse study can have significant effects on airway allergy, with later RSV infections inducing 
less viral-exacerbated-disease and heightened IFN-y responses (Culley, F. J. et al. 2002). 
The inflammatory response and tissue damage incurred during early respiratory viral 
infections may enhance allergen capture and sensitisation, contributing to allergy 
exacerbations (Holt, P. G. and Sly, P. D. 2002). In addition, allergic airway inflammation and 
viral respiratory infections both induce AHR (Folkerts, G. et al. 2000) and may synergise to 
enhance AHR and associated airway conditions (Makela, M. J. et al. 2002). 
An allergy-like phenotype following viral infection can also be replicated in animal models. 
RSV and parainfluenza-3 (P13) virus infections can recruit eosinophils and enhance IL-5 
secretions (Harrison, A. M. et al. 1999; Scheerens, J. et al. 1999; Schwarze, J. et al. 1999) 
and potentiate RANTES secretions from eosinophils (Lacy, P. et al. 1999). Influenza A viral 
infection, with increased IFN-y production, also enhanced airway inflammation by promoting 
both allergen-specific Thi and Th2 responses, orchestrated, in part, by altered DC function 
(Dahl, M. E. et al. 2004). Thus, it is clear that respiratory viral infections can exacerbate 
airway allergy, through mechanical disruption, exacerbated Th2 cytokine secretions, DC 
manipulation and induction of AHR. 
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Evidence of gastrointestinal viral infections have, however, shown a stronger negative 
association with allergic diseases. For example, fewer allergic symptoms have been observed 
in Hepatitis A virus (HAV) seropositive Italian military students, compared to seronegative 
collegues (Matricardi, P. M. et al. 1997). As described above, a role of HAV and protection 
from allergic manifestations in humans is emerging with interaction of HAV with its receptor 
(huTiml) potentially modifying the Th2 cell pool and preventing the development of asthma 
(Umetsu, D. T. et al. 2002). Recent studies of German and Spanish students found an 
inverse association between Hepatitis B virus (HBV) seropositivity and the development of 
allergic rhinitis, however in this study no association was seen with Hepatitis A, H. pylon or 
herpes simplex virus-1 (Uter, W. et al. 2003). 
HIV-1 infection and the effects on allergic disease outcome are varied. It has recently been 
proposed that HIV-1 shed gp120 virions, are allergenic (Becker, Y. 2004) and can induce IL-
4, Th2 cell differentiation and IgE production. Furthermore, the author also proposes that a 
deviated Th2 response can significantly limit the induction of Thi cells and cytotoxic I cell 
(CTL) responses following anti-viral treatment. However, hypersensitivities to anti-viral drugs 
are more commonly discussed in HIV infected patients (REF- Montero Mora 15237910), 
Marshall 10566099, Dikeacou, 7902154, Carr- 1676034), with multiple drug sensitivities 
reported. 
In conclusion, the association between viral and bacterial infections and the development of 
asthma and allergic diseases is highly variable. Genotypic differences, bacterial and viral 
species variation, timing of infection and the final infection niche are just some of the 
parameters to consider. Tacking a course through the sea of epidemiological and 
experimental literature has uncovered contradictions and diverging mechanistic explanations. 
However, despite the differences, there still appears to be strong evidence for protective 
bacterial and viral pathogens or particles in relation to allergic diseases. 
The exact pathogens and mechanisms remain unresolved, with some of the strongest 
possibilities to date discussed above. Future studies require prospective, long-term birth 
cohort studies, taking into account immunological profiling combined with diagnostic methods 
capable of detecting all common viral and bacterial infections; 
1.1.3.7 Helminth Infections and Allergic Disease 
There is now sufficient evidence, both observational and post-therapy, to support an inverse 
association between chronic helminth infection and overt allergic responsiveness in humans 
(reviewed by (Yazdanbakhsh, M. et al. 2001)). The available data favour an effect mediated 
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by regulation of effector phase mechanisms, with the proto-allergic IgE response remaining 
intact in infected patients. Some of the key findings in recent studies are discussed below. 
Seminal work by Van den Biggelaar (van den Biggelaar, A. H. et al. 2000) compared 520 
Gabonese schoolchildren (5-14 yrs) for skin-prick test (SPT) responses to standard allergens, 
in relation to parasitological data for S. haematobium and filarial nematode infection. Children 
with urinary schistosomiasis had a lower prevalence of skin reactivity to house dust mite 
compared to those free of infection. A critical point is that infected children were strongly 
sensitised to house dust mite allergen (judged by specific IgE) but had lower overt skin 
reactivity. The proposition that helminths down-regulate the effector phase is supported by 
the negative correlation between SPT scores and the parasite-specific IL-10 response in 
infected children. Following this study group further Van den Biggelaar discovered that older 
age-groups who had higher levels of S. haematobium and filarial infections, as well as 
increased mite sensitisation, were in fact lowest in terms of skin test reactivity (van den 
Biggelaar, A. H. et al. 2001). Again this study suggests an immunomodulatory mechanism, 
possibly mediated via IL-b, aimed at the effector stages of an allergic reaction. Recent work 
from the same group(van den Biggelaar, A. H. et al. 2004), conducted in Gabon, has shown 
that removal of Ascaris and Trichuris infections, with long term anthelmintic treatment, results 
in a significant, but transient, increase of atopic reactivity, implying that active infection is 
required for protection from allergic reactivity. 
Selassie and co-workers studied 153 Ethiopians from 17-67 years of age, measuring specific 
IgE for Necator, Ascaris and Der p  1, as well as parasite loads, total IgE and bronchial 
hyperreactivity. They found asthma correlated positively with levels of Der p 1-specific IgE, 
but inversely to infection with Ascaris and/or Necator (Selassie, F. G. et al. 2000). As with 
other studies, the presence of Der p 1-specific IgE was not affected by infection status, again 
implying helminth infection does not alter the generation of atopy but rather its translation into 
asthma. 
Araujo et al (Araujo, M. I. et al. 2000) studied Brazilian patients with chronic, heavy 
S.mansoni infections as judged by egg excretion (> 200 eggs I gram of faeces). While 24% of 
uninfected controls were skin-test positive to house dust mite allergen, this figure was below 
5% in chronically infected individuals, demonstrating again a strong inverse association 
between infection and atopy. In this study, however, uninfected individuals mounted a greater 
allergen-specific IgE response, indicating that both sensitisation (allergen-specific IgE 
production), and reactivity can be compromised in infection. Furthermore, the severity of 
allergic symptoms, use of anti-histamines and pulmonary complaints were lowest in patients 
with chronic S. mansoni infections, compared to other asthmatic subjects (Medeiros, M., Jr. et 
al. 2003). 
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In Venezuela, Lynch and co-workers reported a higher incidence of allergic reactivity in 
residents of low helminth transmission areas than in those exposed to high transmission 
intensities. When children were anthelmintic treated, they showed increased allergen-specific 
IgE and SPT-manifested skin allergy (Lynch, N. R. et al. 1993). Thus, not only does infection 
repress atopy, but removal of helminth infection results in the reappearance or introduction of 
allergic reactivity. These studies are some of the most influential, examining helminth-allergy 
interactions and confirm the inverse association between helminth infection and allergy. 
Thus, it is clear that despite IgE sensitisation to aeroallergens, helminth-infected individuals 
are somehow protected from mast cell degranulation and inflammation. Cooper and 
colleagues (Cooper, P. J. et al. 2003; Cooper, P. J. et al. 2004) working in Latin America, 
found similar inverse associations with geohelminth infection and allergen reactivity in skin 
tests, with protection from allergy in children associated with anti-Ascaris lgG4 antibodies, 
suggesting that a modified Th2' response is present in non-reactive subjects. 
The majority of other studies support these general conclusions. For example, Nyan (Nyan, 
0. A. et al. 2001) reported from a large study (693 adults) in rural and urban areas of The 
Gambia, an inverse association between skin-test reactivity and the presence of intestinal 
helminth (Ascaris or hookworm) infection. They correctly pointed out that this finding would 
also result if atopic individuals had a higher level of anti-parasite immunity. Thus, the 
comparison of sensitisation versus allergic symptoms is needed to discriminate, because if 
atopy is protective against parasites, sensitisation rates would be higher in uninfected 
individuals. 
Scrivener's work in rural Ethiopians argues indeed that in high-intensity infections, Der p  1 
sensitisation rates remain high among non-atopics, again suggesting only effector phases are 
down-modulated by parasitism (Scrivener, S. et al. 2001). Work in a similar region by Dagoye 
and collegues (Dagoye, D. et al. 2003) found similar helminth associated protection of 
children in rural and urban Ethiopia. These authors propose that higher allergy incidence in 
urban Ethiopians (measured as wheeze) is due at least in part with the loss of the protective 
effect of hookworm infection. 
However, not all studies of helm inth-allergy interactions have concluded with an inverse 
association. Lynch and co-workers reported in a separate study that clinical improvement of 
asthma could be achieved with anthelmintic (albendazole) treatment for a year, compared to 
untreated controls (Lynch, N. R. et al. 1997). Thus, there are contexts in which helminth 
infection can actually exacerbate allergic symptoms. This may be due to their migratory 
pathway, many travelling through the pulmonary system, with consequent local inflammation 
and airway trauma, or indirectly via potentiation of allergic reactivity to allergens. Quite 
possibly, as suggested previously (Hagel, I. et al. 1993) (Cooper, P. J. 2002), occasional or 
short-lived infections may be more pro-allergic, while frequent or chronic infection may build 
up sufficiently to generate a suppressive effect. 
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In summary, the wealth of data from human studies sets out an enticing scenario in which 
helminth infections keep allergies at bay, but as with many epidemiologically-based systems, 
experimental models must be tested if we are to distinguish cause from consequence in these 
two complex immunological responses. 
1.1.3.8 Model Systems of Helminth Infection and Allergic Airway 
Inflammation. 
Model systems offer great opportunities to dissect the interplay between pathogens and 
allergic disease. While the suppressive influence of mycobacteria, for example, has been well 
established in animal models of Th2-type allergic lung inflammation (Erb, K. J. et al. 1998) 
(Wang, C. C. and Rook, G. A. W. 1998; Yang, X. et al. 1999; Hopfenspirger, M. T. and 
Agrawal, D. K. 2002; Zuany-Amorim, C. et al. 2002; Zuany-Amorim, C. et al. 2002) studies on 
helminth parasites at this level have only recently been initiated. Nevertheless, recent data 
now provide experimental evidence for mitigation of allergic outcomes by helminth infections. 
Among the first reports, Wang et a! (Wang, C. C. et al. 2001) infected mice with two doses of 
the human parasite Strongyloides stercoralis, which produces a short-lived tissue infection. 
Mice sensitized to ovalbumin (OVA) shortly after the second infection showed greatly reduced 
allergen-specific IgE production. At the effector level, asthma-like responses can be 
measured in terms of cytokine secretion and leukocyte exodus into the bronchoalveolar 
lavage fluid (BALE) following intratracheal challenge with specific allergen. S. stercoralis 
infected mice showed reduced eotaxin secretion, but no overall change in pulmonary 
eosinophilia or the local recruitment of other lymphocytes in the BAL fluid. 
Because S. stercoralis introduces an abortive and highly immunogenic infective episode, its 
effects may be less far-reaching than a long-lived chronic infection; nevertheless these data 
show significant inhibition on components of both the sensitisation (IgE) and effector (eotaxin) 
phases. 
Bashir et a! (Bashir, M. E. et al. 2002) showed that allergic responses to a food allergen (from 
peanut) is down-modulated by infection with the gastrointestinal nematode H. polygyrus; both 
allergen-specific lgE and IL-13 were inhibited, but the whole effect was reversed in animals 
given anti-IL-10. This implicates a suppressive mechanism involving an immunoregulatory 
pathway. These results indicate ablation of both sensitisation and effector mechanisms. As 
discussed above, IL-13 is a crucial initiator of allergic responses in mice including airway 
mucus production, and IL-10 -is pivotal in its inhibitory effects in experimental allergy. 
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Most recently, Wohlleben and collegues (Wohlleben, G. et al. 2004) showed that airway 
allergy, including airway eosinophilia, eotaxin levels and OVA-specific IgE and IgGi in BALE, 
was suppressed with chronic (4 week and 8 week pre-challenge) but not acute (1 week and 2 
week pre-challenge) Nippostrongylus brasiiensis infections, pre OVA challenge. This effect 
was attributed to IL-b, with increased CD4 lL-10 1-cells in BAL fluid of chronically infected 
OVA-challenged mice. IL-10 deficient animals showed no signs of protection with infection. 
This is the first experimental study to support a regulatory mechanism generated during 
helminth infection, with the capacity to down regulate airway allergy. 
One study has gone so far as to demonstrate that helminth products can modulate allergic 
disease, without the presence of live infection. Inhibition of lung inflammation and hyper -
responsiveness was observed following Ascaris suum extract implants (Lima, C. et al. 2002). 
Suppressed IL-4, IL-5 and Eotaxin in the BALE may help to explain such an inhibitory effect, 
however IgE and lgG levels were also significantly decreased in both serum and BALE. Such 
experiments promise to quickly elucidate candidate modulators with potential to dampen 
allergies in vivo. 
Importantly, not all experimental helminth infections modulate allergic disease. Under 
conditions of existing elevated IL-4 and IL-5 and consequent IgE and localised eosinophilia, 
an incoming wave of helminth larvae migrating through the respiratory system may 
exacerbate airway hyperresponsiveness (Silveira, M. R. et al. 2002; Negrao-Correa, D. et al. 
2003). As with the human situation, a key distinction may lie between acute and chronic 
helminth infections, and the extent to which the allergic state pre-exists at the time of parasite 
invasion. 
1.2 Helminth infections and immune regulation 
Helminths are long-lived, multicellular parasites, which induce strong and characteristically 
trammelled immune responses in their hosts. The common features of helminth infections are 
the slow accumulation of parasite burdens, the prevalence of chronic infection, and the 
primary role of the immune response in pathology. 
The parasite-specific immune response is well described as being overwhelmingly polarised 
towards the Th2 phenotype (Sher, A. E. and Coffman, R. L. 1992; Maizels, R. M. et al. 1993; 
Pearce, E. J. and MacDonald, A. S. 2002) Immunocompetent hosts typically secrete IL-4, IL-
5, IL-10 and IL-13 from polarised 1-cells with mobilisation of effector cells such as mast cells 
and granulocytes (basophils, neutrophils and eosinophils) to the site of parasite encounter. 
Immunity to GI helminth infection in humans is not well understood, however, parasite 
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expulsion is thought to involve immune-mediated mechanisms acting on non-immune cells 
within the intestinal tract (Reviewed in (Hayes, K. S. et al. 2004)). How these events manifest, 
the immunology of murine GI helminth infections and more interestingly how these effector 
mechanisms are avoided and manipulated by GI helminths will be discussed in relation to 
experimental infections, focusing, where possible, on Heligmosomoides polygyrus, a natural 
Cl helminth of mice. 
1.2.1 Polarised Th2 responses in GI-helminth infections. 
Excretory-secretory glycoproteins from the potent Th2-inducing gastro-intestinal nematode, 
N. brasiiensis, ( NES) have allowed Holland and colleagues to dissect some of the key 
features of initial Th2 induction by helminths. Using mice deficient in B-cells, MHC class I or 
IL-5, they have shown that at least these factors are not required for Th2 induction (Maizels, 
R. M. et al. 2004). Furthermore, NES actively induces a Th2-inducing phenotype in DCs 
(Balic, A. et al. 2004). Th2 'development requires IL-4 (Abbas, A. K. et al. 1996), with 
basophils or eosinophils (Voehringer, D. et al. 2004) possibly providing the initial IL-4 
'gesture' require for DC's to polarise a Th2 response. 
Unlike Thi induction, DCs polarising towards a Th2 phenotype are proving harder to 
characterize, with an unenthusiastic proposition that Th2 induction is a default pathway in the 
absence of sufficient Thi induction (Default hypothesis) (Jankovic, D. et al. 2001). The 
involvement of CD86, OX40L and IL-6 appear to be important (Ekkens, M. J. et al. 2003; 
Balic, A. et al. 2004), however, the precise mechanisms are unresolved. The ubiquity of Th2 
responses to helminths suggests that an innate recognition system exists to detect these 
parasites and initiate the type-2 pathway; however, no helm inth-specific molecular patterns 
have yet been identified. 
The importance of Th2 responses for protective immunity to GI helminths, however, is clear 
(Finkelman, F. D. et al. 1997; Morimoto, M. et al. 2004). 
Depletion of CD44 T cells (Urban, J. F., Jr. et al. 1991) or neutralising IL-4 (Urban, J. F., Jr. et 
al. 1991), but not IL-5 (Finkelman, F. D. et al. 1997), during challenge H.polygyrus infections, 
or N. brasiiensis infection (Katona, I. M. et al. 1988) severely amputates effective immunity, 
promoting a Thi response with higher levels if IFN-'y. Additionally, mice chronically infected 
with H.polygyrus and given an IL-4 formulation, boosting IL-4 levels, can cure an otherwise 
chronic infection (Urban, J. F., Jr. et al. 1995). 
IL-13 shares many functional and structural properties, as well as receptor complexes with IL-
4 (Grencis, R. K. and Bancroft, A. J. 2004). Not surprisingly, IL-13 is important in Cl helminth 
infections, with persistence of infection, in otherwise resistant mice, being one of the earliest 
phenotypes observed in lL13 deficient mice (McKenzie, C. J. et al. 1998). Interestingly, 
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during H.polygyrus infection IL-13 is down-modulated (Finkelman, F. D. et al. 2000), a 
possible mechanism of survival. 
The precise mechanism of GI helminth expulsion remains unclear and differs between GI 
helminth species, despite similar immune profiles. Th2 cytokines (Urban, J. F., Jr. et al. 1998) 
and nitric oxide (Ben-Smith, A. et al. 2003) acting on mucosal mast cells (Finkelman, F. D. et 
al. 1997; Ben-Smith, A. et al. 2003), epithelial cells and goblet cells, invoke physiological 
reactions including increased smooth muscle contractility (Finkelman, F. D. et al. 1997; Zhao, 
A. et al. 2003), small intestine permeability and mucus hypersecretion from goblet cells 
(McKenzie, G. J. et al. 1998). Mast cells and goblet cells play a central role in parasite 
expulsion. IL-9 is important in the production of mucosal mast cell responses and the 
production of lgE during intestinal helminth infections (Faulkner, H. et al. 1997). Primary 
infections with H.polygyrus in IL-9 transgenic mice, results in complete expulsion by day 21, 
where as wild type litter mates harbour chronic infections (Hayes, K. S. et al. 2004). Taken 
together these data suggest an IL-9 and mast cell mediated mechanism of H.polygyrus 
expulsion. 
Recently, Benn-Smith and colleagues (Ben-Smith, A. et al. 2003), observed the involvement 
of both Thi and Th2 responses in H.polygyrus expulsion in fast responder' mice. However, 
the necessity of the Thl response or possible involvement of commensal bacteria in their 
experiments may confound the role of Thl cells. 
Eosinophils, often thought of as anti-helminth effector cells, are not so important in parasite 
expulsion. Anti-IL-5 mAb treatment, to ablate eosinophils, did not prevent H.polygyrus 
expulsion (Urban, J. F., Jr. et al. 1991), suggesting that eosinophils are not the major effector 
mechanism involved in adult parasite expulsion, but rather as effector cells against larval 
stages (Herbert, D. R. et al. 2000). Th2 induction in helminth infections incites a sizeable 
lgGl and IgE response with passive transfer experiments of purified IgGi protecting mice 
from H.polygyrus infection (Pritchard, D. I. et al. 1983). Furthermore, i. chain deficient mice, 
which lack B-cells, develop a more severe secondary infection (Finkelman, F. D. et al. 1997), 
suggesting that antibody responses or B-cells themselves are an important factor in 
controlling H.polygyrus infection. 
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Thus, Th2 responses are protective against CI helminths (Urban, J. F. et al. 1992), where as 
tissue dwelling helminths, may require a more complex battery of both type-1 and type-2 cell-
mediated mechanisms, such as activated macrophages and granulocytes (Al-Qaoud, K. M. et 
al. 1999; Ben-Smith, A. et al. 2003), with the Th2 response restraining immunopathology 
(Pearce, E. J. et al. 1996; Hoffmann, K. F. et al. 2000). Alternatively, it is possible that Th2 
responses actually benefit certain helminth parasites, particularly in the tissues, and that 
some species have evolved the capacity to enhance this arm of the immune response. 
Most in-bred strains of mice do not rapidly expel H.polygyrus, allowing chronic infections to 
persist in the face of a highly polarised Th2 response (Svetic, A. et al. 1993; Wahid, F. N. et 
al. 1994). The chronicity of infection, in immunocompetent mice, suggests that 
immunomodulatory properties of H.polygyrus can suppress effector mechanisms, achieving 
survival for the parasite and reducing immunopathology for the host (Hoffmann, K. F. et al. 
2002). 
1.2.2. Helminth induced Immune regulation. 
Inherent regulation of potentially hazardous peripheral immune responses ensures only 
controlled responses arise. A robust Th2 response seen in helminth infections must therefore 
have sufficient resolving mechanisms to avoid immunopathology. Despite many pathological 
conditions observed in helminth infections (Schistosomiasis (Hoffmann, K. F. et al. 2002) and 
filariasis (Yazdanbakhsh, M. 1999)) most chronic infections remain asymptomatic (Maizels, R. 
M. et al. 2004). 
Many chronic infections, both microbial and parasitic, induce forms of immune suppression or 
down-modulation (Karp, C. L. et al. 1996; Erb, K. J. et al. 1998). Restraining Th2 responses 
may be the prime objective observed in the recently described 'modified Th2 response' 
(mentioned earlier in the context of cat allergen exposures) a phenomenon that is also seen 
in helminth infections. Asymptomatic, but still highly infected, filariasis patients mount a strong 
lgG4 response with lower levels of IgE, compared to symptomatic patients with higher lgE 
and lower lgG4 (Maizels, R. M. et al. 1995). These effects can be induced by changes in 
cytokine balances, with IL-10 differentially regulating lgG4 and IgE (Jeannin, P. et al. 1998) 
as well as suppressing T-cell proliferation (Joss, A. et al. 2000). 
Effector cytokines are down modulated during chronic helminth infection, with depressed IL-5 
(Sartono, E. et al. 1997) and the cleavage of Eotaxin (Culley, F. J. et al. 2000), presumably 
reducing eosinophil recruitment and attenuating anti-larval responses. Similarly, IL-8 and 
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TNF-a secretions (van der Kleij, D. et al. 2004) are depressed during human S. haematobium 
infections, possibly reducing neutrophil recruitment. From a parasite perspective, to sever 
communication between cells may be one relatively simple yet effective way of disabling 
effector responses. Alternatively, the host may use similar mechanisms to rapidly down 
regulate and switch off responses, preventing immunopathology. 
Elegant work by Wynn and colleagues have identified such a mechanism, involving the decoy 
receptor for IL-13, IL-13Ra2. The importance of IL-13 in the fibrotic process following egg 
deposition in the liver during S. mansoni infections has been clearly identified (Chiaramonte, 
M. G. et al. 1999). Therapeutic treatment with a soluble receptor for IL-13, slL-13Ra2, 
blocking the effects of IL-13, significantly reduced liver fibrosis. Furthermore, IL-13Ra2 
deficient mice develop significant exacerbations of fibrosis, which could be reversed by 
restoring IL-13Ra2, confirming that exacerbated fibrosis was indeed due to heightened IL-13 
activity (Chiaramonte, M. G. et al. 2003). Finally, elevated levels of IL-13Ra2, have been 
found in the sera of S.mansoni infected mice and Ugandan patients harbouring chronic S. 
mansoni infections (Mentink-Kane, M. M. et al. 2004), representing another modification to 
the Th2 response. Taken together, IL-13Ra2 and other, as yet undiscovered, cytokine or 
chemokine decoy receptors represent a novel and exciting area involved in immune 
regulation. 
Maizels and Yazdanbakhsh propose that these modified Th2 mechanisms regulating within 
the Th2 framework may represent a 'mature' Th2 response, regulating immunopathology and 
providing 'stop' signals to an ambitious immune response. 
Th2 (T-helper type 2) responses are by definition T-cell mediated responses. Thus, sufficient 
control of T-cells would represent an essential component of an immunoregulatory network. 
Helminth infections strongly modulate immune responses to parasite antigens, with 
substantial evidence of T cell hyporesponsiveness in helm i nth-i nfected individuals (reviewed 
in (Maizels, R. M. et al. 1993))(Satoguina, J. et al. 2002). The second coming of suppressor 
or regulatory T-cells (T-reg) has spilt over into helminth immunology, with evidence of 
peripheral T-reg populations. Briefly, many Treg populations suppress effector T-cell 
activation via secretion of IL-10 and for TGF- (Joss, A. et al. 2000). The function and 
diversity of these cells will be discussed in more detail below. 
T cell hyporesponsiveness in filarial (Mahanty, S. et al. 1997; Doetze, A. et al. 2000; 
Satoguina, J. et al. 2002) and S. haemafobium ( King, C. L. et al. 1996) infected patients can 
be reversed in-vitro with antibodies to IL-10 and /or TGFI3, suggesting a Treg component in 
these infections. 
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Direct measures, and identification of Treg activity during experimental fungal (Montagnoli, C. 
et al. 2002; Netea, M. C. et al. 2004) viral (Dittmer, U. et al. 2004); (MacDonald, A. J. et al. 
2002); (Suvas, S. et al. 2003) protozoan (Belkaid, Y. et al. 2002; Hisaeda, H. et al. 2004; 
Mendez, S. et al. 2004) and bacterial (McGuirk, P. et al. 2002; Lundgren, A. et al. 2003) 
infections have also been reported. Interestingly, most report that removal of, or inhibition of 
Treg cells lead to effective clearance of infection and restoration of antigen specific activity, 
providing direct evidence of dampened effector responses by Tregs during infection. 
Evidence of Tregs in helminth infections is accumulating: for example, an active Treg 
compartment is observed in S. mansoni infections. Hesse and colleagues (Hesse, M. et al. 
2004) used elegant adoptive transfer experiments using IL-10/RAG-2 KO mice to 
compartmentalise the source of IL-10 during S. mansoni infection. They found that 
CD4CD25 Treg cells and innate cells produced IL-10, regulating Th2 development, 
pathology and ultimately survival. McKee and colleagues (McKee, A. S. and Pearce, E. J. 
2004) further identified that both Treg cells and Th2 cells generated during S.mansoni 
infections regulate Thi development and immunopathology. Regulation of immunopathology 
during S. mansoni infection, however, is not restricted to T-cells. B-cells are also important 
regulators of pathology. Unlike wild type mice, [LMT and FcRy chain deficient mice do not 
down-modulate egg-induced granulomas, during S. mansoni infections (Jankovic, D. et al. 
1998), implying that antibody responses or B-cells themselves play an important role in 
regulating T-cell mediated inflammation. 
The chronicity of helminth infections, particularly Cl helminth infections, and the above 
mentioned profound changes in immune function, would suggests that Treg populations 
operate during Cl helminth infections. Few reports conclusively identify T-cells with regulatory 
function in Cl helminth infections. Wohileben and colleagues, reported a population of 
CD4CD25iL10 T-cells in the BAL fluid of mice infected with N.brasiliensis. 
However, these cells also secrete IL-4, suggesting that they may be, or at least contaminated 
with, activated Th2 cells. 
Forkhead box p3 (Fox p3) programs Treg development (Fontenot, J. D. et al. 
2003)(discussed further below) and has been observed in H.polygyrus infection (Elliott, D. E. 
et al. 2004). However, characterisation of Treg cells or evidence of the suppression of effector 
T-cells was not confirmed in this study. 
To my knowledge, no other studies have conclusively demonstrated an active Treg 
compartment in GI helminth infections. Treg-associated effects, however, are plentiful, 
particularly the involvement of IL-10 and TGF-P during infection (Sher, A. F. and Coffman, R. 
L. 1992). Schopf and colleagues (Schopf, L. R. et al. 2002 (helminth)) identified the critical 
role of IL-10 in Th2 development and resistance, presumably by suppressing IFN-y and IL-12 
induced Thi development, and the maintenance of colon barrier function during T.muris 
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infection. Furthermore, mice deficient in IL-1 production show increased fatalities following 
T.muris or S. mansoni infections (Wynn, T. A. et al. 1998). 
During T.spiralis infection of mice; IL-10 appears to have contrasting functions throughout 
infection. During larval stages, IL-10 appears to dampen host responses, with the later 
requirement of IL-10 for successful expulsion (Helmby, H. and Grencis, R. K. 2003). This 
particular study highlights the diverse function of IL-10, with the ability to promote Th2 
response by suppressing IFN-y (Hoffmann, K. F. et al. 2000), along with the common 
description of IL-10 as a general suppressive cytokine of both Thi and Th2 effector T-cells 
(Joss, A. et al. 2000) (reviewed in (Mocellin, S. et al. 2003)). 
The literature is abound with evidence of critical roles of IL-10 during schistosome infections. 
Whether from Treg cells or innate cells, as described above, IL-10 critically regulates 
granuloma organisation as well as size and ultimate severity (Sadler, C. H. et al. 2003). 
Generation of peripheral Tregs was previously thought to develop from long standing chronic 
infections. However, acute and even initial antigen encounter may be accompanied by Treg 
action. Induction of regulatory T-cells, may lie in the cytokine environment, with IL-10 or TGF-
3 (Nakamura, K. et al. 2004; Schramm, C. et al. 2004) inducing Tregs and creating a broad 
suppressed state in the host. Signals during helminth infections may promote a regulatory 
environment. One such example is the capacity of lysophosphatidylserine, a lipid fraction 
derived from S. haematobium, to stimulate DC's and convert naïve T-cells into IL-10 secreting 
T-cells (van der Kleij, D. et al. 2002), providing a framework of helminth induced regulatory 
responses, rather than host initiated. 
Helminth-derived molecules with immunomodulatory properties have been reported from 
several experimental systems (reviewed in detail in (Maizels, R. M. and Yazdanbakhsh, M. 
2003)). IMF, an Immunomodulatory factor' isolated from H.poiygyrus, has the ability to inhibit 
IgE, IgGI and lgG4 production in a T-cell dependant manner (Telford, G. et al. 1998 
(helminth)). Similarly, ES-62, a filarial secreted glycoprotein has recently been shown to 
modulate B-cell function, rendering them hyporesponsive to BCR stimulation (Wilson, E. H. et 
al. 2003). These studies highlight the ability of helminth derived products to modulate both 
arms of the adaptive response. 
Thus, the immune response, whether converted into a regulatory unit or suppressed directly 
by parasite-derived molecules, is altered during helminth infection. In a two dimensional 
model these modifications, as mentioned above, develop to aid survival of the parasite and 
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limit pathology for the host. Adding a further dimension to this model and introducing other 
immunological stresses on the host has uncovered an array of transformed responses. 
1.2.3 Altered immunological responses during helminth infection. 
Is helm inth-associated immune suppression strictly antigen-specific, or is there a systemic 
effect, down-modulating the response to bystander antigens or other infectious episodes? 
Regulation of non-antigen specific responses has indeed been reported in both protozoal 
parasite infections (Sternberg, J. M. and Mabbott, N. A. 1996) and, as detailed below, in a 
number of different helminth parasitisms. 
Earlier human studies identified instances in which helminths either alleviate or aggravate the 
consequences of bystander infections. In 1977, Murray et a! reported on two neighbouring 
Camorron, Islands, one of which had high Ascaris infections and little cerebral malaria in 
comparison to the other (Murray, M. J. et al. 1977). Remarkably, half of the asymptomatic 
group infected with Ascaris suffered clinical malaria attacks following anthelmintic treatment 
(Murray, J. et al. 1978). More recent studies have strengthened this association between 
gastrointestinal nematode infection and protection from cerebral malaria (Nacher, M. et al. 
2000; Nacher, M. et al. 2001). Protection from pathology occurs without any diminution in 
parasitaemia, suggesting that effector stages, rather than sensitisation events, are most 
affected. 
Parallel evidence stems from the response of infected individuals to antigen challenge during 
routine vaccination. One example is the ablated response to tetanus toxoid (TT) immunisation 
in S,mansoni-(Sabin, E. A. et al. 1996) and O.volvu!us-(Cooper, P. J. et al. 1998) infected 
patients and response to Cholera vaccine in Ascaris (Cooper, P. J. et al. 2001) infected 
patients. In the former case, the IFN-y response to TT was inversely correlated with infection 
intensity, although Th2-type responses remained intact. Onchocerciasis patients were 
likewise depressed in their IFN-y response to the antigen, but significantly mounted an IL-10  
response not seen in uninfected individuals. Ascaris-infected patients showed similar 
reductions in IL-2 response to cholera toxin. 
The impact of HIV infection on helminth-infected individuals has been a focal interest. In 
Ethiopian subjects migrating to Israel, HIV plasma viral load correlated with helminth burden 
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and impaired cellular immune responses to HIV and a Purified Protein Derivative of tuberculin 
(PPD)(Borkow, C. et al. 2001). As cellular immunity recovered after anthelmintic treatment, 
parasite infection rather than HIV itself appeared to be responsible for the depressed immune 
function, which arguably disabled defences against HIV in the same individuals. 
Experimental studies in rodents abound with examples of profound immune dysfunction in 
helminth infections. A systemic Th2 bias is often found, as demonstrated with model antigens 
such as myoglobin in S. mansoni-infected mice (Kullberg, M. C. et al. 1992). Functionally, 
S.mansoni-infected mice are impaired in vaccinia virus clearance, with poorer cytotoxic T-
lymphocyte (CTL) responses and type-1 cytokine production (Actor, J. K. et al. 1993), while 
N. brasiliensis infection delays the rejection (averaging 32 days versus 10 days in controls) of 
allogeneic kidney grafts (Ledingham, D. L. et al. 1996). Similarly, N. brasiiensis drives Th2 
differentiation of DOl 1.10 transgenic TCR-bearing, ovalbumin-specific T cells in infected mice 
(Liu, Z. et al. 2002), and can also provoke tolerant I cells into IL-4 responsiveness to 
Staphylococcal enterotoxin (ROcken, M. et al. 1992). Particularly profound antigen-non-
specific immuno-suppression is associated with H. polygyrus, for example depressing 
antibody responses to sheep red blood cells compared to uninfected littermates (Ali, N. M. 
and Behnke, J. M. 1984). 
A key finding has been that nonliving parasite extracts or secreted products can induce 
similar switches in the immune system (Ledingham, D. L. et al. 1996; Holland, M. J. et al. 
2000; Goodridge, H. S. et al. 2001; Paterson, J. C. et al. 2002; Boitelle, A. et al. 2003). This 
strongly suggests that active immunomodulators are being produced, either to generate a 
less damaging Th2 response, or as illustrated by the action of Ascaris pseudocoelomic body 
fluid (ABF), to induce production of IL-10 (Paterson, J. C. et al. 2002). 
The elucidation of the molecular nature of these modulators, and the pathways by which they 
effect their functions, will provide exciting new leads for understanding parasite immunology, 
perhaps offering new immunomodulators for therapeutic use. 
Animal models of autoimmune diseases are among the most defined and instructive in 
medical science: they have led to clear identification of target epitopes, reactive populations 
and pathogenic mechanisms. These models are ideal settings to study the impact of infection, 
with a spectrum of possible outcomes, depending on infectious agent and disease model 
used. Several key studies have highlighted the suppression of autoimmune disease in 
helminth infection systems. 
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In experimental autoimmune encephalomyelitis (EAE), the subcutaneous injection of CNS 
antigens leads to localised CNS inflammation, demyelination and progressive paralysis, 
modelling human multiple sclerosis. The disease is strikingly modified in the presence of 
helminth infections (Sewell, D. L. et al. 2002). In the most detailed study thus far, Sewell and 
co-workers elegantly show that treatment of mice, either before or after induction of EAE, with 
S.mansoni ova reduces the degree of muscle paralysis and inflammatory cell infiltration into 
CNS tissue, white switching the cytokine profile from predominant IFN-y to IL-4 (Sewell, D. et 
al. 2003). 
The principal model for diabetes is the non-obese diabetic (NOD) mouse, which is reported to 
show lower frequencies of diabetes in "dirty" animal houses (Bach, J. F. 2002). Infection of 
NOD mice with S.mansoni reduces incidence of autoimmune disease by approximately 50%. 
This may be attributed to a systemic shift towards Th2 responses as the same effect can be 
achieved by injection of the strongly Th2-inducing S. mansoni eggs (Cooke, A. et al. 1999), or 
even nonliving parasite extract (Zaccone, P. et al. 2003). 
Inflammatory bowel disease or colitis, such as human Crohn's disease, is an interesting 
syndrome which sits at the cusp of autoimmunity and allergy: essentially this is an 
inflammatory reaction to harmless commensal gut flora, with all the consequences of an 
autoimmune disease although in fact the antigenic target is an extraneous organism. In a 
trinitrobenzesulphonic acid (TNBS) model of Crohn's disease administration of 10,000 dead 
S.mansoni ova deviated the cytokine response of splenic and mesenteric lymph node cells, 
with impeded IFN-y production and enhanced IL-4, while reducing mortality from 68% to 28% 
(Elliott, D. E. et al. 2003). In essentially the same model, DNBS-induced colitis, evidenced by 
macroscopic and microscopic changes to colonic architecture and cell infiltration or loss, was 
significantly reduced in mice previously infected with the intestinal nematode T. spiralis 
(Khan, W. I. et al. 2002). In this system, modulation of immunopathology coincided with 
increased polyclonal IL-4 and IL-13, and decreased IFNLy. 
It may be significant that in this system, parasite infestation in the gut is relatively short-term, 
so that protection against pathology may have outlived the infection itself. 
A similar case of exogenously-induced autoimmune type pathology is found in mice, infected 
with Helicobacter, which develop Thi mediated gastritis and gastric atrophy. In this model for 
gastric ulcer and carcinoma formation in humans, mice concurrently infected with H. 
polygyrus display a protective immune deviation with enhanced type 2 cytokines and lower 
gastric levels of mRNA for the inflammatory cytokines IFN-y, TNF-a and IL-1f3 (Fox, J. G. et 
at. 2000). Moreover, immune deviation in this model is accompanied by elevation of the 
immunomodulatory cytokines IL-10 and TGF-3. 
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Interestingly, uninfected IL-10 KO mice spontaneously develop severe colitis due to failure to 
suppress bacterial-reactive T cells, with fatal consequences (Berg, D. J. et al. 1996). 
However, it has been reported that such animals can be rescued by infection with H. 
polygyrus or T. muris, indicating that parasites can induce an IL-10-independent route to 
block immunopathology in vivo (Elliott, D. E. et al. 2000). 
Is there a common theme to these protective effects of helminths against auto-immunity? 
One probable mechanism could be a simple Th2 polarisation (Elliott, D. E. et al. 2003), 
supported by the finding that S.mansoni egg-induced-protection of EAE was dependent on 
STAT-6 (Sewell, D. et al. 2003). Perhaps, however, the link to IL-10 and TGF-3 most evident 
in the H. polygyrus system (Fox, J. G. et al. 2000; Elliott, D. E. et al. 2004) hints at activation 
of a regulatory pathway. It would be instructive to test the impact of such parasites on Th2-
associated autoimmune disease models, as exacerbation of autoimmunity would indicate 
amplification of Th2 polarisation, while a protective effect would argue for expansion of 
regulatory mechanisms in a manner possibly analogous to protection against allergy. 
As with allergy models, there are few reports of isolated parasite antigens exerting any effect 
on the regulation of autoimmunity. One such example is a product from the filarial parasite 
Dirofilaria immitis, described as rDiAg (lmai, S. et al. 2001) and a homologue of the nematode 
polyprotein allergen family (Kennedy, M. W. 2000). Administration of this protein, expressed 
in bacteria, elicits non-specific IgE production and when given to 6-week old NOD mice 
completely prevented the onset of insulitis and diabetes (lmai, S. et al. 2001). Further testing 
of this product in other autoimmunity models, and comparison with control proteins expressed 
in similar vectors, would confirm the significance of this finding. 
While the forces which generate an effective Th2 and regulatory T cells (Tregs) have yet to 
be defined, it is clear that the immunological environment created by helminth infections has a 
major impact on concurrent responses to third party antigens, whether from other pathogens, 
allergens or autoantigens. Can helminth infection shift the whole foundation of the immune 
response towards a Th2 or a Treg mode, to establish an altered immunological state? If so, 
can such an altered state lead to lower susceptibility to allergies, autoimmunity and other 
immunopathologies? Finally, what can we learn of the control processes inherent to the 
immune system from these observations? 
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1.3 Mechanisms of Helm i nth -associated Protection from Allergies 
Several contending hypotheses are available to explain how infections in general, or helminth 
infections in particular, could down-regulate allergies and inflammatory disorders. Before 
discussing specific alternative postulates, one should consider whether a simple homeostatic 
model (Barthlott, T. et al. 2003) could account for the observed features of helminth 
modulation. This supposes that if the immune system has a predetermined capacity for 
responsiveness, then infection would distract from a proto-allergic (or autoimmune) pathway, 
restraining it below the threshold of pathology. Mechanistically, this could operate at the level 
of competition between two simultaneous responses (one to pathogen, one to allergen) for 
cytokines, growth factors, or suitable physical niches within lymphoid tissue, of antigen-
specific peripheral T-cell populations (Stockinger, B. et al. 2001). Future experimental work 
will need to address this issue. 
A second generic model for down-regulation in infection arises from the sustained high 
antigen levels associated with chronic parasitism. With repeated transmission of infective 
stages and long-lived adult worm populations, humans in endemic areas suffer a scenario of 
continuous antigen exposure. One outcome may be repeated generation of pro-inflammatory 
signals, perhaps leading to chronic pathology such as elephantiasis or hepatosplenic 
schistosomiasis. Conversely, continuous stimulation may create counter-regulatory conditions 
such as receptor down-modulation on individual cells, or more complex suppression through 
regulatory T cell populations. In these ways, the host immune system could reach a 
compromise to minimise pathological damage at the cost of accepting long-term parasitism. 
Any such regulatory mechanism must operate against both antigen-specific and non-specific 
inflammatory responses, to explain the anti-allergic effects described above. 
1.3.1 Direct mechanisms and interference 
Mast cells are well recognised as playing a principal role in acute and systemic allergic 
responses such as atopic asthma, allergic rhinitis and anaphylaxis (Williams, C. M. and Galli, 
S. J. 2000; Williams, C. M. and Galli, S. J. 2000). Helminths clearly activate these cells, as 
described above in the case of N. brasiiensis and T. spira/is infections (Dehlawi, M. S. et al. 
1987; Yamaguchi, M. et al. 1999) and the phenotype associated with parasite expulsion 
(Knight, P. A. et al. 2000; McDermott, J. R. et al. 2003). In contrast, chronic infections of mice 
with H. polygyrus display a reduced mast cell accumulation in the intestinal epithelium and 
lamina propria, and this depression pertains even in animals co-infected with N. brasiiensis 
or T. spiralis which individually stimulate mastocytosis (Dehlawi, M. S. et al. 1987). If chronic 
nematode infections can down-regulate mast-cells, this would provide a satisfactory model for 
amelioration of allergy. 
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The other effector cell with prominence in allergy is the eosinophil (Hamelmann, E. and 
Gelfand, E. W. 2001), strongly associated with asthma in humans. Eosinophil-deficient mice 
(lacking IL-5) do not develop airway hypersensitivity following standard sensitisation protocols 
(Hamelmann, E. et al. 1999). Helminths have long been known to elicit peripheral 
eosinophilia (Brown, T. R. 1898), and eosinophils are able to kill migrating larvae of many 
helminth species - particularly in a non-natural host (Meeusen, E. N. T. and Balic, A. 2000). 
Indeed, the human filarial nematode Brugia malayi induces eosinophil-dependent airway 
allergy in mice (Hall, L. R. et al. 1999). Why then do helminth infections not exacerbate 
allergies by activating eosinophils in the human population? Perhaps in the natural host, 
helminths have evolved specific mechanisms to defuse innate immune attack from cells such 
as the eosinophil (Culley, F. J. et al. 2000), and such de-activation may spill over to minimise 
allergic outcomes. In S.mansoni infection, lung stage schistosomula produce prostaglandin 
E2, which stimulates IL-6 production from lung epithelial cells, in turn down-modulating 
eosinophilia and other leukocyte recruitment (Angeli, V. et al. 2001). On a general note, not 
all eosinophils are pro-inflammatory, and it is possible that in an environment rich in down-
modulating cytokines, that these cells will be switched into a counter-inflammatory role. 
1.3.2 The IgE hypothesis and Mast Cell Saturation. 
One of the most direct models to explain helminth down-regulation of allergic responses is 
that infection results in both parasite-antigen-specific IgE, and very high levels of polyclonal 
IgE. The resulting elevation in total serum IgE would either, or both, dilute out allergen-
specific IgE and saturate the FccRl receptors on mast cells and basophils (Lynch, N. R. et al. 
1999). For example, non-allergic children in Venezuela with high rates of helminth infection 
showed the highest levels of polyclonal IgE and relatively low levels of either parasite- or 
environmental allergen-specific IgE (Hagel, I. et al. 1993; Lynch, N. R. et al. 1993). Many 
other studies, however, do not reproduce these findings; for example, in the Gabonese study 
described earlier, there were no differences in polyclonal IgE levels between atopic and non-
atopic S. haematobium-infected individuals (van den Biggelaar, A. H. et al. 2000). An 
important caveat is that the regulation of FcERI receptor expression, and the absolute number 
of mast cells, are both influenced by IgE concentration (Kawakami, T. and Galli, S. J. 2002), 
calling into question whether mast cell FcERI receptors on a systemic level can reach 
saturation even in individuals producing high levels of IgE. Furthermore, allergic airway 
hyperreactivity is intact in mice carrying a null mutation of CE and are thus unable to produce 
IgE (Mehlhop, P. D. et al. 1997). A more general reservation is that regulation via saturation 
of FcERI would operate only in allergy and could not explain how, for example, autoimmune 
reactivities are also down-regulated in parasite infection. 
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In a recent review of parasite-allergy interactions, Yazdanbakhsh and colleagues temptingly 
speculate, that a cross sensitisation may occur during chronic helminth infections, whereby 
sensitisation to parasites may induce clinically irrelevant cross-reaction to house dust mites, 
in a similar manner to cross-sensitisation between pollen and foods (Yazdanbakhsh, M. et al. 
2002). However this requires much work to identify potential cross-reactive epitopes within 
parasite antigens and allergens. 
1.3.3 Modified Th2, IL-10 and IgG4 
The 'modified Th2' response is associated with elevated IL-10 and lgG4 responses and could 
be regarded as a form of tolerance (Platts-Mills, T. et al. 2001). As described above, chronic 
parasite diseases such as Bancroftian (Hussain, R. et al. 1992) and Brugian (Kurniawan, A. 
et al. 1993) filariasis, display a similar modified Th2 response. In these infections, extremely 
high levels of lgG4 predominate, a curious feature as this isotype of antibody is poorly 
cytophilic and is, not associated with any effector responses. Moreover, filarial antigen-
specific lgG4 has been shown to block IgE reactivity in vitro (Hussain, R. et al. 1992). 
The IL-b-regulated dichotomy between IgE and lgG4 production (Jeannin,P. et al. 1998) 
would, if replicated in a helminth infection, provide a link between the cellular and humoral 
mechanisms involved in chronic infection and allergy. Evidence that this may indeed be the 
case comes from recent studies in Ecuador in which children seropositive for lgG4 to Ascaris 
had a lower frequency of atopy to common allergens than those who were lgG4-negative 
(Cooper, P. J. et al. 2003). Interestingly, in this study high total IgE was independently 
associated with protection from allergy, emphasising that multiple mechanisms of mitigating 
atopy may be at play. 
1.3.4 Immune deviation 
The Hygiene Hypothesis has developed, from its original formulation that a dearth of Thi-
associated infections led to exaggerated Th2 immune responses to aeroallergens. 
Nevertheless, the control of many allergic disorders appears to be tightly linked to the balance 
between Thi and Th2 responses. 
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In humans, influential data included the finding that T cells from non-allergic individuals 
produce type I cytokines in response to allergic epitopes (Romagnani, S. 1994), while murine 
experiments of note include the inhibition of airway eosinophilia and suppression of local Th2 
cytokine production with previous Chiamydia trachomatis infection (Bilenki, L. et al. 2002) and 
the reduction of airway hyperresponsiveness by the administration of IL-12 alongside 
allergens (Tsitoura, D. C. et al. 2000). However, in other settings, both Thi and Th2 clones 
can cause airway inflammation when transferred into recipient animals (Hansen, G. et al. 
1999). Thus, as with many other immunological systems, a simple ThlITh2 divide maybe too 
simplistic (Allen, J. E. and Maizels, R. M. 1997). Further evidence in support of deficient 
immune deviation as a possible explanation for the allergy epidemic, has been reviewed in 
(Romagnani, S. 2004). Immune deviation does not, however, explain the protection from 
allergy observed in Th2-dominant helminth infections. Indeed, it can be argued that the whole 
concept of immune deviation (the alleviation of pathology by diversion to/ from ThI or Th2) 
falls because of the contrasting phenotypes mediating allergy and autoimrriunity. 
1.3.5 Treg cells 
A model has been proposed that the increasing level of overt allergy is linked to under-
development of general down-regulatory controls of the immune system, such as the 
regulatory T cell population (Wills-Karp, M. et al. 2001; Yazdanbakhsh, M. et al. 2001; 
Herrick, C. A. and Bottomly, K. 2003). This revised Hygiene Hypothesis postulates that the 
protective effect observed with chronic helminth infections may be attributed to appropriate 
development or education of the immune system, arguably under the conditions for which it 
has optimally evolved. This hypothesis would not exclude the promotion of a regulatory 
population from sources other than chronic helminth infections, such as viral, bacterial and 
fungal pathogens and also takes into account the parallel increase in autoimmune diseases, 
as a common consequence of an ill-balanced immune system and deficient regulatory 
population. 
Several phenotypes of Treg cells have been described, based on their mode of action, 
generation, phenotype, function, location, surface receptor expression and antigen specificity 
(Battaglia, M. et al. 2002). Beyond Thl vs. Th2 antagonism, a unifying feature of Treg 
phenotypes; (CD4CD25, CD45RBI0  CD4 (CD25'), T regulatory I (Tr), Th3, CD8 T-reg, 
TCR yôT cells, NKT cells) is their ability to regulate the magnitude of immune responses. In 
one form 'natural' Treg (CD4CD25) are induced before leaving the thymus and mature as 
essential components of the peripheral immune response, without which various spontaneous 
organ-specific autoimmune diseases ensue (Sakaguchi, S. et al. 2001). In other guises, they 
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mediate tolerance to extraneous specificities derived from commensal gut flora as well as 
food antigens. 
Whether natural Treg cells are expanded or stimulated during infection or whether DCs or 
microbial products convert peripheral ThO cells into Treg functioning cells is unknown. 
Coherence is emerging, with three commonly studied and described Treg phenotypes; 
Natural- CD4CD25, as described above, regulating self reactive T-cells in the periphery; 
Th3 cells, activated in the mucosal surface of the gut and secreting IL-10 and TGF-P and 
finally; IL-la secreting TO cells. 
Evidence is accumulating to support the peripheral development of Treg cells similar to those 
of natural, thymic emigrant Treg cells (Apostolou, I. et al. 2002; Belkaid, Y. et al. 2002; 
McGuirk, P. et al. 2002). Treg function is associated with lL-10, TGF-13 and CTLA-4. Whether 
these molecules are required for the generation of T-reg cells or simply involved in their 
function is not yet fully understood. Additional markers such as the surface receptors CD25 
(IL-2Ra) and GITR, as well as the transcription factor Foxp3 (Fontenot, J. D. et al. 2003; 
Khattri, R. et al. 2003) are now available to chart the development and activity of this cell 
population. Foxp3 may be a critical component of Treg cell differentiation, as its mutation or 
genetic dysfunction results in several autoimmune disorders in humans (lpEX/XLAAD 
syndrome) and mice (Scurfy)(Kasprowicz, D. J. et al. 2003). Furthermore, over expression of 
Foxp3 induces a Treg phenotype from cells that did not express a Treg phenotype capable of 
inhibiting autoimmune disease (Fontenot, J. D. et al. 2003; Hori, S. et al. 2003; Khattri, R. et 
al. 2003). 
1.3.6 Treg cells in Allergy 
There is growing support for regulatory models of allergy, in which some form of Treg 
population is at the centre of an anti-inflammatory network (Tsitoura, D. C. et al. 2000; Wills-
Karp, M. et al. 2001; Bach, J. F. 2002; Umetsu, D. T. et al. 2002; Zuany-Amorim, C. et al. 
2002; Akbari, 0. et al. 2003; Herrick, C. A. and Bottomly, K. 2003; Jutel, M. et al. 2003; 
Karlsson, M. R. et al. 2004), with particularly strong evidence that T cells transfected with IL-
10 or TGF-13, to confer regulatory. function (Oh, J. W. et al. 2002) (Hansen, G. et al. 2000), 
can prevent allergic airway inflammation or autoimmune disease models (Kohm, A. P. et al. 
2002). 
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Treg's can suppress both Thi (Kohm, A. P. et at. 2002) and Th2 (Cottrez, F. et al. 2000) 
effector responses. However, cells with Treg markers from allergic patients show a deficiency 
in the ability to suppress effector responses (Bellinghausen, I. et al. 2003; Cavani, A. et at. 
2003; Akdis, M. et al. 2004; Grindebacke, H. et at. 2004; Ling, E. M. et at. 2004). 
This deficiency in Treg function and lack of control with respect to pro-allergic-Th2 responses, 
may be an important finding in relation to increasing allergies. 
Directly, a defective regulatory compartment of the immune system may be the underlying 
cause of the present allergy epidemic and wider epidemic of immune disorders. 
Strong evidence of Tregs in allergy, derive from allergen-specific immunotherapy (SIT). 
Successful SIT for bee (Muller, U. et at. 1998) and wasp venom allergy (Pierkes, M. et al. 
1999) often results in T-cell hyporesponsiveness to allergen stimulation, accompanied with 
enhanced IL-10 secretions. IL-10 and TGF-3 production appear to be essential components 
of successful treatment in humans (Akdis, C. A. and Blaser, K. 1999; Bellinghausen, I. et at. 
2001) and mice (Hall, G. et at. 2003; Vissers, J. L. et al. 2004). High dose Der p1 
immunotherapy induced significant reductions of Der p1 specific IL-5, IL-13 and IFN-y from 1-
cells with a paralleled increase in CD4CD25 derived IL-10 and TGF-3. Furthermore, Tregs 
isolated following SIT have shown classical suppression of allergen-responsive effector T-
cells in vitro (Jutet, M. et al. 2003). SIT is also associated with an increase in lgG4 with a 
decrease in IgE production (Pierkes, M. et al. 1999; van Neerven, R. J. et at. 1999) 
comparable to a 'modified Th2' response described with natural exposure to high levels of cat 
or dog allergen. IL-10 treatment of B-cells from individuals hyperimmune to phospholipase A, 
increases phospholipase A-specific lgG4 responses and decreases IgE levels (Muller, U. et 
al. 1998), supporting the work of Jeannin (Jeannin, P. et at. 1998), with IL-10 promoting lgG4 
and suppressing IgE (Punnonen, J. et at. 1993). 
Animal studies have identified Tregs in allergic airway inflammation (Hadeiba, H. and 
Locksley, R. M. 2003) (Jaffar, Z. et at. 2004) and allowed the dissection of possible roles Treg 
cells may play. Using monoclonal populations of HA-specific-B cells and OVA-specific T-cells, 
de Lafaille (de Lafaille, M. A. et al. 2001) showed that a single immunisation with a cross-
linked OVA-HA antigen induced a hyper IgE state, which could be prevented with the infusion 
of Treg cells. 
CTLA-4 is actively involved in down-regulating T cell activation and maintaining lymphocyte 
homeostasis and has been associated with Treg function (Vasu, C. et al. 2004). Blocking 
CTLA-4 in vivo, with several injections of anti-CTLA-4 mAb, Hellings and colleagues 
(Hellings, P. W. et al. 2002), were able to show an exacerbated allergy phenotype, 
suggesting that Tregs use CTLA-4 to regulate airway allergy. 
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OVA-specific Trl cells can suppress Th2 cell proliferation and cytokine secretion (Cottrez, F. 
et al.. 2000). Akbari and colleagues (Akbari, 0. et al. 2002) demonstrated that mature 
pulmonary DC's exposed to allergen can induce IL-10 secreting TO cells, which can 
significantly suppress allergen-induced airway reactivity. 
Recent studies from this group have further identified that Tr cells, derived from naïve 
CD4CD25 T-cells, which express Foxp3 and IL-1 0 T-cells, can inhibit AHR. 
Interestingly, these Tr cells also expressed Tbet and IFN-y, indicating that they are either 
related to, or contain contaminant, Thi cells (Stock, P. et al. 2004). The dependence of ICOS 
ligation in Treg activity has also been demonstrated in a murine model of diabetes, with 
blockade of ICOS progressing insulitis to diabetes (Herman, A. E. et al. 2004). Disease 
progression was associated with a shift in the LaIance between Treg and T-effector cells. 
In summary, evidence for Treg cell generation during helminth infection, as described above, 
is mounting and may account for heightened levels of IL-10 and TGF-, the regulation of 
immunopathology and overall chronicity of infection. Contrastingly, a deficiency of Tregs, or 
Treg cell function and development, is a feature of human allergy and has been confirmed in 
experimental settings. Moreover, allergy can be suppressed, through restoration of the Treg 
compartment, through successful immunotherapy in humans or adoptive transfer experiments 
in animal model systems. An obvious articulation of these two worlds is laid out. If Treg cells 
can act in a non-specific manner, through IL-10 and TGF-P secretions, or can tolerise cells to 
secondary antigens, then the emergence of helm inth-induced T-cell regulation together with 
new concepts of allergy control by T cells, provides a feasible model for helminth suppression 
of allergy. 
1.3.7 Cytokine modulation- IL-10 and TGF-f3 
Cytokine modulation is involved in all models of cross-regulation, and a very wide range of 
additional cytokines, chemokines, receptors and antagonists are intimately involved in the 
generation and regulation of allergies (Nakae, S. et al. 2003). Much of the anti-allergic 
phenomenon can, however, be explained by shifts in the expression of a few pivotal cytokines 
such as IL-b, and consequent changes to other cytokines (e.g IL-5), cytokine receptors, and 
cell activation states in general. It is important to note that IL-10 has proved to be essential for 
host survival of parasite infection, due to its ability to restrain both Thi and Th2 over-reactions 
in pathology. Thus, double-knockout mice, in which IL-10 deficiency is coupled to either IL-4 
(Th2) or IL-12 (Thb) gene deletions show that excessive type I responses in IL-4 and IL-10 
double knockouts result in uncontrolled pro-inflammatory reactions, while excessive type 2 
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responses, in IL-10 / IL-12 double knockout animals result in significant mortality during the 
chronic stages of infection with hepatic fibrosis and the formation of large eosinophil-rich 
granulomas (Schopf, L. R. et al. 2002 (helminth)) (Hoffmann, K. F. et al. 2000). 
One may conceive, therefore, that if IL-10 is necessary in infected mice to minimise parasite-
induced pathology, it might at the same time exert a dampening effect on both Thi and Th2 
responses to concurrent challenge with allergens or other antigens. 
IL-10 has received much attention in the allergic setting. Reduced IL-10 transcription in BAL 
fluid of-asthmatic individuals, compared to non-asthmatics (Borish, L. et al. 1996), is often 
found. IL-10 deficient mice succumb to a heightened inflammatory response in an OVA 
induced airway inflammation model (Tsitoura, D. C. et al. 2000). Increasing IL-b, using 
replication-deficient adenovirus vectors, can prevent airway eosinophilia (Stampfli, M. R. et al. 
1999). IL-10 has strong suppressive effects on the immune system (reviewed in (Moore, K. 
W. et al. 1993)), and has been put forward as a marker of successful immunotherapy in 
allergy patients. Could IL-10 be the non-specific cytokine mediating helminth protection from 
allergy? If so at what level might this operate in respect to allergy? 
The regulation of T-cell activation, through reduced antigen-presenting capacity of DCs and 
ablated IL-2 secretion (Zeller, J. C. et al. 1999; Akdis, C. A. et al. 2001) is the most likely 
mechanism of IL-10 related suppression in allergy. Restoration of T-cell responsiveness using 
anti-IL-10 mAbs, in the earlier mentioned studies of chronic infection, support this mechanism 
(Mahanty, S. et al. 1997; Doetze, A. et al. 2000) in helminth protection of allergy. In addition, 
mast cells (Royer, B. et al. 2001) and eosinophils (Takanaski, S. et al. 1994) are also pliant to 
the suppressive effects of IL-b, with reduced degranulation in vitro. Taken together, 
heightened IL-10 levels accompanying Treg cells during helminth infection provide many 
potential mechanisms of reduced allergy. 
TGF-f3, like IL-10, is a major feature of chronic helminth infections and, as part of the anti-
inflammatory network, has been suggested as significant features of the inverse association 
between helminth infections and allergy (Yazdanbakhsh, M. et al. 2001). In addition to the 
earlier mentioned study of TGF-P induced suppression of airway allergy by Hansen and 
colleagues (Hansen, G. et al. 2000), high dose, unlike optimal dose, airway challenge in 
animal studies did not induce airway eosinophilia, but could be reversed with anti- TGF-f 
mAb's. The role of TGF-P in suppressing eosinophilia in this study was confirmed with high 
levels of TGF-P secretions following in vitro stimulation (Haneda, K. et al. 1999). TGF-
reduces the cell cycle rate of antigen-specific CD4 T-cells (Tiemessen, M. M. et al. 2003), 
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reducing the pool of specific effector cells and in turn reducing antigen induced cytokine 
secretion (Espevik, T. et al. 1987). 
An explanation for these observations is aided by two studies, both indicating that TGF-P can 
induce Foxp3CD4CD25 Treg cells (Chen, W. et al. 2003); (Fu, S. et al. 2004). 
Furthermore, TCR engagement, IL-2 receptor and TGE-R ligation was found to be essential 
for TGF-P induced generation. Reduced proliferation and Ig secretion by B cells has also 
been reported following TGF-3 exposure in vitro. 
Significantly, B cells represent a source of TGF-P and may use TGE-13 as an autocrine 
regulator, or as a contributor to local suppression (Kehrl, J. H. et al. 1986). Reduced T-cell 
responses by TGF-P supports a regulatory mechanism and could account for helminth-
induced protection from allergy. Zeller and co-workers reported a synergistic effect of both IL-
10 and TGF-3 in the induction of T-cell hyporesponsiveness (Zeller, J. C. et al. 1999). 
In the context of allergy, IL-13 is a remarkably important cytokine (Walter, D. M. et al. 2001). 
As well as essential functions in Th2 induction (Herrick, C. A. et al. 2003), fibrogeriesis 
(Chiaramonte, M. G. et al. 1999) and airway hyperreactivity (Walter, D. M. et al. 2001), IL-13 
is a necessary component in the development of acute and chronic allergic asthma (Grunig, 
G. et al. 1998). The importance of IL-i 3Ra2 to control active IL-13 and immunopathology in 
helminth infections is paramount, as described earlier. Furthermore, lL-13Ra2 is up-regulated 
by IL-10 as well as by IL-13 itself (Chiaramonte, M. G. et al. 2003), making this an elegant 
feedback mechanism to prevent over-reactions leading to pathology and could very well be 
responsible for the suppression of allergic effector mechanisms associated with the Th2-
inducing parasitic helminths. 
One of the striking features of helminth infections is the preponderance of asymptomatic 
infections; in which either parasite immune suppression or host feedback inhibition regulate 
the degree of inflammatory immuno-pathology, which results from infection (Maizels, R. M. 
and Yazdanbakhsh, M. 2003). It is therefore not surprising that helminths can modulate 
immunopathology, such as allergic inflammation, either directly or indirectly. Perhaps 
parasites simply take advantage of a suppressive mechanism already in the repertoire of host 
immune functions. Understanding immuno-regulatory mechanisms, in particular their 
induction by helminths, may lead to new therapeutic avenues for immune disorders and also 
bring some clarification to why inflammatory reactions occur in autoimmunity and allergy. 
Perhaps one danger of this scenario, in which the regulatory T cell is cast as a beneficial 
force preventing pathology, is to ignore the other side of the coin: the regulatory environment 
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may hamper essential responses to other antigens, to vaccinations and to life-threatening 
pathogens. Amongst the panoply of infectious agents there are likely to be many which can 
induce or direct the generation of a regulatory mechanism, although in the first instance the 
purpose will be to modulate immune responses directed at itself. 
As chronic infections establish and (in the example of helminths) accumulate, the suppression 
may become more generalised. As a consequence, some circumstances could render the 
host more susceptible to secondary infections, whilst others might prevent disease otherwise 
generated by immunopathology. Few direct examples can be offered, but Borkow (Borkow, 
G. et al. 2001) argues that helm inth-induced hypo-responsiveness reduces resistance to HIV 
and TB infection with fatal outcomes. 
At this stage of our understanding, we can at least begin to identify both beneficial and 
deleterious consequences of helminth infections, with the prospect of influencing future 
strategies to control both infection and immunopathology. This work addresses the above-
mentioned scenarios head on, with the aim of dissecting potential mechanisms that could 
explain the inverse relationship between helminth infections and allergic reactivity. 
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1.4 Hypothesis and Thesis Aims. 
The regulation and manipulation of immune responses during helminth infection is well 
appreciated. From many of the above-mentioned studies, mechanisms of infection-related-
protection from allergy remain unresolved. In particular, how helminth infections protect from 
allergic and other inflammatory diseases, is not fully understood. Detailed research has 
uncovered many ways of regulating allergic airway inflammation, particularly the pliancy of 
allergic responses to cellular regulatory events involving immunoregulatory cytokines, such as 
IL-10 and TGF-13. 
We propose that the two immunological arenas described for helminth infections and allergic 
reactivity convene, with the net effect of either a 'restored' or expanded regulatory population, 
suppressing allergic and indeed other inflammatory responses. An immunoregulatory 
mechanism would support the recent findings of expanded Treg cells found in helminth 
infections and the deficiency or dysfunction of Treg cells found in allergic patients, and could 
explain the inverse association between helminth infections and allergy. 
Using two independent murine models, OVA-induced- and Der p1-induced- allergic airway 
inflammation and the gastrointestinal nematode, Heligmosomoides polygyrus, we aim to 
address the following key questions; 
Can a chronic intestinal nematode infection suppress allergic airway inflammation? 
And, if so 
What is the basis for parasite modulation of the allergic response? 
These 'chestnut' questions have propagated a 'forest' of further questions, which will be 
unveiled throughout this thesis. 
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Chapter 2. Materials and Methods 
2.1 Animals 
Female BALB/c and C57BL/6 mice, 6-8 weeks of age, were purchased from Harlan (Oxon, 
UK)or bred in-house (Ann Walker House, University of Edinburgh). C57BL/6-Ly5.1 and IL-10  
deficient mice were a kind donation from Dr. Steve Anderton (IIIR, University of Edinburgh). 
All mice were housed in individually ventilated cages (IVC), with all experiments complying 
with Home Office 1986 Animals Scientific Act. A minimum of 5 mice per group were used in 
every experiment. 
2.2 Parasites 
2.2.1 Parasite maintenance and life cycles 
Heligmosomoides polygyrus bakeri infective third stage larvae were kindly donated by Dr. 
J.Behnke, (University Of Nottingham, Nottingham, UK). The H.polygyrus lifecycle was 
propagated and third stage larvae were stored at 40  C until use. Infected mice were housed in 
wire-bottomed cages with moist tissue paper placed on a capture tray beneath. Fresh faecal 
pellets were collected and mixed with tap water into thin slurry. Faecal slurry was pasted onto 
filter paper and placed on a small petri dish within a larger petri dish of water and covered. 
Pétri dish cultures were incubated at 28° C, to stimulate hatching. After 9 days, third stage 
larvae were collected from the water following larval hatching and migration into water. 
Infective, ensheathed third stage larvae were washed and stored at 4°C until use. 
Litomosoides sigmodontis was a kind gift from Dr Judi Allen (IIIR, University of Edinburgh). 
2.2.2 Parasite Antigen and Allergen preparations 
H.polygyrus Ag. For H. polygyrus antigen, somatic extracts of mixed sex adult H. polygyrus 
worms were taken up in imI of PBS in the absence of protease inhibitors and homogenised 
using a ground-glass homogeniser (Jencons H103/32/324), followed by centrifugation at 
10,000 x g for 20 mins. The soluble supernatant fractions were passed through a 0.2tm filter 
(Millipore) prior to protein concentration determination using the Coomassie Plus protein 
assay (Pierce). H.polygyrus (Hp) antigen was kept at —80°C until use, for in vitro re-
stimulation assays or immunisation following cell transfer. 
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Der p1. House dust mite allergen, Derpl, was affinity-purified from spent mite medium using 
the monoclonal antibody 4C1 (INDOOR biotechnologies Ltd, UK). Der p1 was isolated by 
affinity chromatography from spent mite medium (SMM) of Dermatophagoides pteronyssinus 
(provided by Commonwealth Serum Laboratories, Victoria, Australia) by Andrew Jeske and 
Dr Mel Leach (CIR, Edinburgh). In summary, a 20% SMM solution with phosphate buffered 
saline (PBS) was prepared and stirred overnight (0/n) at 4°C. Mite extract was collected after 
centrifugation at 3000 rpm (1400g) for 30 min at 4°C, filtered through 0.2!lm filter paper and 
supplemented with 0.05% sodium azide. The solution was passed through a sepharose 4B 
column coupled with Der p1-specific monoclonal Antibody (mAb) 4C1. (4C1 was kindly 
provided by Dr. M Chapman, Charlottesville, Virginia, USA). Der p1 was allowed to bind for 1 
day, and then rinsed with 5 bed volumes of PBS containing 0.5M NaCl, 0.05% sodium Azide. 
Der p1 was eluted using ammoniated water (NH40H, elution buffer) pHIl and collected 
directly into fractions of 30% sterile 0.2M Sodium dihydrogen orthophosphate, to counteract 
the alkalinity of the elution buffer. The concentration of Der p1 was calculated using a 
Bradford protein assay and, if necessary, dialysed in PBS 0/n and placed on polyethylene 
glycol crystals. Der p1 was stored at -20C until use. 
OVA. Grade V chicken egg ovalbumin (OVA) was purchased from Sigma-Aldrich (Dorset, 
UK). 
2.3 Models 
2.3.1 Model 2.1- H.polygyrus infection 
Mice were infected orally with 200 infective, ensheathed third stage larvae using a gavage 
needle. Following oral infection H.polygyrus resides in the intestinal tract (Monroy, F. G. and 
Enriquez, F. J. 1992) and remains an enteric dwelling nematode, without deviating or 
migrating from the intestinal tract and immediate tissues. In addition, H.polygyrus has been 
reported to have immunosuppressive properties and for these reasons was chosen as a 
model of chronic helminthiasis. In experiments involving a chronic H.polygyrus infection, 
fecund adults within the intra-luminal region of the small intestines and eggs evident in faecal 
samples were confirmed with at necropsy (Model 2.1). 
2.3.2 Model 2.2- Allergen Induced Airway Inflammation 
Mice were immunized by i.p. inoculation with 10 tg ovalbumin (OVA, BALB/c) or Der p  1 
(C57BL16) adsorbed to 9% potassium alum (Sigma A7167), and boosted again with 10 tg 
OVA or Der p  1 in alum i.p. 14 days later. On days 28 and 31, mice were anaesthetised with 
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20plIg body weight i.p. of a tribromoethanol anaesthetic, Avertin. Mice were then given 2 
airway challenges with 10 tg of OVA or Der p  1 in PBS by the intratracheal (it.) route. Mice 
were killed 24 hours after the final airway challenge to assess airway inflammation (Model 
2.2). The reagents used, doses and kinetics was used following characterisation within the 
Lamb lab (Jarman, E. R. and Lamb, J. R. 2004). 
2.3.3 Model 2.3- H.polygyrus and Allergy (1 host) 
Mice were infected orally with 200 infective, ensheathed third stage larvae using a gavage 
needle. A chronic H.po!ygyrus infection, with fecund adults within the intra-luminal region of 
the small intestines (confirmed by egg recovery from faecal samples) was achieved by day 
28. Mice were immunized by i.p. inoculation with 10 ttg OVA, BALB/c or Der p  1 (C57BL/6) 
adsorbed to 9% potassium alum (Sigma A7167) on day 28, and boosted again with 10 ttg 
OVA or Der p  1 in alum i.p. 14 days later, on day 42. On days 56 and 59, mice were 
anaesthetised with 20 pug body weight i.p. of a tribromoethanol anaesthetic, Avertin. Mice 
were then given 2 airway challenges with 10 ttg of OVA or Der p  1 in PBS by the intratracheal 
(i.t.) route. Mice were killed 24 hours after the final airway challenge, day 60, to assess airway 
inflammation (Model 2.3). The duration of infection (28 days) prior to the first allergen 
sensitisation was established and determined in the course of this thesis and allowed us to 
address questions pertaining to a chronic infection and allergic reactivity. 
2.3.4 Model 2.4- Allergen Pre-sensitisation and H.polygyrus 
infection (1 host). 
BALB/c or C57BLJ6 mice were immunized by i.p. inoculation with 10 .tg OVA, BALB/c or Der 
p 1 (C57BL/6) adsorbed to 9% potassium alum (Sigma A7167) on day I and boosted again 
with 10 tg OVA or Der p  1 in alum i.p. 14 days later, on day 14, establishing a pre-sensitised' 
state, or Atopy. On day 28 pre-sensitised mice were infected orally, with 200 infective, 
ensheathed third stage larvae using a gavage needle. A chronic H.polygyrus infection, with 
fecund adults within the intra-luminal region of the small intestines (confirmed by egg 
recovery from faecal samples) was achieved by day 56. On days 56 and 59, mice were 
anaesthetised with 20 pug body weight i.p. of a tribromoethanol anaesthetic, Avertin. Mice 
were then given 2 airway challenges with 10 .tg of OVA or Der p  1 in PBS by the intratracheal 
(i.t.) route. Mice were killed 24 hours after the final airway challenge, day 60, to assess airway 
inflammation (Model 2.4). Sensitisation prior to infection (initiated on 28 days) was 
established and determined in the course of this thesis and allowed us to address questions 
pertaining to a chronic infection and its effects on allergen sensitised hosts and subsequent 
allergic reactivity. 
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2.3.5 Model 2.5- H.polygyrus and Allergy with Ab Intervention with 
anti-CD25 or anti-IL-1 OR Ab (I host) 
Mice were infected and sensitised, as in Model 2.3, with 200 infective, ensheathed third stage 
larvae using a gavage needle. A chronic H.polygyrus infection, with fecund adults within the 
intra-luminal region of the small intestines (confirmed by egg recovery from faecal samples) 
was achieved by day 28. Mice were immunized by i.p. inoculation with 10 ig ovalbumin 
(OVA, BALB/c) or Derp I (C57B1J6) adsorbed to 9% potassium alum (Sigma A7167) on day 
28, and boosted again with 10 .tg OVA or Der p  1 in alum i.p. 14 days later, on day 42. On 
day 49, mice were given 1 mg of anti-CD25 (P061) or 1 mg of anti-IL-1 OR Ab on day 55 and 
58, 1 day before each airway challenge. These doses were chosen based on previously 
described protocols with similar in-vivo usage (Liu, H. et al. 2003; Long, T. T. et al. 2003). On 
days 56 and 59, mice were anaesthetised with 20p1/g body weight i.p. of a tribromoethanol 
anaesthetic, Avertin. Mice were then given 2 airway challenges with 10 g of OVA or Der p  1 
in PBS by the intratracheal (it.) route. Mice were killed 24 hours after the final airway 
challenge (day. 60) to assess airway inflammation (Model 2.5). 
2.3.6 Model 2.6- Litomosoides sigmodontis and Allergy (I host) 
BALB/c mice were infected with 25 infective third stage larvae by subcutaneous inoculation, 
based on previously described protocols (Babayan, S. et al. 2003). A chronic L.sigmodontis 
infection, confirmed with microfilariae in blood samples, was achieved by day 60. Mice were 
then immunized by i.p. inoculation with 10 g OVA adsorbed to 9% potassium alum (Sigma 
A7167) on day 60, and boosted again with 10 tg OVA in alum i.p. 14 days later, on day 74. 
On days 88 and 91, mice were anaesthetised with 20pI/g body weight i.p. of a 
tribromoethanol anaesthetic, Avertin. Mice were then given 2 airway challenges with 10 g of 
OVA in PBS by the intratracheal (i.t.) route. Mice were killed 24 hours after the final airway 
challenge (day 92) to assess airway inflammation (Model 2.6). The duration of infection (60 
days) prior to the first allergen sensitisation was established and determined in the course of 
this thesis and allowed us to address questions pertaining to a chronic filarial infection, 
previously described at day 60 (Babayan, S. et al. 2003) and allergic reactivity. 
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2.3.7 Model 2.7- Adoptive cell transfer- Allergy (Donor-recipient 
system) 
Donor BALB/c, C57BL16, C57BL/6-Ly5.1 or IL-10 -/- mice were infected with 200 H. polygyrus 
larvae. A chronic infection had established by day 28, confirmed by egg recovery from faecal 
samples. Chronically-infected donor mice were killed, mesenteric lymph nodes (MLN) 
removed and single-cell suspensions prepared. Cells were washed out of serum 
supplemented media into PBS and counted using the CASY cell counter (Casy, Schaerfe, 
Reutlingen, Germany). The following cell numbers were transferred, where indicated and 
were determined throughout this thesis: 
I 
Mesenteric lymph node cell (MLNC) 	5x107, 2x107 and 1x107 
CD4orCD4 	 4x106 
CD4CD25 or CD4CD25 	 3x105 
CD11c 	 3.5x105,4.5x104 
CD19 	 4.5x106, 1.25x105 
Recipient mice were sensitised by i.p. inoculation with 10 ig OVA (BALB/c), or Der p1 
(C57BL/6) adsorbed to 9% potassium alum (Sigma A7167) on day 1, and boosted again with 
10 g OVA in alum i.p. 14 days later, on day 14. On day 21, cells from chronically infected 
donors were transferred via the tail vein into allergen sensitised recipient mice. On days 28 
and 31, mice were anaesthetised with 20p1/g body weight i.p. of a tribromoethanol 
anaesthetic, Avertin. Mice were then given 2 airway challenges with 10 .tg of OVA in PBS by 
the intratracheal (it.) route. Mice were killed 24 hours after the final airway challenge, day 32, 
to assess airway inflammation. 
2.3.8 Model 2.8- EAE (Adoptive cell transfer) 
Donor C57BL/6, C57BL16-Ly5.1 or IL-10 -1- mice were infected with 200 H. polygyrus larvae. A 
chronic infection had established by day 28, confirmed by egg recovery from faecal samples. 
Chronically infected donor mice were killed, mesenteric lymph nodes (MLN) removed and 
single-cell suspensions prepared. Cells were washed out of serum supplemented media into 
PBS and counted using the CASY cell counter (Casy, Schaerfe, Reutlingen, Germany). The 
following cell numbers were transferred, where indicated: 
Mesenteric lymph node cell (MLNC) 	1x107 
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On day 0, recipient C57BL16 mice were immunised with 100g of MOG (35-55) peptide 
emulsified in CFA containing 5001g of heat killed Mycobacterium tuberculosis H37A (Sigma, 
Poole, Dorset, UK). The emulsion was administered as two 50tl subcutaneous injections, one 
in each hind leg. Mice also received 200 ng of pertussis toxin (Ptx) (Speywood 
Pharmaceuticals, Maidenhead, UK) intraperitoneally in 0.5 ml of PBS on the same day to 
disrupt blood brain barriers and allow primed cells access to host MOG. On day 1, MOG-
immunised mice received donor cells, as stated in the text and above, followed by 200 ng of 
pertussis toxin (Speywood Pharmaceuticals, Maidenhead, UK) intraperitoneally in 0.5 ml of 
PBS on day 2, with clinical scoring carried out from day 7 onwards, described below. 
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2.4 Determination of the Allergic phenotype 
2.4.1 Bronchoalveolar Lavage (BAL) 
Twenty-four hours after the final airway challenge, mice were terminally anaesthetised with 
ketamine (Vetalar V, Pharmacia & Upjohn) and Xylazine (Rompun 2%, BAYER). The trachea 
was cannulated using an Abocath-T sheath (Abbott, Ireland) and internal airspaces were 
lavaged with an initial 500 .tl of sterile PBS, followed by two 350 .tl washes. 
2.4.2 Differential Cell Counts 
BAL fluids were centrifuged at 300 g, and pellets recovered for cellular analysis. The 
supernatants of the initial 500.tl of BALF were stored at -80°C for biochemical analyses. 
Cytospins were prepared by spinning 5x10 5 cells onto poly-(L-lysine) coated slides (BDH) 
followed by Duff Quick® (Boehringer, UK) staining. Differential cell counts were performed at 
lOOx magnification with the identification of eosinophils, neutrophils, macrophages and 
lymphocytes, based on their morphology and staining characteristics; a minimum of 200 cells 
were counted for each slide. 
2.4.3 -Hexosaminidase Assay 
-Hexosaminidase was measured as an estimation of mast cell degranulation. This assay is 
based on one unit of hexosaminidase, defined as the amount of enzyme required to produce 
1 pmole of p-nitrophenol (pNP) in 1 minute at 37°C, pH 5 from p-nitrophenyl-beta-D-N-acetyl-
glucosaminide. Thus, lOOpi of BAIL fluid and 100.d of 1.3 mg/mI of 4-Nitrophenyl N-acetyl-b-
D-glucosaminide (Naga, N9376, Sigma-Aldrich, Oxon, UK) in 0.1M Citrate was added to a flat 
bottomed 96 well plate and incubated for 2 hours at 37°C. After 2 hours, 100.tI of 0.2M 
glycine (G7126, Sigma-Aldrich, Oxon, UK) was added to stop the reaction. Data was 
presented as a change in optical density, read at 405 nm, from 0 hours to 2 hours, normalised 
with PBS controls. 
2.4.4 Mucin Assay 
A modified sandwich ELISA was designed to measure the mucin content recovered in BAL 
fluid. Between each layer the plates were washed five times with TBS/Tween. 
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Following isolation of BAL fluid, 50iil per well was added to an ELISA plate (NUNC, 
Immunoplate MaxiSorp, NUNC, Denmark), with a mucin standard (M1778, Sigma-Aldrich) in 
a doubling dilution with PBS. Plates were incubated overnight at 4°C. Following overnight 
incubation, plates were blocked with 1% hemoglobin (H2500, Sigma-Aldrich) and incubated 
for a further 2 hours at 37°C. Plates were washed and coated with 50tl per well of 5tg/ml of 
biotinylated Helix pomatia lectin (L6512, Sigma) and incubated for 2 hours at 37°C. Plates 
were washed, coated with streptavidin - HRP (Pharmacia) and incubated for a final time for 1 
hour at 37°C. Following incubation, 50tI/well of ABTS peroxidase substrate system (50-62-
00, KPL) was added, left to develop and monitored at 405 nm. 
2.4.5 Histological analysis 
Following BALF recovery, lungs were infused with 4% Para-formaldehyde in PBS (Formalin). 
After excision, the lungs were immersed in fresh 4% Para-formaldehyde overnight. Right 
lobes were taken, fixed in paraffin blocks and sectioned in the coronal plane at 5 tm ensuring 
that the central airways were visible. Sections were stained with haematoxylin and eosin 
(H&E) (Sigma, 03972) to establish a general inflammatory score. Positively charged mucins 
in mucus-containing goblet cells were stained with Alcian Blue-Periodic acid schiff (AB-
PAS)(Sigma) and analysed with a histological mucus index (HMI) to quantify goblet cell 
hyperplasia. Scoring of inflammation was conducted in a single-blinded method, by myself 
with samples randomly scored without knowledge of treatment groups. An Inflammation score 
from 3 x lOOx fields observed per lung with infiltration around bronchioles, pen-bronchial 
arteries and veins scored by the % of the circumferential or longitudinal area involved with 
any type of inflammation. Quantification and scoring of mucus producing cells was also 
conducted in a similar single-blinded fashion without knowledge of treatment groups, by 
counting PAS positive cells in airways with measurement of basement membrane (BM). 
Values are expressed as mean number of PAS-positive goblet cells per grid intersection of 
BM after evaluating several airways of 5 mice per group. Embedding in paraffin, sectioning 
and staining was kindly performed, and only made possible, by expert assistance from 
Francis Rae and Grace Grant (CIR, University of Edinburgh). 
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2.5 Autoimmunity model. (EAE) parameters 
2.5.1 Clinical Scoring of EAE 
Clinical signs of EAE were assessed daily with a 0-6 scoring system, with scores recorded in 
a single blind regime, without knowledge of treatment groups: 
0. No signs 
Flaccid tail 
Impaired righting reflex and/or gait 
Prtial hind limb paralysis 
Total hind limb paralysis 
Hind limb paralysis with partial fore limb paralysis 
Moribund or dead. 
Differences in total disease burdens between groups were analysed with the Mann-Whitney U 
test. 
2.5.2 CNS Isolation 
CNS was isolated from mice at day 14 during the peak of disease. Spinal cords were 
extruded by flushing the vertebral canal with cold PBS; they were then rinsed in PBS. The 
spinal cords were roughly chopped and forced through 70 - ttm nylon cell strainers (BD 
Pharmingen) to give a single-cell suspension. The spinal cord homogenate was re-
suspended in 30% Percoll (Amersham Pharmacia Biotech) and underlaid with 60% Percoll (5 
mL per tube). The gradients were centrifuged at 500 g at 24°C for 20 minutes. CNS 
mononuclear cells were collected from the 30%/70% interface and were washed and 
resuspended in RPMI 1640 medium supplemented with penicillin (100U/ml) Streptomycin 
(100 tg/ml) (15140-120, GIBCO, UK) and glutamine (4 mM) (25030-024, GIBCO, UK), plus 
10% fetal calf serum (FCS) (21955-023, GIBCO, UK. 
2.6 Proliferation Assay 
All in vitro cultures were performed in RPMI 1640 medium supplemented with penicillin 
(100U/ml) Streptomycin (100 .g/ml) (15140-120, GIBCO, UK) and glutamine (4 mM) (25030- 
024, GIBCO, UK), plus 10% fetal calf serum (FCS) (21985-023, GIBCO, UK), unless 
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otherwise stated. Single cell suspensions from lymph nodes or spleen were incubated in 
quadruplicate at 1x106 cells/ well of a round-bottomed 96 well plate in a total of 200d at 37°C. 
Proliferation in response to media (unstimulated control) H.polygyrus antigen (lOj.tg/ml), OVA 
(Sigma) or Der p1 allergen (10tg/ml), MOG(35-55) peptide (4.tg/ml) or Concanavalin A 
(1 ig/ml)(Mitogen, positive control) (C-0412, Sigma-Aldrich, Poole, UK) was measured by the 
addition of 1l.tCi of [ 3H] thymidine for' the last 18 hours of a 72 hour incubation. Throughout 
this thesis the timing of thymidine addition and cell densities used were established and 
optimised for the antigens used. Supernatants were collected, after 54 hours of culture, and 
stored at -80°C for cytokine analysis. [3H]-thymidine incorporation was used as an indication 
of cellular proliferation, with [ 3H] Thymidine incorporation into cellular DNA, captured on glass 
fibre filter mats (PerkinElmer I Wallac-1450-421) coated with scintillator sheets (PerkinElmer I 
Wallac-1450-411) and measured in a scintillation counter. 
2.7 Cytokine and Chemokine detection by ELISA 
Culture supernatants collected after 54 hours of incubation, or BAL fluid, was assayed for 
cytokine secretions. Cytokines were measured by ELISA according to suppliers' guidelines. 
Between each layer the plates were washed five times with TBSITween. ELISA capture 
monoclonal antibodies were prepared in 0.06% carbonate buffer (0.1 mM NaHCO3, pH 8.2) 
and incubated overnight at 4°C at the following concentrations (Table 2.1), with 50tl added 
per well of an ELISA plate (NUNC, Immunoplate MaxiSorp, NUNC, Denmark). Following 
incubation, plates were blocked with 100RI/well of 1% bovine serum albumin (BSA) in TBS, 
incubated for 2 hours at 37°C. 50l/well of BAL fluid or supernatant was then added with a 
standard curve performed, with doubling dilutions of the recombinant cytokine. Following 
incubation and washing, 50 id/well of matched biotinylated detection antibody was added and 
incubated at 37°C fro 2 hours or overnight at 4°C. Streptavidin-alkaline phosphatase was 
added, 50 itl/weIl at 1tg/ml and incubated at 37°C for a further hour. Finally, plates were 
washed and 100111 of p-nitrophenyl phosphate substrate (Sigma-Aldrich) was added. Once 
colour had developed, optical densities, at 405 nm, were read, with cytokine concentration 
determined by extrapolation from the standard curve. Standard curves were obtained using 
recombinant murine IEN-y, IL-4, IL-6, IL-10 (R&D Systems, Minneapolis, MN), and IL-5, 
Eotaxin, IL-13, IL-13Ra2 (BD PharMingen) and are expressed in picograms per milliliter 
standard error rr r of the mean (SEM), unless otherwise stated: The buffers, substrates and 
concentrations of reagents used were adopted from previously published protocols from this 
laboratory (Lawrence, R. A. et al. 1996) or from in house testing and optimisation. 
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Monoclonal 
Capture Antibodies 







IL-4 (4ig/ml), 11B11- (in house) 0.5 [tg/ml Pharmingen 
IL-5 (2tgIml), Pharmingen 1tg/ml Pharmingen 
IL-6 (2pgIml) R&D 1tg/ml R&D 
IL-lO (4tgIm1) Pharmingen 2tg/rnl Pharmingen 
IL-13 (2tgIml) R&D 0.1tg/ml R&D 
Il-i 3Ra2 (2.5ngIml) R&D 156ng/ml R&D  






Table 2.1. ELlSAAntibodies 
2.8 TGF-13 Bioassay 
Modified mink lung epithelial cells (MLECs) (clone 32) were obtained (by kind donation from 
D. B. Rifkin, Department of Cell Biology, New York University Medical Center) which were 
stably, transfected with an 800-bp fragment of the 5 end of the human plasminogen activator 
inhibitor-1 (PAl-1) gene fused to the firefly luciferase reporter gene in a p19LUC-based vector 
containing the neomycin resistance gene from pMAMneo. Modified MLECs were maintained 
in DMEM supplemented with 10% FCS, 100 U of penicillin/ml, 100 pg/mI of streptomycin, 
2 mM L-glutamine and 200 pg/mI of geneticin (G418) to select only neomycin resistant and 
thus transfected cells. Confluent modified MLECs were trypsinized and resuspended in 
complete media at 1.6 x10 5 cells/ml. Volumes of 100 p1 of cells/well were seeded in triplicate 
in an all-white 96-well tissue culture dish (BMG, Biotechnologies). The cells were incubated at 
37°C for 3 h for optimal attachment. lOOpI of BAL fluid and recombinant TGF-P dilutions 
(250 to 4 pg/mI; 100 p1/well) were added to the MLECs. Samples were incubated overnight at 
37°C. After incubation, a luciferase assay was performed according to the manufacturer's 
instructions (Bright-Glo Luciferase Assay System; Promega). 100 p1 of Bright-Glo reagent 
was added to the 100-pi 'samples in each well. Cells were incubated for 2 min at room 
temperature to allow complete lysis. Luciferase activity was assayed using a Luminometer 
(BMG Biotech nobogies). Luciferase activity was reported as relative light units. 
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2.9 Allergen specific Isotype detection by ELISA 
Allergen-specific IgE, IgGI and lgG2a antibodies were determined by ELISA. Unless 
otherwise stated, serum samples collected 1 day after final airway challenge were diluted in 
TBS/Tween and wells washed between each incubation step with TBS/Tween. Flat-bottomed 
96 well plates were coated with 4 [tg/ml of Der p1 or OVA diluted in carbonate buffer (0.1 mM 
NaHCO3, pH 8.2). After washing, non-specific binding was blocked by incubating wells with 
5% BSA (Fraction V, Gibco) in carbonate buffer, for 2 hours at 37°C. Doubling dilutions of 
serum from 1:10 to 1:1280 was then added and plates were incubated overnight at 4°C. For 
measurement of allergen-specific-IgE, lgG was first depleted as allergen-specific-lgG 
antibodies, which may be in more than 100-fold excess to IgE antibodies, interfere with the 
detection of allergen-specific .lgE, possibly by competitive binding to allergenic epitopes. A 1:4 
dilution of serum in PBS was incubated overnight on a rotator at 4°C with protein-G bound 
sepharose beads (Pharmacia Biotech) (851d, packed beads). igG-depleted serum was 
recovered by centrifugation, diluted in TBSiTween and added to allergen-coated plates. 
Plates were incubated with Biotinylated anti-mouse IgE (Clone R35 118, Pharmingen) for 2 
hours before Extravidin—alkaline phosphate (Sigma-Aldrich, direst, UK) was added to the 
plate at 4tg/ml for 1 hour at 37°C. Finally, p-nitrophenyl substrate was added and the 
reaction was allowed to develop before monitoring at 405nm. 
For IgGI, HRP conjugated anti-rn lgGl (BD PharMingen, Oxford, UK) was added at 1:6000 
dilution, HRP conjugated anti-rn lgG2a (BD PharMingen, Oxford, UK) was used at 1:4000 
dilution. Following incubation, 50l/well of ABTS peroxidase substrate system (50-62-00, 
KPL) was added, left to develop and monitored at 405nm. 
2.9.1 Total lgE detection. 
The level of total IgE was measured by capture ELISA. Monoclonal anti IgE (R35-72) (BD 
PharMingen, Oxford, UK) was diluted to 4tg/ml in 0.06M carbonate buffer and coated onto 
plates at 50i1/well and incubated overnight at 4°C. Wells were blocked with 5% Foetal calf 
serum (FCS) in carbonate buffer at 37°C. Doubling dilutions in TBS/0.05% Tween (Sigma-
Aldrich, direst, UK) of serum samples were added to the plate and incubated overnight at 
4°C. Biotinylated anti-IgE (R35-118) (BD PharMingen, Oxford, UK) was added at a 
concentration of 2tg/ml in TBST/FCS, 50ul/well. Extravidin —alkaline phosphate (Sigma-
Aldrich, direst, UK) was added to the plate at 4tg/ml for 1 hour at 37°C. Finally, p-nitrophenyl 
substrate was added and the reaction was allowed to develop before monitoring at 405nm. A 
standard curve was generated using dilutions of 500ng/ml to 0.122 ng/ml of mlgE (R27-74) 
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(BD PharMingen, Oxford, UK). Between each layer the plates were washed five times with 
TBS/Tween. 
2.10 Cell Isolation using magnetic beads 
	
2.10.1 	CD4 Isolation or depletion 
To allow us to identify the roles of distinct cellular populations within the MLN of infected mice 
we partitioned the heterogeneous MLN cells into CD4 or CD4 compartments, following our 
hypothesis that a regulatory T cell population expressing CD4 may be involved in helminth 
mediated protection from inflammatory disorders. For CD4 purification or depletion, 1x10 7 
cells in a single cell suspension were incubated with lOpi of anti-CD4 (L3T4) microbeads 
(130-049-201, Miltenyi biotech) in RPM[ 1640 medium supplemented with penicillin (100U/ml) 
Streptomycin (100 ig/ml) (15140-120, GIBCO, UK) and glutamine (4mM) (25030-024, 
GIBCO, UK), plus 10% FCS (21985-023, GIBCO, UK). Cells were incubated for 15 minutes at 
4°C. Cells were washed with bead-bound cells separated using the mini-MACS magnets with 
MACS LS separation columns (130-042-401, Miltenyi biotech) and passed through pre-
separation filters (130-041-407, Miltenyi biotech). All Miltenyi biotech reagents were used in 
accordance with manufacturers recommendations. Positively selected cells (CD4) were 
retained on the magnetic column, and subsequently washed off into sterile filtered PBS 
before i.v. transfer. CD4 cells that passed over the column were similarly washed into sterile 
filtered PBS before i.v. transfer. 
Samples of purified CD4 cells or CD4 depleted (CD4) cells were stained with fluorescently 
labelled antibodies for flow cytometry, described below. For adoptive transfer experiments 4 x 
106  CD4 cells or CD4 depleted (CD4) cells were transferred into recipient mice by i.v. 
injection. Purified CD4 cells were typically >97% pure, with similar purities obtained for CD4 
depleted (CD4) populations. 
2.10.2 	CD4CD25 and CD4CD25 Isolation. 
For CD4+CD25+ cell enrichment, CD4 cells were first negatively isolated. A single cell 
suspension was incubated with Biotinylated: anti-CD11b (557395, BD Pharmingen), anti-
CD8a (553029, BD Pharmingen), anti-MHC-class II (clone M5114) and anti-lgK (clone 187.1) 
for 15 minutes at 4°C in RPMI 1640 medium supplemented with penicillin (100U/ml) 
Streptomycin (100 ig/ml) (15140-120, GIBCO, UK) and glutamine(4mM) (25030-024, 
GIBCO, UK), plus 10% FCS (21985-023, GIBCO, UK). Cell suspensions were washed and 
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incubated with streptavidin microbeads (130-048-101, Miltenyi Biotech) according to 
manufacturers recommendations. Unlabelled cells (CD4) were separated from antibody-
bead bound cells (CD4) using mini-MACS magnets with MACS LS separation columns and 
pre-separation filters. Unlabelled CD4 cells were collected in the effluent, with CD4 cells 
retained on the column. CD25+ cell enrichment within the CD4+ population was performed by 
positively selecting CD25 expressing cells with Biotinylated anti-CD25 (552070, BD 
Pharmingen) and Streptavidin microbeads. 
3x105 CD4+CD25+ or CD4+CD25- cells from chronically infected donors were transferred, 
i.v., into uninfected, allergen-sensitised recipients. All cell isolations were washed and 
filtered into sterile PBS and transferred byi.v. injection into recipient mice via the tail vein, 7 
days before the first of two airway challenges. CD4+CD25+ and CD4+CD25- cells were 
purified to> 80% purity using this method. 
	
2.10.3 	CD11c Isolation. 
CD1 lc is highly expressed on dendritic cells, as well as variable expression on monocytes, 
macrophages, granulocytes and NK cells. CD1 ic was initially used as a marker to follow the 
suppressive capacity from the heterogeneous MLN populations. For CD11c purification, 
1x107 cells in a single cell suspension were incubated with 10l of anti-CDIIc microbeads 
(130-052-001, Miltenyi biotech) in RPMI 1640 medium supplemented with penicillin (100U/ml) 
Streptomycin (100 [tg/ml) (15140-120, GIBCO, UK) and glutamine (4mM) (25030-024, 
GIBCO, UK), plus 10% FCS(21985-023, GIBCO, UK). Cells were incubated for 15 minutes at 
4°C. Cells were washed with bead-bound cells separated using the mini-MACS magnets with 
MACS LS separation columns (130-042-401, Miltenyi biotech) and passed through pre-
separation filters (1 30-041-407, Miltenyi biotech) All Miltenyi biotech reagents were used in 
accordance with manufacturers recommendations. Positively selected cells (CD11c) were 
retained on the magnetic column, and subsequently washed off into sterile filtered PBS 
before i.v. transfer. Typically CDllci - cells were enriched/purified to 2.70%. 
2.10.4 	CD19 Isolation. 
Most B cell subsets express CD19 throughout all stages of development, making CD19 a 
suitable marker for B cell isolation. Following the isolation of populations within the CD4 
compartment, the isolation of B cells expressing CD19 was therefore undertaken. For CD19 
purification, 1x10 7 cells in a single cell suspension were incubated with 10tl of anti-CDI9 
microbeads (130-052-201, Miltenyi biotech) in RPMI 1640 medium supplemented with 
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penicillin (100U/ml) Streptomycin (100 tg/ml) (15140-120, GIBCO, UK) and glutamine (4mM) 
(25030-024, GIBCO, UK), plus 10% FCS (21985-023, GIBCO, UK). Cells were incubated for 
15 minutes at 4°C. Cells were washed with bead-bound cells separated using the mini-MACS 
magnets with MACS LS separation columns (130-042-401, Miltenyi biotech) and passed 
through pre-separation filters (130-041-407, Miltenyi biotech) All Miltenyi biotech reagents 
were used in accordance with manufacturers recommendations. Positively selected cells 
(CD19) were retained on the magnetic column, and subsequently washed off into sterile 
filtered PBS before i.v. transfer. CD19 cells were typically >97% pure using this isolation 
method. 
2.11 Cell culture and Antibody production- Anti-IL-IOR Ab and 
Anti-CD25 (PC6I) 
Rat anti-mouse IL-2Ra (CD25) monoclonal lgGl antibody (PC61) (hereafter called anti-CD25 
mAb) was produced in-house from cells kindly provided by Fiona Powrie (University of 
Oxford), and grown in serum-free ?nedia in a Vectra cell growth bag (810-VECTRA). Antibody 
was purified on a protein G-sepharose column, dialysed against PBS, and administered i.p. at 
10 mg/ml. Rat anti-mouse CD2I0 (IL-10R) antibody was IgGI monoclonal 1BI.3a (BD 
Pharmingen, Cat No. 559912). 
2.12 Flow cytometric analysis 
Cells were stained with fluorescently labelled antibodies diluted in PBS with 0.5% BSA 
(Sigma-Aldrich) and 0.05% sodium azide (Sigma-Aldrich) for 20 minutes at 4°C. Antibodies 
were directly conjugated to fluorochromes, unless stated. For detection of: 
• CD4CD25 and CD4CD25 cells, monoclonal rat anti-mouse CD4 (L3T4, clone 
RM4-5, Isotype Rat lgG2a, working dilution of 1:100, Allophycocyanin) and rat anti 
mouse-CD25 (clone PC6I 5.3, Isotype Rat IgGI, CALTAG Labs., working dilution of 
1:100, Phycoerythrin) were used. 
• C571BL16 CD45.1 (Ly5.1) cells in recipient mice, mouse anti-mouse CD45.1 (clone 
A20, mouse lgG2a, working dilution of 1:100, Phycoerythrin) or 
• C57BL/6 CD45.2 (Ly5.2), mouse anti-mouse CD45.2 (clone 104, mouse lgG2a, 
working dilution of 1:100, Biotinylated) with Streptavidin Quantum Red (Sigma- S-
2899, working dilution of 1:50) 
65 
Chapter 2. Materials and Methods 
• Surface bound TGF-P was detected using rat anti-mouse TGF-1 (clone A75-3, rat 
lgG2a, working dilution of 1:50, Biotinylated) with Streptavidin Quantum Red (Sigma-
S-2899, working dilution of 1:50). 
CD11c cells, monoclonal rat anti-mouse CD11c (clone HL3, Isotype Rat lgG2a, 
working dilution 1:1 00 Fluorescein); 
CD19 cells, monoclonal rat anti-mouse CD19 (clone 1D3, isotype Rat lgG2a, 
working dilution 1:100, Fluorescein); 
S 	 • B220' cells, monoclonal rat anti-mouse B220 (clone RA3 6B2, isotype Rat lgG2a, 
working dilution 1:200, Phycoerythrin); 
CD8 cells, monoclonal rat anti-mouse CD8 (clone 53-76, isotype Rat lgG2a, 
working dilution 1:100, CyChrome); 
GITR cells, purified anti-mouse GITR (TNFRSF18) (clone DTA-1, isotype Rat 
lgG2a, working dilution 1:250, Fluorescein); 
• CTLA-4 (CD152) cells, purified Hamster anti-mouse CTAL-4 (clone UC1O-4F10-11, 
Isotype Hamster lgGl, working dilution 1:10, Phycoerythrin); 
• CDI03 (Integrin' aIEL  chain)' cells, monoclonal rat anti-mouse CDI03 (clone M290, 
Isotype Rat IgG2a, working dilution 1:50, Fluorescein); 
yÔTCR' cells, purified hamster anti-mouse yöTCR (clone GL3, Isotype hamster 
lgG2a, working dilution 1:100, Fluorescein) 
The expression of surface markers was analysed on a FACSCalibur flow cytometer using 
FlowJo software (Tree Star). All flourochrome-labelled antibodies were obtained from BD 
Pharmingen, unless otherwise stated. 
2.12.1 	Intra-cellular Cytokine (ICC) staining 
Single cell suspensions were stimulated with 50ng/ml phorbol myristic acid (PMA) - a PKC 
activator) (Sig ma-Aldrich) and 1ig/ml ionomycin (Sig ma-Ald rich) (a calcium ionophore) for 4 
hours at 37° C. Following incubation, 20 .Lg/ml Brefeldin A (Sigma-Aldrich) was added and 
the cultures were incubated for a further 7 hours. Cells were washed and 5x10 6 cells were 
taken for intracellular cytokine analysis. Cells were first stained for surface markers, as 
above. Cells were then permeablised in 100tl of cytofix/cytoperm (BD Pharmingen) for 30 
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minutes, washed in perm/wash buffer (BD Pharmingen) according to the manufacturer's 
recommendations and stained for 30 mins with; 
IL-5 - rat anti-mouse IL-5 (clone TRFK5, Isotype rat lgGl, working dilution 1:50, 
Allophycocyanin) 
IL-10 - rat anti-mouse IL-10 (clone JES5-16E3, Isotype rat lgG2b, working dilution 
1:50, Phycoerythrin) 
INF-y - rat anti-mouse INF-y (clone XMG1.2, Isotype rat IgGi, working dilution 1:50, 
Phycoerythrin) 
TNF-a - rat anti-mouse TNF-a (clone MP6 XT22, Isotype rat IgGI, working dilution 
1:50, Phycoerythrin) 
The expression of surface markers and intracellular cytokines was analysed on a 
FACSCalibur flow cytometer using FlowJo software (Tree Star). All flourochrome-labelled 
antibodies were obtained from BD Pharmingen, unless otherwise stated. 
2.13 SDS-Page GEL 
To resolve subtle differences in protein content within the BAL fluid recovered from airway 
challenged mice, 10tg of total protein, measured by Bradford protein assay, was loaded onto 
a pre-cast 10% NuPage Novex Bis-Tris Gel (lnvitrogen) with a pre-stained Precision Plus 
Protein standard (BioRad). 
The Gel was run at a constant 200 V to obtain optimum protein resolution. Gels were stained 
with 0.1% Coomassie Blue dye in 50% methanol and 10% glacial acetic acid (Sigma) or were 
stained with a silver nitrate solution. 
2.14 Statistical Analysis 
Student's t test or Mann Whitney U test were used, as indicated, for statistical comparisons 
between groups with equal and unequal distributions, respectively. P values <0.05 were 
considered significant and were calculated using GraphPad Prism. 
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Chapter 3. Infection and Allergy 
3.1 	Introduction 
The 'Hygiene Hypothesis', proposing that the rise in allergic diseases in developed regions of the 
world is due to reduced exposure to 'protective' infections, has gained much support over the 
past few years. The paradox that allergies are less prevalent in helm inth-infected populations 
revised the original hypothesis from a dysfunctional Th1/Th2 balance towards a state of 
disordered immunoregulation (Wills-Karp, M. et al. 2001; Yazdanbakhsh, M. et al. 2001; Gale, E. 
A. 2002; Rook, G. A. and Brunet, L. R. 2002; Umetsu, D. T. et al. 2002; Yazdanbakhsh, M. et al. 
2002). 
Evidence for immune suppression during helminth infections is well established (Maizels, R. M. et 
al. 1993; Doetze, A. et al. 2000; Maizels, R. M. and Yazdanbakhsh, M. 2003) and recent studies 
have begun to identify the regulatory mechanisms which may operate at a systemic level to 
dampen allergic pathologies (Bashir, M. E. et al. 2002; Chiaramonte, M. G. et al. 2003). The 
wealth of data from human studies sets out an enticing scenario in which helminth infections keep 
allergies at bay but, as with many epidemiologically based studies, experimental models must be 
tested if we are to distinguish cause from consequence in these two complex immunological 
settings. 
This chapter details experiments carried out to address the following questions; 
1. Can a chronic nematode infection suppress allergic airway inflammation? 
Initial familiarisation and optimising experimental conditions were carried out, as the chosen 
models were new to the laboratory. Heligmosomoides polygyrus, a natural enteric nematode of 
murine hosts, was chosen as a model of chronic helminthiasis. Immunological parameters 
governing chronicity of H. polygyrus infection was initially sought, before continuing to asses its 
influence on allergy. Animal models of allergic airway inflammation were set up, with assistance 
from the Lamb (CIR, University of Edinburgh) and Lloyd (Leukocyte biology, Imperial College 
London) labs. Measurements of cytokine and chemokine levels resulting in cellular influx and 
airway pathology in allergen-sensitised mice were employed to characterise the allergic 
phenotype. 
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Allergen sensitised, and un-sensitised, mice with, and without, H.polygyrus infection allowed us to 
directly address the above question; assessing the effect of chronic infection on the allergic 
phenotype. Secondly, the timing of infection was varied, prying into the effects of immunological 
imprinting and 'therapeutic infection'. 
2. Can a chronic helminth infection suppress allergic airway inflammation in an allergen-
sensitised host? 
The effect of immunological imprinting by early exposure to infectious agents is an area of the 
hygiene hypothesis. Viral infections during childhood can exacerbate airway allergy (Nafstad, P. 
et al. 2000; Sigurs, N. et al. 2000). However, early exposure to schistosome infections can protect 
from allergic reactivity (van den Biggelaar, A. H. et al. 2000; Cooper, P. J. 2002). Addressing this 
issue, by altering the timing of infection in naïve or pre-sensitised mice, could have wider 
implications on developmental immunology and more specifically on the development of allergic 
reactivity. 
Chapter 3. Infection and Allergy 
3.2 Results 
3.2.1 A primary H.polygyrus infection elicits a canonical local and 
systemic Th2 response. 
To appreciate the immunological kinetics of a primary H.polygyrus infection, BALB/c and C57BLJ6 
mice were infected with 200 infective, ensheathed third stage larvae (1-3) using a gavage needle. 
(Model 2.1. Described in Materials and methods). On day 7, 17, 27 and 47, mice were killed and 
spleens, lungs, mesenteric lymph nodes and Peyers patches removed for in vitro I cell recall 
responses; sera were also taken for antibody detection. 
As this was a new parasite to the laboratory, some basic in vitro parameters were initially 
established with mesenteric lymph node cells and splenocytes recovered from mice, 17 days post 
infection. Optimal antigen concentration for in vitro re-stimulation was found to be at 10ig/ml (Fig. 
3.1A) with optimal antigen specific proliferation established with 106  mesenteric lymph node cells 
(MLNC) per well of a 96-well plate (Fig. 3.1 B). Local (Peyers patch (PP) and MLNC (Fig 3.2A)) 
and systemic (splenocyte and lung cell (Fig 3.213)) responses to H.po!ygyrus antigen were 
measured throughout infection, revealing a dissemination of parasite-specific T cells throughout 
the infected host. Maximal H.polygyrus-specific proliferation and responsiveness was seen in the 
two most proximal sites tested, MLNC and PP, at 27 days post infection (Fig 3.2A). Splenocytes 
recovered at day 27 and re-stimulated in vitro with either H.polygyrus antigen or with the mitogen, 
Concanavalin A (ConA) produced large amounts of IL-4 and IL-10 (Fig 3.3A). Furthermore ; 
unstimulated splenocytes were found to constitutively secrete IL-10 in vitro. The Thi marker, lEN-
y, was suppressed in splenocyte cultures, indicative of a governing Th2 response (Fig. 3.3). 
Isotype responses, measured in the sera of infected mice, revealed a Th2-dominated phenotype 
with significantly elevated anti-H.polygyrus IgGi from Day 17 (P<0.004) with significantly 
elevated polyclonal lgE from Day 17 (Fig 3.313, P<0.008). Anti-H.polygyrus lgG2a was almost 
undetectable throughout infection. The data shown are from BALB/c mice. C57BL/6 mice were 
found to respond in a similar way. 
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Fig 3.1 Optimisation of in vitro re-stimulation conditions. Splenocytes (A) from infected and naïve BALBIc mice 
were cultured in 96-well plates in the presence or absence of varying concentrations of H.polygyrus Ag. Varying 
densities of MLNC (B) from infected BALB/c mice were cultured in the presence of l0ag/ml of H.polygyrus Ag 
(Hp), 1tg/ml of Concanavalin A (ConA) or media alone (-). Proliferation was measured by 1 3H1 thymidine 
incorporation and expressed as mean counts per minute (CPM). Data presented are mean ± SEM of triplicate wells 
from 5 mice per group. 
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Fig 3.2 Systemic dissemination of H.polygyrus specific T-cells. MLN, Peyers patches (PP), splenocytes and lung 
cells, from infected and naïve BALB/c mice were cultured at 106  cells per well of a 96 well plate. Cells were 
stimulated with l0tg/ml of H.polygyrus Ag (Hp stimulated) or l.&g/ml of Concanavalin A (ConA-stimulated) or 
unstimulated. Local (A) and systemic (B) proliferation in response to stimuli was measured by J'Hj thymidine 
incorporation and expressed as a stimulation index (response to stimulant / unstimulated response) ± SEM. Data 
represent triplicate wells from 5 individual mice per group. 
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3.2.2 Der p1 and OVA-induced allergic airway inflammation in 
C57BLJ6 and BALB/c mice, respectively. 
BALB/c and C57BL/6 mice were given two intraperitoneal (i.p.) immunisations of OVA or Der p1, 
respectively, in alum adjuvant, followed by two localised intra-tracheal (it.) airway allergen 
challenges (Model 2.2. Described in materials and methods). This was also a new model to our 
laboratory and, although having expert assistance, optimisation and familiarisation were required. 
Allergen-specific IgE production is a hallmark of allergy. Allergen immunised BALB/c and 
C57BL/6 mice with or without airway challenges, were assessed for allergen specific IgE 
responses. BALBIc mice responded to OVA with significant anti-OVA serum IgE following 
immunisation (O:-)(P<0.02), with further elevations following airway challenge (O:O)(Fig. 3.4A). 
Anti-OVA IgE was undetectable in immunised C57BL16 mice, with or without OVA airway 
challenge (Fig. 3.4A). The converse strain-specific responses were observed in response to Der 
p1, with C57BL/6 mice producing significant amounts of anti-Der p1 IgE with (D:D, P<0.05), and 
without (D:-, P<0.04), airway challenge (Fig. 3.413). Anti-Der p1 IgE was undetectable in 
immunised BALB/c mice (Fig. 3.413). 
Following airway challenge with the respective allergen, the airspaces of the allergic lung are 
infiltrated by allergen-reactive Th2 cells producing IL-4, IL-5, IL-9 and IL-13, recruiting mast cells, 
basophils and the keystone cells of allergic airway inflammation, eosinophils. OVA or Der p1 
sensitised mice were given two intra-tracheal allergen challenges, and airway infiltrates recovered 
by bronchoalveolar lavage (BAL), 24 hours after the second airway challenge. OVA challenge in 
OVA-sensitised BALB/c and OVA-sensitised C57BL/6 mice resulted in a significant increase in 
cellular infiltrates recovered in BAL fluid (Fig 3.5A). Significant airway infiltration following Der p1 
challenge was only found in Der pl-sensitised C57BL/6 mice and not in Der pi-sensitised 
BALB/c mice (Fig 3.513). In vitro T cell restimulation of thoracic lymph node (TLN) cells revealed a 
lack of Der p1-specific proliferation in Der pi-sensitised BALB/c mice (Fig 15C), which may 
account for the lack of airway infiltration observed in BALB/c mice, following Der p1 challenge. 
TLN isolated from Der pi-sensitised and challenged C57BL/6 mice showed significant in vitro 
proliferation in response to Der p1 (Fig. 3.5C, P<0.008). From these phenotypic parameters of 
allergy, BALB/c mice responded to OVA with measurable specific IgE and airway infiltration. 
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Fig 3.3 Systemic Th2 profile during H.polygyrus infection. (A) Splenocytes from infected and naïve BALB/c 
mice were cultured in 96 well plates in the presence or absence of 10tg/ml H.polygyrus Ag or 11g/ml of 
Concanavalin A (ConA). Supernatants were collected 54 hours after stimulation with cytokine secretions measured 
by ELISA. (B) Antibody isotype profiling from sera, was carried out on infected and naïve BALB/c blood samples. 
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Fig 3.4 Anti-allergen lgE as a marker of Allergic sensitisation. BALB/c and C57BL/6 mice were given two 
intraperitoneal (i.p.) immunisations on day 1 and 14, with lOtg/ml of OVA (A) or Der p1 (B) in alum adjuvant, 
with (0:0, D:D) or without (0:-, D:-) two localised intra-tracheal (i.t.) airway allergen challenges, on day 28 ad 31 
of lOg/ml of allergen in PBS. 24 hours later (Day 32) sera was isolated for allergen-specific IgE detection by 
ELISA. Data presented are mean ± SEM of triplicate wells from 5 mice per group 
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C57BL/6 mice produced significant amounts of anti-Der p1 IgE with airway infiltration measured 
in response to either OVA or Der p1 challenge. We therefore decided to use the experimental 
allergen, OVA, with BALB/c mice and the natural allergen, Der p1, with C57BL/6 mice. 
By pairing mouse strain with allergen (BALB/c-OVA and C57BL/6-Der p1), it allowed us to focus 
on two allergens in two strains of mice and allowed us to test our hypotheses in parallel with two 
independent systems, excluding the possibility of fortuitous cross reactivity between H.polygyrus 
and one allergen molecule. 
To ensure that we were recovering airway infiltrates at the peak of airway infiltration, providing an 
optimal window to observe modifications in cellular influx, we recovered BAL cell infiltrates 24, 48, 
72 and 96 hours post challenge. The greatest cellular airway influx occurred 24 hours post-
challenge in both OVA-challenged BALB/c and Der p1-challenged C57BU6 (Fig. 3.50). 
The stage was set to combine the two models. A primary H.polygyrus infection induced a local 
and systemic Th2 cytokine and antibody profile, with the height of immunological reactivity 
occurring around day 28. At this time, chronicity of infection was confirmed with eggs detected in 
faecal pellets and adults found in the lumen of the intestinal tract. Initial experiments 
characterising the allergy model allowed us to assemble suitable allergen and strain 
combinations, with significant responses in terms of airway infiltration and IgE production. 
3.2.3 Significantly reduced airway inflammation in allergen-
challenged H. polygyrus-i nfected animals. 
BALB/c and C57BL16 mice were infected with 200 infective H.polygyrus larvae before given the 
first of two immunisations (Day 28 and 42) with OVA or Der p1 in alum adjuvant, respectively. 
Mice were then given two airway challenges with the respective allergen in PBS on day 56 and 
day 59 with allergic phenotype assessed 24 hours later on day 60 (Model 2.3. Described in 
material and methods). 
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Airway cellular infiltrates were recovered in BAL, on day 60, at which time infection status was 
also confirmed by detection of faecal eggs and intestinal adults. BAL recovery revealed 
significantly reduced cellular infiltrates into the airways following airway challenges with OVA 
(BALB/c, P<0.001) or Der p  1 (C57BU6, P<0.003), respectively (Fig. 3.6). Differential counting of 
cytospins, from BAL cell recovery, revealed a profound reduction of airway eosinophils (Fig. 3.7, 
P<0.0005). Neutrophilia was also inhibited (Table 3.1). H. polygyrus-infected BALB/c mice 
showed 81.6% and 66.7% decreases in airway eosinophils and neutrophils, respectively, 24 
hours after final challenge with OVA (Table 3.1). 
Similarly, infected C57BL/6 mice had reductions in airway eosinophils (89.0%) and neutrophils 
(29.0%) upon Der p  1 challenge, compared to un-infected littermates, 24 hours after final 
challenge with Der p  1 (Fig. 3.7 and Table 3.1). The reduction of airway infiltrates in chronically 
infected animals was not limited to polymorphonuclear cells (Table 3.1). Macrophage and 
lymphocyte numbers were also reduced in infected mice following OVA or Der p  1 airway 
challenge, although changes did not reach statistical significance. 
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Fig 3.5 Allergen-strain pairing and optimisation of Allergen-induced airway inflammation. BALB/c and 
C57BL16 mice were given two intraperitoneal (i.p.) immunisations on day I and 14, with 10tg/ml of OVA (A) 
or Der p1 (B) in alum adjuvant followed by two localised intra-tracheal (i.t.) airway allergen challenges (0:0 
and D:D) on day 28 and 31 with 10g/ml of allergen in PBS. 24 hours after airway challenge (Day 32) BAL was 
performed with total cell infiltrates in response to OVA (A) or Der p1(B) counted. Thoracic lymph nodes (TLN) 
were removed and single cell suspensions cultured at 106  cells per well of a 96-well plate (C). TLN cells were 
stimulated with 10.sg/mI of Der p1 (Der p1) or lcg/ml of Concanavalin A (ConA) or media alone (-). 
Proliferation was measured by [ 3H] incorporation and expressed as mean counts per minute. BAL cell infiltrates 
were collected from groups of animals 24, 48, 72 and 96 hours post challenge (D) in response to OVA or Der p1. 
Data points are from individual animals (A, B, C) or represent mean a SEM (D) from 5 individual mice per 
group. 
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3.2.4 Reduced tissue pathology following allergen provocation in 
infected mice 
To determine if suppressed airway cellular infiltration represented a more general down-
modulation of pathology, histological sections of lung tissues were compared in infected and 
uninfected allergen sensitised mice. Haematoxylin and eosin (H&E) staining was used to 
characterise cellular infiltrates, and Alcian Blue-Periodic Acid Schiff (AB-PAS) staining to identify 
mucus-producing goblet cells (GCs) in the epithelial border. In addition, mast cell degranulation 
was estimated by measuring levels of the mast cell-specific enzyme, f3—hexosaminidase, in the 
BAL fluid. In uriinfected, allergen-sensitized mice of both strains, airway challenge leads to a 
dense peribronchiolar inflammatory infiltrate of lymphocytes, mononuclear and 
polymorphonuclear cells with epithelial shedding and extended columnal cells. Furthermore, an 
accumulation of mucin-containing GCs were seen to line the connecting airways, underpinning 
the overall increase in mucus production. In contrast, infected mice showed significantly reduced 
tissue inflammation following OVA (BALB/c) or Der p  1 (C57BL16) challenge (Fig. 3.8). In H&E-
stained sections, significantly less pen-bronchial and perivascular cellular infiltration and mucin 
staining was observed, however, epithelium vacuolisation could be seen in the bronchial epithelial 
layer of infected mice. Quantitation of goblet cell numbers showed a substantial reduction in the 
GC response (Fig. 3.9), P<0.0005). Unexpectedly, an increase in BAL fluid mucin was measured 
in chronically infected BALB/c mice following OVA challenge (Fig. 3.10), an observation not seen 
in infected and challenged C5713L16 mice. Allergen-challenged animals also displayed increased 
13—hexosaminidase activity in the BAL fluid, an indication of mast cell degranulation and mediator 
release, which was significantly attenuated in infected mice (Fig. 3.11). 
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Fig 3.6 Reduced cellular infiltration in chronically infected allergen-sensitive mice. Infected (Hp) and uninfected BALBIc 
and C57BL16 mice were given two intraperitoneal (i.p.) immunisations on day I and 14, with l0.ig/ml of OVA (A)or Der p1 
(B) in alum adjuvant followed by two localised intra-tracheal (it.) airway allergen challenges (0:0 and D:D) on day 28 and 31 
with 10.tg/ml of allergen in PBS. 24 hours after airway challenge (Day 32) BAL was performed with total cell infiltrates in 
response to OVA (A) or Der p1 (B) counted. Data presented are mean counts ± SD compiled from 3 experiments (15 mice per 
group). This experiment was conducted six times. 
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Fig 3.7 Reduced airway eosinophilia in chronically infected allergen-sensitive mice. Infected (Hp) and uninfected BALB/c 
and C57BV6 mice were given two intrapentoneal (i.p.) immunisations on day I and 14, with 10sg/ml of OVA (A) or Der p1 
(B) in alum adjuvant followed by two localised intra-tracheal (it.) airway allergen challenges (0:0 and D:D) on day 28 ad 31 
with 10zg/ml of allergen in PBS. 24 hours after airway challenge (Day 32) BAL was performed with eosinophils counted in 
response to OVA (A) or Der p1 (B). Data presented are mean counts ± SD compiled from 3 experiments (IS mice per group). 
This experiment was conducted six times. 
Cell Type 
(xlO'+/-SD) 
Eosinophils Neutrophils Macrophages Lymphocytes 
Naïve 0.028±0.014 0.089±0.011 0.646±0.089 0.104±0.025 
BALB/c 0:0 1.054±0.175 1.265±0.349 0.909±0.275 0.236±0.042 
Hp:0:0 0.224±0.062 0.421±0.050 0.410±0.053 0.144±0.027 
CeH Type Eosinophils Neutrophils Macrophages Lymphocytes 
Naïve 0.018±0.005 0.073±0.016 0.460±0.026 0.064±0.011 
C57BL/6 D:D 1.639±0.312 1.591±0.343 0.394±0.058 0.339±0.059 
Hp:D:D 0.239±0.045 1.129±0.236 0.371±0.041 0.188±0.024 
Table 3.1. Airway cellular infiltrates following airway challenge. BAL cells were identified and quantified by 
morphological and staining characteristics. Data presented are mean counts ± SD compiled from 3 experiments (IS mice per 
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Fig. 3.8 Reduced pathology in H.polygyrus infected allergen sensitised mice. Formalin-fixed 
lung tissue from naïve, allergic (0:0 or D:D) and infected-allergic (Hp:0:0 or Hp:D:D) mice was 
analysed in 5 pm sections stained with Hematoxylin and Eosin (H&E) for nuclear staining of 
infiltrating cells, or Alcian Blue - Periodic Acid Schiff (AB-PAS) for mucin-producing goblet cell 
numbers. This exneriment was conducted six times. 
Fig. 3.9 Reduced goblet 
cell accumulation in 
H.polygyrus infected mice. 
Enumeration of goblet cells. 
stained with Alcian Blue - 
Periodic Acid Schiff (AB-
PAS) in the 3 groups of 
mice. Data represent mean 
and standard error (SEM) of 
5 mice, with a mean score 
from 3 representative lung 
sections per mouse. This 
experiment was 
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3.2.5 Suppression of local type 2 effector cytokines in infected mice. 
Local cytokine and chemokine levels were measured in the BAL fluid, 24 hours following the final 
allergen challenge. Infected and uninfected mice did not differ in levels of the "signature" Thi and 
Th2 cytokines, IFN-y or IL-4, respectively, in BALB/c (Fig. 3.12A) or C57BLJ6 mice (Fig. 3.13A). 
The predominance of IL-4 over IFN-y indicates that infection does not alter the highly polarised 
type 2 cytokine environment associated with airway allergy in both strains. 
The type 2 effector cytokines IL-5, and the chemokine eotaxin, were both elevated in the BAL 
fluid of uninfected BALB/c mice following OVA airway challenge (Fig. 3.1213) and in the BAL fluid 
of uninfected C57BL/6 mice following Der p1 airway challenge (Fig. 3.13B). However, IL-5 and 
eotaxin were significantly diminished by infection (P< 0.008) in both models. IL-5, in addition to 
having eosinophil chemotactic attributes is a priming agent for eosinophils, acting as a 
differentiation and growth factor, increasing responsiveness of mature eosinophils. Eotaxin is a 
local eosinophil chemoattractant, which also acts synergistically with IL-5, helping to mobilise 
eosinophils from the bone marrow and induce eosinophil extravasation into local tissue. Reduced 
IL-5 and eotaxin, in chronically infected mice provides a mechanistic explanation for the 
dramatically reduced airway eosinophilia. Although levels of IL-13 showed less variation between 
groups, this cytokine was highest in uninfected BALB/c mice with the most marked goblet cell 
hyperplasia, with a downward trend in infected mice of both strains (Fig. 3.1213 and Fig. 3.1313). 
We also examined the down-regulatory cytokines IL-10 and TGF-13 (BALB/c, Fig. 3.12C and 
C57BL/6, Fig. 3.13C). The trend for higher IL-10 in infected animals only reached statistical 
significance in C57BL/6 mice (Fig. 3.13C, P<0.008). In some individual animals, the levels of 
active TGF-13 in the lavage fluid of chronically-infected BALB/c mice were greatly elevated, 
suggesting that this mediator may play a major part in immune regulation during infection. 
However in C57BL16, active TGF-P was significantly reduced (P<0.008). Overall, the two strains 
appear to differ in prominence of IL-10 (in C57BL/6 Fig. 3.13C) versus TGF-3 (in BALB/c, Fig. 
3.12C). 
Thus, chronic H. polygyrus infection protects mice against a range of allergic airway inflammatory 
pathologies, including fluid and tissue infiltration, mast cell degranulation and goblet cell 
proliferation. 
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3.2.6 Antibody isotype responses in infection and allergy. 
Helminth infections stimulate a strong type 2 antibody response (IgGi and IgE) both to the 
parasite and to bystander antigens (Jarrett, E. and Bazin, H. 1974; Finkelman, F. D. et al. 1990). 
Parasite driven antibody responses could then presumably interfere with allergen driven antibody. 
production. We therefore decided to measure allergen-specific IgGi and lgG2a isotype 
responses in BALB/c mice to OVA allergen and in C57BL16 mice to Der p1 allergen. OVA-
specific-IgGI levels increased significantly in infected BALB/c mice (Fig. 3.14A, P<0.05) 
consistent with the reported high IL-4 environment (Finkelman, F. D. et al. 1997)(Fig. 3.12A). 
Less expectedly, lgG2a also rose in both strains (BALBIc Fig. 3.14B and C57BL/6 Fig. 3.15B), 
although without reaching statistical significance. We next established that allergen-specific-IgE 
responses are not compromised in helm inth-infected mice (BALB/c- Fig. 3.14C and C57BL16- Fig. 
3.15C). However, infected animals displayed greatly elevated polyclonal IgE titres compared to 
uninfected animals, (BALB/c- Fig. 3.14D and C57BL/6- Fig. 3.15D). 
Elevated polyclonal IgE is symptomatic of most helminth infections, and has been posed as a 
mechanism of escape from allergy, out-competing parasite-specific lgE for binding sites on mast 
cell IgE receptors (Lynch, N. R. et al. 1999). However, in chapters 4 and 5 we show, using 
transfer experiments, that this hypothesis does not provide a sufficient mechanism to protect 
infected mice from allergic airway inflammation. 
3.2.7 Changes in BAL fluid composition in infected mice. 
In search of additional, possibly more subtle, changes in the composition of BAL fluid exudates of 
infected, compared to uninfected, allergen-challenged mice, the composition of BAL fluid was 
analysed using 1 dimensional electrophoresis. Initially 10 ug of total protein obtained from BAL 
fluid, freeze dried to a suitable volume, was run on an SDS-PAGE gel. Additional or more 
pronounced bands were visible at around 37kDa in BAL fluid from infected BALB/c (Fig. 3.16A) 
and C57BL/6 mice (Fig. 3.16B), compared to uninfected mice, following Coomassie blue staining. 
Using an identical quantity of total protein on a similar gel, silver staining revealed greater 
differences in the lavage fluid of infected and uninfected allergen challenged mice. Interestingly, 
in BAL fluid from uninfected-OVA-challenged BALB/c mice a prominent band could be seen at 
around 15 kDa with a comparable band more prominent in infected-Der p1 challenged C57BL/6 
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Fig. 3.11. Reduced mast cell activity in infected allergen sensitised mice. Mast cell degranulation was 
estimated by measuring activity of the mast cell-specific enzyme, b-hexosaminidase, in the BAL fluid of 
naïve, infected and uninfected allergen sensitised mice. Data presented represent enzyme activity measured 
as OD change, relative to background. Data points represent individual animals. This experiment was 
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Fig. 3.12 BAL Cytokine Responses. BAL fluid from naive, allergic, and infected-allergic mice were assayed 
for the indicated cytokines and the chemokine Eotaxin. Data are shown from individual mice responding to 
allergen challenge, with arithmetic mean points shown in solid boxes. (A) Canonical type 1 and type 2 
cytokines, IFN-? and IL-4, (B) Th2 Effector cytokines IL-5 and IL-13, and the chemokine Eotaxin, (C) 
Regulatory cytokines IL-10 and TGF-. Cytokines and chemokine eotaxin were measured by ELISA. P values 
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Fig. 3.13 BAL Cytokine Responses. BAL fluid from naïve, allergic, and infected-allergic C57BL/6 mice were assayed 
for the indicated cytokines and the chemokine Eotaxin. Data are shown from individual mice responding to allergen 
challenge, with arithmetic mean points shown in solid boxes. (A) Canonical type I and type 2 cytokines, IFN-y and IL-4, 
(B) Th2 Effector cytokines IL-5 and IL-13, and the chemokine Eotaxin, (C) Regulatory cytokines IL-10 and TGF-. 
Cytokines and chemokine eotaxin were measured by ELISA. P values were calculated using a Mann-Whitney test. This 
experiment was conducted six times. 
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Fig. 3.14 Antibody isotype 
profile. Allergen-specific serum 
IgGI and lgG2a titres in naïve, 
allergic, and infected-allergic 
mice one day following the final 
airway challenge, measured by 
ELISA with isotype-specific 
monoclonal antibodies. Allergen-
specific IgE titres, measured by 
ELISA in lgG-depleted serum 
samples taken one day following 
the final airway challenge, and 
polyclonal (total) IgE levels, 
measured by capture ELISA in 
the same serum samples. P values 
were calculated using a Mann-
Whitney test. This experiment 
was conducted six times. 
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Fig. 3.15 Antibody isotype 
profile. Allergen-specific serum 
lgGl and lgG2a titres in naïve, 
allergic, and infected-allergic 
mice one day following the final 
airway challenge, measured by 
ELISA with isotype-specific 
monoclonal antibodies. Allergen-
specific IgE titres, measured by 
ELISA in IgG-depleted serum 
samples taken one day following 
the final airway challenge, and 
polyclonal (total) IgE levels, 
measured by capture ELISA in 
the same serum samples. P values 
were calculated using a Mann-
Whitney test. This experiment 
was conducted six times. 
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Fig. 3.16. BAL fluid composition. BAL fluid was concentrated with 101g of total 
protein from naive, allergic and infected-allergic mice separated on an SDS PAGE 
gel. Protein bands were visualised following Coomassie blue staining (BALB/c-A and 
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Fig. 3.17. Serum cytokine profiles. The cytokines IL-4, IL-5, IL-10 and IFN -y were 
measured in serum from naive, allergic and infected allergic mice. Cytokines were measured 
by ELISA. Data represents mean ± SEM from 5 animals per group. This experiment was 
niiu'tp1 6Y time 
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3.2.8 Serum cytokines reveal a systemic reduction in IL-5. 
Finally, due to the enteric location of H.polygyrus and the distal airway challenge site, it was 
decided to measure serum cytokines for potential systemic effects due to infection. Firstly, similar 
to BAL fluid measurements, BALB/c mice did not differ in levels of the signature Thi and Th2 
cytokines, IFN-y or IL-4 (Fig. 3.17A). Interestingly, IFN-y was elevated in the serum of infected-
allergen challenged C57BL/6 mice, possibly explaining the observed lgG2a response, although 
statistical significance was not reached. Furthermore, serum IL-4 was significantly elevated in the 
same mice (P<0.05), possibly counterbalancing IFN-y levels (Fig. 3.17B). Most important, serum 
IL-5 was significantly reduced in both infected BALB/c (P<0.05) and infected C57BL/6 mice 
(P<0.05), compared to uninfected mice. 
In the periphery, eotaxin and IL-5 enter the blood stream and act synergistically to mobilise the 
large reserve of mature eosinophils within bone marrow (Sklar, L. A. et al. 2004). IL-5, in addition 
to its chemotactic attributes is a priming agent and growth factor for eosinophils, increases 
eosinophil responsiveness and differentiation (Hamblin, S. 1993). Thus, a decrease of IL-5 in the 
serum compared to uninfected mice, suggests that systemic suppression of IL-5, may be a key 
feature of helminth associated protection from allergy. 
3.2.9 The timing and possible chronicity of H. polygyrus infection 
may influence the degree of airway suppression. 
To determine whether the timing of infection was important for the observed modulation of allergic 
airway inflammation, mice were either pre-sensitised before infection or infected before 
sensitisation. In the former group, mice were sensitised to OVA or Der p1 on dayl and 14 and 
rested for 14 days before infection with 200 H.polygyrus infective larvae on day 28. Mice were 
then given two airway challenges on day 56 and day 59, with allergic phenotype assessed 24 
hours later (Model 2.4. Described in material and methods). The second group of mice were 
infected first and sensitised from day 28 of infection. This change in protocol, of infecting pre-
sensitised animals, may be more akin to the human situation. Despite allergen sensitisations 
taking months to manifest into allergic disease (Holt, P. G. 2004), sensitisations may precede 
infection. 
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Mice sensitised before infection (0:Hp:0 and D:Hp:D) showed, on challenge, reduced cellular 
influx into the airways in both strains, compared to uninfected mice (0:0), however statistical 
significance was only achieved in C57BL/6 mice (Fig. 3.18B, P<0.03). Airway eosinophilia, 
however, was significantly reduced in BALB/c (Fig 3.18C, P<0.04) and C57BL/6 (Fig. 3.18D, 
P<0.05) mice that were sensitised before infection, compared to uninfected mice. Importantly, this 
experiment also shows that infection alone (Hp:-:-) does not result in any cellular influx into the 
airways. 
The timing of infection did not change the elevated polyclonal IgE levels (BALB/c- Fig. 3.19A and 
C57BL/6- Fig. 3.1913). However, C57BL16 mice, but not BALB/c mice, that were sensitised before 
infection had reduced anti Der p1 IgE levels in the sera (Fig. 3.19), suggesting that infection may 
re-direct or suppress allergen specific IgE production. Statistical significance was not achieved in 
this experiment due to small group sizes. 
Thus, infection of pre-sensitised mice may provide therapeutic protection from allergen induced 
airway inflammation and allergen-specific IgE production. Further investigation is warranted here, 
to elucidate the effects of infection on previous allergen-specific IgE levels, the role of 
immunological imprinting and the therapeutic potential of H.polygyrus infection. H.polygyrus 
derived products, without infection, may have similar 'protective factors', providing new 
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Fig. 3.18. Airway influx can be prevented in pre-sensitised mice with H.polygyrus. BAL cells were 
recovered 24 hours after airway challenge from naïve, infected only (Hp), Allergen sensitised only 
(0:0), Infected and allergen-sensitised (Hp:O:O) and pre-sensitised-infected (0:Hp:0) BALB/c and 
C57BL/6 mice. All mice were given two localised intra-tracheal (i.t.) airway allergen challenges with 
lOigIml of allergen in PBS. Data presented are individual animals with a mean bar. This experiment 
was conducted twice. 
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Fig. 3.19 IgE isotype responses. Allergen-specific and total serum IgE titres in naïve, infected only 
(Hp), Allergen sensitised only (0:0). Infected and allergen-sensitised (Hp:O:O) and pre-sensitised-
infected (0:Hp:0) BALB/c and C57BL/6 mice were measured by ELISA with isotype-specific 
monoclonal antibodies. Allergen-specific IgE titres were measured in IgG-depleted serum samples and 
polyclonal (total) IgE levels, measured by capture ELISA in the same serum samples taken one day 
following the final airway challenge. Data presented are individual animals with a mean bar. This 
experiment was conducted twice. 
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3.2.10 Filarial helminths, as well as intestinal helminths, modulate 
allergic airway inflammation. 
To test the hypothesis that a chronic filarial helminth could also suppress allergic airway 
inflammation, we used the filarial nematode Litomosoides sigmodontis. To date, Litomosoides 
sigmodontis is the only filarial parasite that can achieve chronicity in a murine host (Petit, G. et al. 
1992). Furthermore, preliminary data suggests that a Treg compartment suppressing effector 
responses directed at L.sigmodontis prevents clearance of infection (Taylor, M. et.al  submitted). 
L.sigmodontis is quite distinct from H.polygyrus with respect to lifecycle patterns and localisation 
within the thoracic cavity, surrounding the lungs. The L.sigmodontis model provides an 
independent system to observe the effect of chronic helminth infection on allergic airway 
inflammation. 
BALB/c mice, a strain susceptible to chronic L.sigmodontis infections, were infected sub 
cutaneously on day 0 with 25 infective third stage larvae (1-3) before the first of two OVA-
sensitisations on day 60 and day 74 (Model 2.6. Described in materials and methods) . These 
time points were chosen to allow the infection to become chronic before allergen was 
encountered: Mice were then given two i.t. OVA-challenges on day 88 and 91 with the allergic 
phenotype assessed on day 92 post-infection. BAL was performed 24 hours after the second 
airway challenge. Significantly fewer cells were recovered from L.sigmodontis infected mice 
(Ls:0:0), compared to uninfected controls (0:0) (Fig. 3.20A, P<0.03). Analysis of BAL cellular 
composition revealed significantly fewer airway eosinophils in mice harbouring L.sigmodontis 
(Fig. 3.20B, P<0.002). BAL fluid IL-5 was highest in uninfected animals correlating with airway 
eosinophilia, with reduced IL-5 in some L.sigmodontis infected mice (Fig. 3.20C), however, this 
was not statistically significant. Similar to H.polygyrus infections, polyclonal IgE was elevated in 
mice harbouring L.sigmodontis with uncompromised anti-OVA IgE (Fig. 3.20D). 
L.sigmodontis, establishing a chronic infection prior to allergen sensitisation, significantly reduced 
allergic airway inflammatory responses following airway challenge. Taken together with 
H.polygyrus data, this result may highlight a common mechanism of chronic helminth infections 
involving regulatory networks operating to dampen airway inflammation. Is this a phenomenon of 
chronic helminth infection, or could protection from airway inflammation be achieved with other 
classes of parasite? Furthermore, is the protection from allergy associated with chronic infections, 
regardless of the offending pathogen? These and other intriguing questions relating to infection-
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Fig. 3.20. Chronic Litomosoides sigmodontis infection protects mice from allergic airway inflammation. 
Mice infected with L. sigmodontis for 60 days, establishing a chronic infection, were sensitised with OVA in 
ALUM on day 60 and 74 and given two intratracheal airway challenges on day 88 and 92. BAL was 
performed 24 hours later (Day 92) with Total cell influx (A) and airway eosinophilia (B) assessed. BAL fluid 
was separated for IL-5 measurement (C) by ELISA. OVA-specific and total serum lgE (D), isolated from 
blood collected on day 92, was measured also by ELISA. Data points presented represent individual animals 
with arithmetic mean bars. Statistical analysis and P values were calculated using a Mann-Whitney test. This 
experiment was conducted twice. 
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3.2.11 CD25 cells, but not IL-10, appear to mediate suppression of 
airway inflammation. 
One mechanism by which allergic responses can be down-modulated is by the action of Treg 
cells, releasing antigen-non-specific mediators such as TGF- (Chen, W. et al. 2003) or IL-10  
(Vieira, P. L. et al. 2004). Many Treg populations constitutively express the IL-2Ra chain, CD25, 
and such cells can be depleted in vivo using anti-CD25 (PC61) monoclonal antibody (McHugh, R. 
S. et al. 2002), with the caveat that CD25-expressing effector cells such as activated T- and B-
lymphocytes and activated macrophages may also be affected. Thus, enhanced responsiveness 
following CD25 cell depletion is likely to reflect Treg activity, while diminished responses may 
result from effector cell depletion. In addition, IL-10 is considered to exert a major influence on 
airway allergy, and overexpression of this cytokine can suppress airway inflammation (Oh, J. W. 
et al. 2002). The action of IL-10 family cytokines can be ablated in vivo by injection of antibody to 
the IL-i OR (O'Farrell, A. M. et al. 1998). 
Using H.polygyrus, we investigated whether either or both CD25 cells and IL-10 govern 
protection from allergic airway inflammation. We hypothesised that the expansion of a Treg 
population during H.polygyrus infection has the ability of suppressing not only H.polygyrus-
specific-CD4 effector cells (explaining the chronicity of infection), but also allergen-reactive 
effector cells (explaining the relative protection from allergy). 
In the first set of experiments, 1 mg of anti-CD25 was administered to infected allergen-sensitised 
mice on day 49, seven days before the first of two airway challenges, presuming that C625 cells 
would be depleted throughout both airway challenges (Shimizu, J. et al. 1999). In a separate 
group of infected allergen-sensitised animals, we administered 1mg of anti-IL-10R antibody, 1 
day before the first of 2 airway challenges (Day 55), blocking IL-la signalling during the airway 
challenge period (Model 2.5. Described in materials and methods). 
Infected and allergen-sensitised BALB/c mice, receiving anti-CD25 had significantly , more airway 
infiltrates (Fig. 3.21A, P<0.02) and airway eosinophils (Fig. 3.21C, P<0.02), compared to similar 
infected and allergen-sensitised BALB/c mice given a control antibody. The restoration of airway 
infiltrates and eosinophils suggests that CD25celIs are an essential part of a regulatory network, 
governing protection from allergy. Infected and allergen-sensitised C57BL/6 mice in a parallel 
experiment receiving anti-CD25 on day 49, however, did not show such a dramatic reversal, 
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Fig. 3.21 Anti-CD25 and anti-IL-1OR antibody intervention in infected and allergic mice. Naïve or 
chronically-infected mice were sensitized as previously described. Mice received I mg of isotype control (on 
day 58). PC6I (anti-CD25, on day 51) or I13I.3a (anti-IL-IOR, on day 57). The experiment was terminated on 
day 60. Total BAL cell counts (A. B) and eosinophil numbers (C. D) were counted I day after challenge. Data 
presented represents individual animals and mean bar. This experiment was conducted twice. 
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Fig. 3.22. BAL fluid cytokines following 
anti-CD25 and anti-IL-10R antibody 
treatment. BAL fluid from naïve or 
chronically-infected mice treated with anti-
CD25 or anti-IL-10 was assayed for the 
indicated cytokines and -Hexosaminidase. 
Data are shown from individual mice with 
arithmetic mean points shown in solid boxes. 
P values were calculated using a Mann-
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Fig. 3.23. Antibody isotype responses following anti-CD25 and anti-IL-1OR antibody treatment. Allergen-
specific and total serum IgE titres in naive or chronically-infected mice treated with anti-CD25 or anti-IL-10 were 
measured by ELISA with isotype-specific monoclonal antibodies. Allergen-specific IgE titres were measured in IgG-
depleted serum samples taken one day following the final airway challenge. Data shown are from individual mice 
with arithmetic mean points shown in solid boxes. P values were calculated using a Mann-Whitney test. This 
experiment was conducted once. 
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Fig. 3.24 Anti-CD25 and 2 x anti-IL-10R antibody intervention in infected and allergic mice, with additional 
controls. Naïve or chronically-infected mice were sensitized as previously described; mice were given I mg of control 
Ab (on day 58), PC6I (anti-CD25, on day 51) or IBI.3a (anti-IL-lOR, on day 57 and 60). The experiment was 
terminated on day 62. Total BAL cell counts and eosinophil numbers were counted 1 day after challenge. Data presented 
represents individual animals and mean bar. Significance was tested using the Mann Whitney test. This experiment was 
conducted once. 
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Anti-IL-1OR Ab treatment also restored cellular infiltration in infected and allergen-sensitised 
BALB/c mice (Fig. 3.21C), however eosinophilia was not significantly restored to uninfected 
levels, suggesting that the partial restoration of airway eosinophilia, reflects both IL-10 dependent 
and independent mechanisms, suppressing airway eosinophilia. C57BL/6 mice treated in the 
same way, however, did not show a requirement for IL-b. In this experiment, C57BL/6 mice did 
not show such profound helm inth-induced-suppression of airway allergy, as seen earlier in this 
chapter, which together with small group sizes limited the ability to interpret these data. 
In this series of experiments, infected and allergen-sensitised BALB/c mice had reduced BAL IL-
4, IL-5 and 3-hexosaminidase. Each of these parameters were restored to levels of uninfected 
mice following the depletion of CD25 cells (Fig. 3.22). Reversal of suppressed cytokine levels 
following anti-CD25 treatment further suggests the involvement of CD25 cells. Anti-CD25 Ab 
treatment of infected sensitised C57BL/6 mice, appeared to reduce IL-5 and enhance IL-b, 
suggesting that in this instance anti-CD25 treatment had removed effector cells; however a clear 
interpretation of C57BLi6 data in this experiment could not be carried out. 
Blocking IL-10 signalling in infected allergen-sensitised BALB/c mice did not reverse the levels of 
reduced BAL IL-5 and IL-10 seen in infected BALB/c mice give a control antibody (Fig. 3.22), 
indicating that the reduction in cytokine secretions is not mediated by IL-b. In both strains, 
treatment with either anti-CD25 or anti-IL-1OR did not interfere with total IgE levels (Fig. 3.23) or 
allergen-specific IgE levels (Fig. 3.23), compared to infected allergen sensitised mice given a 
control Ab. 
A caveat in interpreting these experimenti is a lack of treatment controls in uninfected allergen-
sensitised mice. For example, what is the effect of anti-CD25 and anti-IL-10R Ab treatment on 
allergy alone? Therefore, the experiment was modified and repeated in BALB/c mice with 
additional groups of uninfected allergen-sensitised mice receiving antibodies; 2 doses of anti-IL-
1 OR Ab were used, to ensure IL-1 0 signalling was indeed ablated during airway challenge. 
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Fig. 3.26. IgE isotype responses 
following intervention. Allergen-
specific IgE titres were measured in 
lgG-depleted serum samples and 
polyclonal (total) IgE levels, 
measured by capture ELISA in the 
same serum samples taken one day 
following the final airway 
challenge from naïve or 
chronically-infected mice treated 
with anti-CD25 or anti-IL-10. Data 
shown are from individual mice 
with arithmetic mean points shown 
in solid boxes. P values were 
calculated using a Mann-Whitney 
test. This experiment was 
conducted once. 
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Firstly, anti-CD25 antibody treatment had no effect on cellular influx, in particular, eosinophil 
recruitment in uninfected sensitised mice, following airway challenge. Anti-CD25 antibody 
treatment of infected allergen sensitised mice, however, again restored total cellular influx (Fig. 
3.24), with eosinophilia partially restored (Fig. 3.24), back to uninfected levels. Infected allergen 
sensitised recipients of anti-IL-10R antibody showed unchanged levels of eosinophilia with a 
partial increase of total cellular influx (Fig. 3.24), suggesting a partial involvement of IL-b. 
Anti-IL-10R antibody treatment of uninfected-allergen sensitised mice enhanced cellular influx 
into the air spaces (Fig. 3.24), composed mainly of neutrophils; however, anti-IL-10R antibody 
treatment had no effect on airway eosinophilia (Fig. 3.24). 
As shown earlier, changes in BAL cytokines, in particular IL-5 and eotaxin, closely parallel 
changes in airway eosinophilia. Infected and allergen sensitiséd mice again reproduced this 
finding, with reduced IL-5 and eotaxin (Fig. 3.25). Treatment with either anti-IL-10R or anti-CD25 
did not restore these cytokines to uninfected levels, suggesting that neither IL-10 nor CD25 cells 
are uniquely involved in the suppression of these cytokines during H.poiygyrus infection. Anti-IL-
1OR or anti-CD25 Ab treatment had no effect on IL-5 or eotaxin levels in BAL fluid of uninfected 
sensitised mice following airway challenge. IL-4 levels were elevated following anti-CD25 Ab 
treatment of uninfected mice. However, anti-CD25 Ab treatment of infected allergen-sensitised 
mice did not alter reduced IL-4 levels, suggesting that populations other than CD25 cells can 
suppress IL-4 secretion during infection. 
Total IgE was unchanged in infected or uninfected mice, following intervention with either 
antibody treatment (Fig. 3.26). OVA-specific-IgE levels were not altered following antibody 
treatments of uninfected mice. However, infected mice had elevated OVA-specific-IgE levels, 
following anti-IL-10R Ab treatment. Thus, during infection IL-10 may regulate specific IgE 
responses. 
Following allergen encounter and migration to local lymph nodes, airway DCs prime or re-activate 
Th2 cells, propagating further Th2 differentiation with egression back to the airways. We therefore 
decide to look at allergen-driven cytokine secretions in local (thoracic and mediastinal) lymph 
node cultures, to identify any upstream modifications, which may prevent airway inflammation 
(Fig. 3.27). 
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Fig. 3.27 Cytokine secretions within the TLN. TLN removed and cultured from naïve or 
chronically-infected mice treated with anti-CD25 or anti-IL- 10 were cultured in 96-well plates in 
the presence or absence of 10g/ml OVA. Supernatants were collected 54 hours after 
stimulation with cytokine secretions measured by EL1SA. Data presented represent individual 
animals from triplicate wells with mean bar. P values were calculated using a Mann Whitney 
test. This experiment was conducted once. 
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TLN from uninfected allergen-sensitised mice produced considerable amounts of IL-4, IL-5 and 
IL-13, with slightly increased IL-10 secretions, compared to naïve mice (Fig. 3.27), characteristic 
of Th2 mediated airway inflammation. Of note, IL-4 was constitutively secreted while IL-5 was 
generally antigen-specific. Blocking IL-10 binding in uninfected mice with anti-IL-1OR Ab 
dramatically increased IFN-y secretions, with slight increases in IL-4, IL-13 and IL-b. IL-5 
however was reduced, following anti-IL-1 OR Ab treatment. Anti-IL-1 OR Ab treatment of infected 
allergen sensitised mice had similar effects as uninfected mice, with dramatically increased IFN-y 
secretions and increased IL-10 and IL-4, but not IL-13 or IL-5, compared to control Ab treated. 
Thus, IL-10R Ab blocking enhances cytokine secretions (IL-4 and IFN-y) irrespective of infection 
status, suggesting that IL-10 plays an important role regulating both Thi and Th2 cytokine 
secretions. IL-10R blocking, however, did not affect IL-5 secretion. Thus, despite controlling 
excessive Thi and Th2 cytokine secretions, IL-10 appears not to be responsible for the observed 
helm inth-related protection from allergy. 
Anti-CD25 treatment of uninfected allergen sensitised mice dramatically increased OVA induced 
IL-13 with an additional increase of IL-4 and IL-10 from lymph node cultures, suggesting that 
CD25 cells in allergy alone may control Th2 cytokine secretions (Fig. 3.27). Anti-CD25 treatment 
of infected allergen-sensitised mice however, did not have the same effect, with IL-4 remaining 
unchanged, compared to either infected or uninfected, with or without treatment. IL-5 and IL-13 
were still reduced and unchanged, compared to uninfected mice treated with anti-CD25, 
indicating that either CD25-independent mechanisms can regulate TLN T112 cytokine secretions 
or that anti-CD25 treatment has also removed effector cells. Significantly, IL-5 was reduced with 
or without anti-CD25 treatment, mirroring BAL (Fig. 3.12) and serum (fig. 3.17) IL-5 levels, 
suggesting a CD25-independent, IL-10-independent mechanism of systemically suppressed IL-5 
during infection. Although not yet identified, a mechanism suppressing IL-5 during infection would 
inhibit both anti-helminth and pro-allergic responses, suggesting a pathway for reduced allergy 
during helminth infection. 
To further appreciate the regulatory events unfolding in the local lymph nodes with infected 
allergen-sensitised mice and mice receiving anti-IL-1 OR or anti-CD25 Ab treatment we decided to 
monitor changes in the CD4CD25 compartment. Induction of airway allergy in uninfected mice 
did not change the number of CD4CD25 cells in the TLN (Fig. 3.28A, C), compared to naïve 
mice. The presence of a chronic H.polygyrus infection increased the number of CD4CD25 cells 
from 6.4% to 9% of the TLN CD4 compartment. H.polygyrus infection, however, did not change 














100 	101 	 102 	 10 3 	 104 
CD4 
10 	- 
i 	1 	1 	I 	lot  
CL)4 









1 04T—.—.--.-  -- 
0 	 520  
0.62 
. 
iSO 	151 	102 	103 	iO4 
C04 






i CP 	10 1 	102 	153 	154 
C04 
.0 	 582  
10 
0 	 0.76 
010 
::. IOLA- , 
100 	101 	102 	13 	104 
CD4 
	
. 	 •:, 
uP lOt 	102 	10 3 	104 I 	 C04 
C 
N V V 
io 






10 0 	101 
2 
83.9 
102 	103 	104  
CD4 
Chapter 3. Infection and Allergy 
A 	TotaITLNCD4 
N 	00 I50 00 p00 00 1p00 
Co"iI A 	n,I1..i0R 	.Il.0O2S 
B 	Total Lung CD4 
25 
SnOn 00 HpOO 00 1400 00 t00 






0 ct 0 
'..I.3O 	0 C0:0 	N0:0 0:0 	Hp:0.0 






Nave 	0:0 	Ho:00 00 	N0:0:0 0:0 	Ro:0:0 
Fig. 3.28. Changes in CD4CD25 expression in TLN following antibody intervention. TLN and lungs 
were removed from naïve or chronically infected allergen-sensitised mice treated with anti-CD25 or anti-IL-
bR. Total CD4' cells and the expression of CD25, on CD4 gated cells, in the TLN (A, C) and Lung (B) 
were determined by flow cytometry. Cells were stained using fluorescently labelled monoclonal antibodies - 
CD4-APC and CD25-PE and were acquired on a FACScalibur using Celiquest and analysed using Flowjo. 
Data points (A, B) represent individual animals with an arithmetic mean bar. This experiment was 
conducted once. 
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Unexpectedly, allergen-sensitised mice treated with anti-IL-10R, irrespective of their infection 
status, had a vastly reduced CD4CD25 compartment in the lung (Fig. 3.288) and TLN (Fig. 
3.28A, C), suggesting that CD4CD25 cells require IL-10 signalling for their survival. This 
fundamental question of basic Treg biology requires further investigation. Is there a compromised 
CD4CD25 compartment in IL-10 deficient mice? Or do compensatory mechanisms bypass this 
deficiency? As expected, CD4CD25 cells were significantly removed following anti-CD25 Ab 
treatment. 
These studies suggest that a cellular population expressing CD25 is partially responsible for the 
suppression of airway infiltration, with partial restoration of airway eosinophilia following CD25 
cell removal in infected mice. IL-10 during airway provocation, however, may not be required for 
the observed protection, or function of a regulatory network, but appears to regulate cytokine 
secretions in uninfected mice. IL-10 blockade results in exacerbated Thi and Th2 cytokine 
secretions and exacerbated cellular influx into the lung, following airway challenge of uninfected 
mice, indicating that IL-10 does indeed play a major role in regulating inflammation in uninfected 
mice. However, the presence of a chronic helminth infection appears to regulate airway 
inflammation independent of IL-10 signalling. 
Intervention studies like these allowed us to remove particular components of a network, without 
using genetically deficient mice, which may have developed compensatory mechanisms to 
overcome their particular deficiency. However, this intervention study also has limitations, with 
multiple cellular populations expressing CD25, and concerns regarding suitable antibody doses to 
ablate IL-b. Thus, these studies can only suggest potential components of a regulatory network. 
To confirm the activity or involvement of particular components, more definitive transfer 
experiments were designed and are described in further chapters. 
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3.3 Discussion 
Allergies are Th2 cytokine-mediated pathologies, involving IL-4, IL-5 and IL-13-dependent 
amplification of innate effector cell populations acting together with antibodies and inflammatory 
mediators (Herrick, C. A. and Bottomly, K. 2003). As Thi and Th2 responses are mutually 
antagonistic, it has been argued that declining microbial stimulation of Thl responses in the 
developing world has led to over-vigorous allergic Th2 reactions (Martinez, F. D. and Holt, P. G. 
1999). However, allergen-specific Thi cells can in fact exacerbate airway inflammation (Hansen, 
et al. 1999). Moreover, epidemiological reports increasingly link Th2-inducing helminth 
parasite infections with reduced allergic disease in humans (reviewed in (Wilson, M. S. and 
Maizels, R. M. 2004)), and murine studies have likewise reported attenuated allergic responses in 
nematode-infected mice (Wang, C. C. et al. 2001; Bashir, M. E. et al. 2002; Wohlleben, G. et al. 
2004). A revised 'Hygiene Hypothesis' has now emerged which postulates that pathogen-
induced regulatory T cell populations (Tregs) control both Thi and Th2 effector populations 
(Wills-Karp, M. et al. 2001; Yazdanbakhsh, M. et al. 2001; Umetsu, D. T. et al. 2002; 
Yazdanbakhsh, M. et al. 2002; Wilson, M. S. and Maizels, R. M. 2004). The possibility that Tregs 
inhibit allergic disease has in parallel received growing support from both animal models (Weiner, 
L. 2001; Akbari, 0. et al. 2003) and human studies (Umetsu, D. T. et al. 2003; Akdis, M. et al. 
2004; Ling, E. M. et al. 2004). 
This chapter now provides additional evidence to support the hypothesis that helminth infection 
down-regulates allergic reactivity, through the action of a regulatory population rather than by 
altering the ThlITh2 balance. To do this we selected the murine intestinal nematode H. polygyrus 
as a model of helminthiasis (Monroy, F. G. and Enriquez, F. J. 1992; Bashir, M. E. et al. 2002). 
H.polygyrus follows a purely enteric infective cycle (Monroy, F. G. and Enriquez, F. J. 1992) and 
establishment; has the ability to establish stable, chronic infections; and evokes a Th2-dominated 
immune response similar to that observed in general with gastro-intestinal nematodes. We were 
able to confirm these reports, with chronic infections accompanied with local and systemic 
dissemination of H.polygyrus specific T-cells. These T-cells are indeed Th2 cells, confirmed by 
their cytokine secretion profile and diminished IFN-y secretions following in vitro re-stimulation 
(Fig. 3.1). Furthermore, anti-H.polygyrus antibodies were significantly skewed towards a Type 2 
profile with lgGl and IgE secretions (Fig. 3.3). 
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We chose an allergic airway inflammation model, which permits us to observe modifications in 
cellular recruitment, cytokine and chemokine expression, and tissue pathology. We also opted to 
study two allergens in parallel, in different strains of mice: the environmental aeroallergen Der p 
1, a major allergen of the house dust mite, which evokes allergy in C57BL/6 mice (Fig. 3.4, 3.5); 
and the well-characterised experimental allergen, ovalbumin (OVA) which induces airway 
inflammation in BALB/c mice (Fig. 3.4, 3.5). 
Mice carrying an established and continuing chronic helminth infection are shown here to be less 
prone to allergic airway inflammation, whether measured by the inflammatory infiltrate in BALF 
(Fig. 3.6, 3.7), by pen-bronchial and pen-vascular inflammation (Fig. 3.8, 3.9) or by mast cell 
activity (Fig. 3.11). Our results extend earlier work with H. polygyrus demonstrating reduced 
allergy to food antigens in mice infected with this gastrointestinal parasite (Bashir, M. E. et al. 
2002). More broadly, these findings can be translated to the human situation, in which individuals 
carrying active helminth infections have, in epidemiological studies, been reported to be less 
responsive to allergen provocation, than co-residents free of infection (Lynch, N. R. et al. 1993; 
Araujo, M. I. et al. 2000; Selassie, F. G. et al. 2000; van den Biggelaar, A. H. et al. 2000; Araujo, 
M. I. et al. 2004). 
A significant explanation for the observed protection from allergy seen in infected humans is that 
helminth infection results in both parasite-antigen-specific IgE, and very high levels of polyclonal 
IgE. The resulting elevation in total serum IgE could either, or both, dilute out allergen-specific IgE 
and saturate the FcERI receptors on mast cells and basophils (Lynch, N. R. et al. 1999). From the 
studies reported within this chapter, we cannot exclude this, as elevated total lgE was observed 
in infected allergen sensitised mice (Fig. 3.14, 3.15), with no change in allergen-specific IgE. 
However, this model of allergic airway inflammation has been scrutinised and is predominately a 
T-cell / IL-4 mediated model (Brusselle, G. G. et al. 1994; Gavett, S. H. et al. 1994) with similar 
allergen-induced airway inflammatory responses observed in mice carrying a null mutation of CF, 
and unable to produce IgE (Mehlhop, P. D. et al. 1997). This model does not allow us to directly 
test this hypothesis. Experiments to exclude the possibility that IgE competition is the basis of 
allergy suppression are presented in subsequent chapters. 
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To dissect the mechanism behind helminth-induced suppression of airway inflammation, we first 
established that no major change to the Th1/Th2 balance had occurred (Fig. 3.12A, 3.13A), 
fulfilling the scenario that suppression of a Th2-associated pathology occurs within the context of 
a Th2-inducing helminth infection. Within the BAL fluid of allergen-sensitised mice, IL-5 and 
eotaxin were consistently elevated (Fig. 3.12B, 3.13B) following allergen airway challenge. Mice 
harbouring a chronic H.polygyrus infection, however, secreted significantly less IL-5 and eotaxin 
following airway challenge, explaining the reduced eosinophilia in infected mice. 
IL-5 is a necessary component for airway inflammation (Coyle, A. J. et al. 1995; Ying, S. et al. 
1997; Hamelmann, E. et al. 1999), working synergistically with the predominant eosinophil 
chemoattractant, eotaxin (Jose, P. J. et al. 1994; Rankin, S. M. et al. 2000). IL-5 induces 
peripheral blood mobilization of mature eosinophils into the circulation with increased CCR3 
expression and thus heightened responsiveness to endogenous chemo- attractants such as 
eotaxin (Park, S. W. et at. 2003). Significantly, IL-5 was considerably reduced in the sera of 
chronically infected mice, compared to uninfected mice (Fig. 3.17). IL-5 is a crucial component in 
allergic asthma and has been proposed as a therapeutic target (Leckie, M. J. et al. 2000). 
Significantly, reduced IL-5 and eotaxin in chronically infected mice provides a suitable explanation 
and down-stream mechanism of reduced airway eosinophilia. 
IL-13, similarly, was highest in uninfected mice and reduced in infected mice, following airway 
challenge. A picture is thus emerging of reduced Th2 effector cytokine secretion into the 
airspaces of mice harbouring a chronic infection. IL-13 is another vital Th2 cytokine implicated in 
allergic airway inflammation, involved in goblet cell hyperplasia (Zhu, Z. et at. 1999; Zhu, Z. et al. 
2001) cellular recruitment (Hart, P. H. S. 2001) airway eosinophilia (Cohn, L. et at. 2001) and pro-
fibrotic developments in chronic asthma (Postlethwaite, A. E. et al. 1992). Reduced goblet cells, 
observed in chronically infected mice (Fig. 3.8, 3.9), may presumably be associated with reduced 
IL-13 in BAL fluid. 
How could IL-5, IL-13 and eotaxin be suppressed or prevented from being produced during 
H.polygyrus infection? Major sources of IL-5 and IL-13 are Th2 cells and mast cells. Suppression, 
by Treg cells, of either T112 cell induction with reduced cytokine secretion or activation of mast 
cells, would accordingly fit into this picture. Elevated secretions of IL-10 in C57BU6 and TGF-p in 
BALB/c airspaces may indicate a role for these immunomodulatory cytokines in regulating Th2 
cell activity and cytokine secretion. 
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The hypothesis that Treg activity may be responsible for this phenomenon was further supported 
by our finding that anti-CD25 antibody treatment reversed suppression. However, allergic 
inflammation was not restored by administration of anti-IL-10R antibody, indicating that Treg 
activity in this setting is not IL-10-dependent. Interestingly, we have uncovered a possible 
dependence of CD4CD25 cells for IL-10 signalling, however this needs further, and more 
detailed and accurate, assessment. 
This chapter has also tested the therapeutic use of H.polygyrus to 'treat' allergen-induced airway 
inflammation. Pre-sensitised mice infected with H.po!ygyrus before allergen provocation did not 
respond to allergen challenge as zealously as uninfected mice. Furthermore, Der p1 sensitised 
C57BL/6 mice showed reduced serum Der p1-specific IgE, implying that infection had reduced 13- 
cell activity or skewed antibody production to another isotype. The modified Th2 hypothesis 
suggests just this, with class switching to lgG4 production (IgGi in mice) from IgE, possibly under 
the control of IL-b. These findings certainly require further investigation. In addition, this maybe 
a suitable model to test parasite-derived molecules as therapeutic agents; to inhibit allergen-
induced airway inflammation. 
Litomosoides sigmodontis, a murine filarial nematode, can also significantly suppress or prevent 
OVA-induced airway inflammation. L.sigmodontis and H.polygyrus both represent 'successful' 
helminths, achieving chronic patent infections in their natural hosts, the cotton rat and mouse 
respectively. Can other helminths that achieve chronicity in their hosts regulate allergic 
inflammation? If so, is there a common mechanism? Can the evolutionary adaptations that 
helminths have acquired to achieve chronicity, with the suppression of inflammatory response 
being a prime example, be exploited and mimicked to suppress unwanted inflammatory 
responses, such as asthma and autoimmune inflammatory disorders? 
In summary, this chapter has combined models of chronic helminthiasis and allergen-induced 
airway inflammation, using OVA and Der p1, which will now be explored to address further 
questions in this thesis. We have shown that a chronic H.polygyrus or L.sigmodontis infection can 
defuse OVA-induced and Der p1-induced airway inflammation, with reduced cellular recruitment, 
cytokine and chemokine secretions and airway pathology. 
104 
Chapter 3. Infection and Allergy 
Furthermore we have shown that anti-CD25, but not anti-IL-10R, antibody treatment reversed 
suppression, suggesting that cells expressing CD25 mediate protection from airway inflammation 
and that H.poiygyrus associated protection operates independent of IL-b. Interestingly, following 
anti-IL-10R Ab treatment, CD4CD25 cells were also diminished, however the reversal of 
suppressed airway inflammation was not. Thus, other cellular populations, in addition to CD25 
cells may also operate to regulate airway inflammation. In the following chapters will directly 
address the regulation of airway inflammation by H.po!ygyrus induced cellular populations and 
ask questions pertaining to cellular mechanism, which govern this phenomenon. 
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Chapter 4.Suppression of Allergic Airway Inflammation with 
MLNC from Chronically Infected Donors 
4.1 Introduction. 
Dysregulated airway inflammation, characteristic of airway allergy, can be tamed by 
expanding or restoring regulatory populations (Zuany-Amorim, C. et al. 2002). Cellular 
models of immune regulation can be experimentally tested by adoptive transfer with defined 
cellular populations. In the simplest form, Thi cells can regulate Th2 induced inflammation 
through the inhibition of Th2 development (Jankovic, D. et al. 2001). However, allergen-
specific Thi cells do not prevent, but have been shown to exacerbate, airway inflammation 
when co-transferred with allergen-specific Th2 cells (Hansen, G. et al. 1999). Regulatory T 
cells (Treg), however, at the centre of a recently proposed anti-inflammatory network, can 
reduce the severity of allergic reactivity (Tsitoura, D. C. et al. 2000; Wills-Karp, M. et al. 2001; 
Bach, J. F. 2002; Umetsu, D. T. et al. 2002; Zuany-Amorim, C. et al. 2002; Akbari, 0. et al. 
2003; Herrick, C. A. and Bottomly, K. 2003; Jutel, M. et al. 2003; Karlsson, M. R. et al. 2004). 
Transfer studies have not only identified the importance of Tregs in controlling allergic airway 
inflammation (Jaffar, Z. et al. 2004) but have permitted innovative studies to dissect the 
possible mechanism of Treg suppression of airway inflammation. For example, the transfer of 
T cells transfected with IL-b 0 or TGF-P can prevent allergic airway inflammation (Oh, J. W. et 
al. 2002) (Hansen, G. et al. 2000). Treg cells from allergic patients show a deficiency in the 
ability to suppress effector responses (Bellinghausen, I. et al. 2003; Cavani, A. et al. 2003; 
Akdis, M. et al. 2004; Grindebacke, H. et al. 2004; Ling, E. M. et al. 2004). Thus, a deficiency 
in Treg function may be the underlying cause of the present allergy epidemic and wider 
epidemic of immune disorders. 
Additionally, mature pulmonary DC's exposed to allergen can induce IL-10 secreting TO cells 
and can significantly suppress allergen induced airway reactivity following adoptive transfer 
(Akbari, 0. et al. 2002).. Thus, other cells such as DCs, B cells and macrophages which 
interact with T cells in an antigen presenting manner, or cells such as NKT cells or non-
lymphoid cells which may influence T-cell development and function indirectly, may also be 
involved in regulation of allergy. 
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From the previous chapter (Chapter 3), we established that a chronic helminth infection 
protected mice from allergen-induced airway inflammation, measured by: 1) cellular 
recruitment into the air spaces and lung tissue; 2) cytokine, chemokine, mucin and - 
hexosaminidase secretions into BAL fluid; 3) pathological changes in lung tissue and 4) local 
antigen-specific responsiveness and cytokine secretion profiles. Following intervention 
studies with the blocking of IL-10R and the depletion of cells expressing CD25, we uncovered 
at least one potential mechanism involving cells expressing CD25, as several of the above 
mentioned parameters associated with an allergic phenotype were restored following CD25 
cell depletion of infected mice, prior to airway challenge. 
Building upon these observations and to test directly the involvement of a cellular population 
responsible for, and capable of, transferring protection from allergic airway inflammation 
during helminth infections, we decided to use an adoptive cell transfer model to address the 
following question; 
1. Can cells from chronically infected mice transfer protection from allergic airway 
inflammation to uninfected, sensitised recipients? 
This question focuses on the nature of cells generated in response to a chronic infection, in 
regard to their in vivo anti-inflammatory properties. We hypothesise that Treg cells are 
particularly important in controlling helm inth-specific responses and that these cells can also 
regulate allergen-specific responses. This would require an indirect, non-specific mechanism, 
through immunomodulatory cytokines such as IL-10 or TGF-, because Treg cells from 
chronically infected donors are allergen-naive. 
Using an adoptive transfer model, this question has been directly addressed, allowing us to 
exclude other confounding mechanisms which may also be involved in reducing allergy 
during helminth infections. 
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4.2 Results 
4.2.1 Mesenteric Lymph node cells (MLNC) from H.polygyrus 
infected mice display both Th2 and Regulatory cell 
phenotypes. 
From the previous chapter, the peak of T-cell responsiveness to H.polygyrus was seen at day 
27 in the mesenteric lymph nodes (MLN) (Fig. 3.2A). In vitro re-stimulation of these MLNC 
with H.polygyrus Ag reveals vigorous proliferation (Fig. 4.1A) and presents a characteristic 
Th2 response, with elevated parasite-specific IL-4, IL-5, and IL-13 and no measurable IFN-y 
(Fig 4.113). In addition, IL-10 secretion was also elevated, which may promote Th2 cell 
development and / or Treg development and function. IL-10 production was confirmed by 
intracellular cytokine staining, which showed an increase in IL-10 expression and a slight 
increase in IL-5 in MLNC from infected mice (Fig. 4.2). IFN-y and TNF-a were both 
measurable, however these levels were reduced, compared to naïve MLNC (Fig. 4.2). 
The percentage and composition of T cells within the mesenteric lymph nodes of infected 
mice also changed at day 26, With significantly fewer CD4 cells in the MLNC of infected mice 
compared to uninfected littermates (Fig. 4.3A, Inset, P<0.02). The CD4 T cell compartment 
of chronically infected mice was then screened for markers associated with regulatory T cells, 
using fluorescently labelled antibodies. MLNC from chronically infected mice had a higher 
percentage of CD4 cells co-expressing CD25, CD103, GITR, CTLA-4 and surface bound 
TGF-13, all markers associated with Treg cells (McHugh, R. S. et al. 2002)(Fig. 4.313). 
Statistical significance was achieved with elevated expression of CDI03, compared to 
uninfected controls (Fig. 4.3, P<0.05). The increased number of cells expressing regulatory T-
cell markers and producing intracellular IL-10 along with surface bound TGF-3, strongly 
support the existence of Treg cells in the MLN during a chronic H.polygyrus infection. The in 
vitro regulatory function of these cells has yet to be demonstrated and will be an important 
area of further investigation. Similarly, the origin of cells expressing Treg markers during 
infection is an unanswered question of major significance. 
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Fig. 4.1 MLNC responses at day 28. MLN cells were isolated 
from BALB/c mice 28 days post infection with H.polygyrus. 
Cells were re-stimulated in vitro with l0tg/ml H.polygvrus Ag 
(Hp), Concanavalin A (ConA) or unstimulated ( - ). (A) 
Proliferation was measured by [ ' 1­11-thymidine  incorporation 
and expressed as mean counts per minute (CPM). (B) Culture 
supernatants were collected 54 hours after stimulation with 
cytokine secretions measured by ELISA. Data presented are 
mean ± SEM of triplicate wells with at least 5 mice per group. 
P values were calculated using a Mann Whitney test. This 
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Fig. 4.2 Intracellular cytokine 
expression of MLNC 28 days post 
infection. Intracellular cytokine 
expression of MLNC from 
chronically-infected mice was 
determined by flow cytometry. Cells 
were stained using CD4-APC and PE-
labelled anti-cytokine and acquired 
using a FACScalibur and Cellquest 
software. Cells were first stained for 
surface CD4, before fixing and 
permeabi I ising. Cells were then 
stained for intracellular cytokines. 
Data presented is the percentage of 
cytokine expressing cells within the 
CD4 or CD4 compartments, as 
indicated, with one representative 
FACS plot. Data is expressed as mean 
percentage ± standard deviation from 
a group of 5 mice. This experiment 




CD4- - C134+ 
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IL-ID 0.81 ± 0.21 138 ± 0.66 0.64 ± 0.16 3.92 ±1.17 
IL-5 0.13 ± 0.02 0.25±0.07 0.04 ± 0.01 0.12± 0.06 
IFN-y 1.87 ± 0.87 112 ± 047 0.98 ± 0.52 0.50±0.20 
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Fig. 4.3 Expression of surface molecules on MLNC (A) and CD4 cells (B), 28 days post infection. 
The percentage of CD4 cells in the MLN of infected mice was first determined, using fluorescently 
labelled anti-CD4. Average number of total MLN cells; naïve = 5.08±O.311xlO', Infected = 
15.43±O.93x10. Co-expression of CD25, CD103, GITR. CTLA-4 and TGF-P on CD4 cells was then 
determined using fluorescently labelled monoclonal antibodies. Cells were acquired on a FACScalibur 
using Cellquest software and analysed using Flowjo. Data is presented as percentage expression of 
MLNC (A) or percentage expression in the CD4 cellular compartment. Data presented is individual 
mice with mean bars. P values were calculated using a Mann Whitney U test. This experiment was 
conducted twice. 
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4.2.2 MLNC from Infected, but not naïve, mice can transfer 
protection from allergic airway inflammation, without the 
requirement for antigen re-exposure. 
The following experiments directly address the question whether cells from chronically 
infected mice can transfer protection from allergic airway inflammation to uninfected 
recipients. Four weeks after primary H. polygyrus infection, MLNC were recovered, washed 
and counted, and transferred into the tail vein of uninfected, allergen-sensitized recipient 
mice. After a further 7 days, recipient mice were given the first of 2 airway challenges, with 
airway responses measured one day after the last airway challenge (Model 2.7. Described in 
materials and methods). In the first instance, 5x10 7 MLNC from infected or uninfected BALB/c 
or C57BL/6 donors were transferred into OVA-sensitized BALB/c or Der pl-sensitised 
C571BLi6 recipient mice. One day after adoptive cell transfer, mice were given 100 pg of H. 
polygyrus antigen, as indicated. OVA-sensitised BALB/c mice, receiving MLNC from 
chronically infected donors, but not from naive donors, had significantly lower levels of airway 
infiltration and eosinophilia (Fig. 4.4A, P<0.04) following OVA challenge. 
Similarly, 5x10 7 MLNC from chronically infected, but not naïve C57BLi6 donors could transfer 
the protective effect, with significantly reduced total and eosinophil infiltrates (Fig. 4.413, 
P<0.03). Furthermore, Der p 1-sensitized C57BL/6 mice were protected from allergen-
induced airway infiltration when given 5x10 7 MLNC from infected donors, whether or not 
recipient animals were given 100 pg of H. polygyrus antigen one day later (Fig. 4.4A). From 
these experiments, MLNC from infected donors could transfer the protection from allergen 
induced airway infiltration and were shown not to require antigen re-exposure and TCR 
engagement to transfer the protective effect. 
BALB/c mice receiving MLNC from infected donors had reduced BAL IL-5 and significantly 
reduced IL-10 following OVA challenge (Fig. 4.5, P<0.008). C57BL/6 mice receiving MLNC 
from infected donors also had significantly less BAL fluid IL-5 (P<0.04), but elevated IL-la, 
with or without exogenous H.polygyrus Ag (Fig. 4.5). Reduced IL-5 in both models, identifies 
a pathway associated with reduced airway eosinophilia. BAL fluid IL-4 was unchanged 
following cell transfer (Fig. 4.5) with undetectable IFN-y (not shown). 
Serum IgE levels showed considerable variability within experimental groups making 
interpretation difficult (Fig. 4.6). Total IgE was unchanged in BALB/c mice receiving cells from 
naïve or infected donors (Fig. 4.6A); however, C57B1J6 mice appeared to have reduced total 
serum IgE following cell transfer (Fig. 4.6C), which was elevated with the addition of 
exogenous parasite antigen. 
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Fig 4.4A Reduced airway cellular infiltrations in mice receiving MLNC from chronically infected 
donors. Uninfected allergen-sensitised mice were given 5xl0 MLNC from infected or naive donors and 
10Og of H.polygyrus antigen where indicated (+Ag), 7 days before two localised intra-tracheal (i.L) airway 
allergen challenges (0:0 or D:D). 24 hours after airway challenge (Day 32), BAL cell infiltrates in response 
to OVA or Der p1 were collected and differentially counted. Data presented are individual animals with 
mean bars. P values were calculated using a Mann Whitney test. This experiment was conducted twice. 
fl-s. 
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Fig 4.4B Reduced airway cellular 
infiltrations of C57BL/6 mice receiving 
MLNC from chronically infected 
donors. Uninfected allergen-sensitised 
C57BL16 mice were given 5xl0 7 MLNC 
from infected or naive donors, 7 days 
before two localised intra-tracheal (i.t.) 
airway allergen challenges (D:D). 24 hours 
after airway challenge (Day 32). BAL cell 
infiltrates in response to Der p1 were 
collected and differentially counted. Data 
presented are individual animals with 
mean bars. P values were calculated using 
a Mann Whitney test. This experiment was 
conducted twice. 
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Fig. 4.5. BAL fluid cytokines following adoptive transfer. BAL fluid recovered from allergen 
sensitised mice receiving 5x 1 0' MLNC from naïve or chronically infected donors, 7 days before 
airway challenge. Where indicated, mice were also given lOOtg of H.polygyrus Ag (+Ag) one 
day after cell transfer. Cytokines were measured by ELISA. Data are shown from individual 
mice responding to allergen challenge, with arithmetic mean points shown in solid boxes P 
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Fig. 4.6 Antibody isotype profile. Allergen-specific serum IgE and total IgE titres in allergen 
sensitised mice receiving 5x1  07  MLNC from naïve or chronically infected donors, 7 days before 
airway challenge. Where indicated, mice were also given 100g of H.polygyrus Ag (+Ag) one 
day after cell transfer. One day following the final airway challenge allergen-specific IgE Litres, 
measured by ELISA in IgG-depleted serum samples and polyclonal (total) IgE levels, measured 
by capture ELISA in the same serum samples were determined. Data are shown from individual 
mice responding to allergen challenge, with arithmetic mean points shown in solid boxes. P 
values were calculated using a Mann-Whitney test. This experiment was conducted twice. 
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In both strains of mice, OVA-specific and Der p1 specific, IgE was unchanged following cell 
transfer and airway challenge (Fig. 4.613, D,). 
To determine the potency of MLNC from chronically infected donors, the number of MLNC 
transferred from infected donors to allergen-sensitised recipients was titrated from 5x10 7 to 
1x107. Significant suppression of total cellular infiltrates and airway eosinophilia could be 
observed with as few as 1x10 7 MLNC from chronically infected donors of either strain (Fig. 
4.7, P<0.05). Further titration may uncover the full potential and potency of this cellular 
population 
BAL fluid IL-5 and eotaxin in both strains of mice following the transfer of 1x10 7 MLNC from 
infected donors was reduced (Fig. 4.8). IL-10 was variably elevated in BAL fluid of Der p1 
sensitised C57BL/6 receiving 1x10 7 MLNC from infected donors, similar to previous 
observations in chronically infected mice challenged with Der p1 (Fig. 4.5). BALB/c recipients 
of MLNC showed no change in BAL fluid IL-10 secretions. 
Levels of total lgE and allergen-specific IgE were unchanged in recipients of infected MLNC 
(Fig. 4.9), indicating that cell transfer can suppress allergy without altering IgE production. 
Thus, the IgE-Hypothesis'- pertaining to a possible mechanism of helminth mediated 
protection from allergy, is not supported in this cell transfer model. 
Together, these experiments demonstrate that cells generated in, or recruited to, the MLN of 
mice chronically infected with H.polygyrus can protect allergen-sensitised recipients from 
airway inflammation and cytokine hyper-secretion following allergen challenge. The inhibition 
of IL-5 and eotaxin secretion into the airways appears to prevent eosinophil recruitment and is 
consistent with the studies presented in chapter 3 with infected allergen-sensitised mice. 
These studies were then extended by analysis of cell subpopulations within the mesenteric 
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Fig 4.7 Reduced total and eosinophil airway infiltration of allergen-sensitised mice receiving MLNC 
from chronically infected donors. Uninfected allergen-sensitised C57BL16 mice were given lx 10 7, 2x107 
or 5xl07  MLNC from infected donors, 7 days before two localised intra-tracheal (i.t.) airway allergen 
challenges (BALB/c -0:0 or C57BL16 —D:D). 24 hours after airway challenge (Day 32), BAL cell infiltrates 
in response to allergen challenge were collected and differentially counted. Data presented is the mean 
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Fig. 4.8. BAL fluid 
cytokines following 
adoptive transfer with 
Ix107 MLNC. BAL fluid 
recovered from allergen 
sensitised mice receiving 
IxlO7-5xl07 MLNC from 
chronically infected donors. 
7 days before airway 
challenge. Cytokines and 
eotaxin was measured by 
ELISA. Data are shown 
from individual mice 
responding to allergen 
challenge, with arithmetic 
mean points shown in solid 
boxes. P values were 
calculated using a Mann-
Whitney test. This 
experiment was conducted 
once. 
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Fig. 4.9 IgE antibody profile. Allergen-specific serum IgE and total IgE titres were measured in allergen 
sensitised mice receiving lx iO - 5x10 7 MLNC from chronically infected donors, 7 days before airway 
challenge. Allergen-specific IgE titres were measured by ELISA in lgG-depleted serum samples and 
polyclonal (total) IgE levels, measured by capture ELISA in the same serum samples. Data are shown 
from individual mice responding to allergen challenge, with arithmetic mean points shown in solid boxes. 








Fig. 4.10. CD4 and CD4 
purification. MLNC were 
incubated with anti-CD4-labelled 
microbeads and separated over a 
magnetic column. Labelled CD4 
cells, retained on the column, and 
unlabelled CD4 cells, which passed 
over the magnetic column, were 
washed and stained with either 
fluorescently labelled anti-CD4 mAb 
(blue line), or a paired isotype 
control (red line) to determine the 
purity. Cells were acquired on a 
FACScalibur using Cellquest 
software and analysed using Flowjo. 
Data are expressed as a percentage 
of CD4 cells, relative to the isotype 
control. This experiment was 
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4.2.3 CD4 and CD4 cells transfer protection from chronically 
infected donors to allergen-sensitised recipients. 
MLN from chronically infected donors were sorted using anti-CD4-labelled microbeads into 
two populations based on CD4 expression. The purity (>96%) of the CD4 and CD4 
compartments was confirmed using a fluorescently labelled anti-CD4 monoclonal antibody, 
analysed by flow cytometry (Fig. 4.10). Based on the ability of 1x10 7 cells to transfer 
protection against allergic airway inflammation, and the fact that approximately 40% of the 
MLNC is comprised of CD4 cells, subset transfers compared 4x10 6 CD4 cells anda similar 
number of CD4 cells. 
OVA-sensitized and Der pl-sensitised mice receiving CD4 cells from infected donors had 
significantly reduced total cell (BALB/c P<0.004, C57BU6 P<0.008) and eosinophil (BALB/c 
P<0.0001, C57BL/6 P<0.002) infiltration in recovered BAL fluid (Fig. 4.11) 24 hours after 
airway challenge. Furthermore, CD4 cells transferred from infected donors also significantly 
reduced airway eosinophilia in both strains (Fig. 4.11, BALB/c P<0.025, C57BL/6 P<0.005). 
However, the effect of CD4 cells was more pronounced in Der p1 sensitised C57BL16 mice, 
with diminished total and eosinophil infiltration, after airway challenge. 
Cytokine analysis of BAL fluid revealed reductions in key cytokines following cell transfer. 
Eotaxin and IL-10 were both significantly reduced following CD4 transfer into OVA-sensitised 
BALB/c mice (Fig. 4.12A, P<0.02), with reductions of BAL cytokines and chemokine; IL-5, 
Eotaxin and IFN-y, with the transfer of CD4 cells into Der pi-sensitised C57BLJ6 mice (Fig. 
4.12B). Of note, IL-10 was elevated, although not significantly, in C57BL/6 mice receiving 
CD4 and CD4 cells, again suggesting a role for IL-10 in suppression of airway allergy in the 
C57BL/6 mouse strain. 
Neither total IgE nor allergen-specific IgE, in either strain, were significantly altered following 
cell transfer into allergen-sensitised mice (Fig. 4.13), compared to allergen-sensitised mice 
alone, although CD4 cell transfer into BALB/c mice tended to result in elevated IgE. Overall, 
these data indicate that suppression is not IgE mediated. 
Thus, CD4 cells generated in BALB/c or C57BL/6 mice chronically infected with H.polygyrus 
can transfer protection from OVA-induced or Der p1-induced airway inflammation, 
respectively. Furthermore, cells within the CD4 compartment of MLN from chronically 
infected C57BL/6 mice, can also transfer protection' from Der p1-induced airway inflammation. 
Not surprisingly, more than one cellular population may be converted or induced to regulate 
inflammatory responses. 
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Fig 4.11 Reduced total and eosinophil airway infiltration of allergen-sensitised mice receiving CD4 or 
CD4 cells from chronically infected donors. Uninfected allergen-sensitised mice were given 4x10 6 CD4 or 
CD4 cells isolated from the MLN of infected donors, 7 days before two localised intra-tracheal (ii) airway 
allergen challenges. 24 hours after airway challenge, BAL cell infiltrates were collected and differentially 
counted. Data are shown from individual mice responding to allergen challenge, with arithmetic mean points 
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Fig. 4.12. BAL fluid cytokines following adoptive transfer with CD4 or CD4- cells from infected 
donors. BAL fluid was recovered from uninfected allergen-sensitised mice given 4xl0 6 CD4' or CD4 cells 
isolated from the MLN of infected donors. BAL fluid was assayed for cytokines and eotaxin, measured by 
ELISA. Data are shown from individual mice responding to allergen challenge, with arithmetic mean points 
shown in solid boxes P values were calculated using a Mann-Whitney test. This experiment was conducted 
five times 
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Fig. 4.13 IgE antibody profile. Allergen-specific serum IgE and total IgE titres were measured by 
ELISA with isotype-specific monoclonal antibodies from allergen sensitised mice receiving 4x10 6 CD4 
or CD4 cells from chronically infected donors, 7 days before airway challenge. Allergen-specific IgE 
titres were measured by ELISA in IgG-depleted serum samples and polyclonal (total) lgE levels, 
measured by capture ELISA in the same serum samples. Data are shown from individual mice 
responding to allergen challenge, with arithmetic mean points shown in solid boxes. This experiment was 
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Fig. 4.14 Cytokine secretion profile (A) and purities of CD4 and CD4 cells isolated from infected IL-10' and 
WI mice. MLNC were isolated from IL-10 - and wild type mice 28 days post infection with H.polygyrus. Cells were 
re-stimulated in vitro with 10ig/ml H.polygyrus Ag (Hp), Concanavalin A (ConA) or medium alone (-). Culture 
supernatants were collected and assayed for cytokine secretions 54 hours after stimulation (A). Cytokine secretions 
measured by ELISA. Data are shown from individual mice, with arithmetic mean points shown in solid boxes of 
triplicate wells. (B) MLNC were incubated with anti-CD4-labelled microbeads and separated over a magnetic column. 
Labelled CD4 cells, retained on the column, and unlabelled CD4 cells, which passed over the magnetic column, were 
washed and stained with fluorescently labelled anti-CD4 or isotype mAb. Cells were acquired on a FACScalibur using 
Cellquest software and analysed using Flowjo. Data are expressed as a percentage of CD4 00 cells. This experiment was 
conducted once. 
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4.2.4 Transfer of protection with IL-10-deficient MLN cells from 
infected mice 
To address the role of IL-10 in the down regulation of allergic responses, CD4 and C04 
cells were isolated from MLN of chronically-infected IL-10 deficient mice (IL-10) on the 
C57B1J6 background (Fig 4.14B) and transferred into uninfected, allergen-sensitized recipient 
wild-type mice seven days before Der p1 airway challenge. 
Before transfer, MLNC from WT and IL-10 deficient mice were re-stimulated in vitro, to 
confirm IL-10 deficiency and identify other changes in cytokine secretions due to the lack of 
IL-b. No major changes in cytokine profile were observed other than generally elevated IL-5 
in the absence of IL-b. Interestingly, parasite specific IFN-y was produced in response to in 
vitro re-stimulation (Fig. 4.14A). 
Der p1 sensitised mice, receiving 4x1 06  CD4 cells from chronically infected IL-10 -/- mice 
showed reduced airway infiltration and eosinophilia in comparison to allergen-sensitised mice 
receiving CD4 cells from infected wild-type donors (Fig. 4.15). Transfer of CD4 cells from 
either IL-10-/- or wild type mice showed a diminution of allergic outcome, which narrowly failed 
to attain statistical significance. This experiment suggests that IL-10 is not an essential 
component of the pathway by which helminth-induced cells can suppress recipient airway 
infiltration. However, importantly, this does not exclude the involvement of IL-10, as allergen-
sensitised wild type recipient mice were IL-10 competent. Conceivably, cells from infected 
donors may induce IL-10 production from recipient cells, in turn preventing the manifestations 
seen in allergen-induced airway inflammation. 
IL-5 and eotaxin secretion into the airspaces, collected in BAL fluid, was suppressed following 
the transfer of 4x106 CD4 cells from IL-10-/- mice, indicating that CD4 cells can suppress the 
secretion of these mediators independent of donor IL-10 (Fig. 4.16). However, despite 
reduced cellular infiltrates following CD4 cell transfer from IL-10 -/- mice, reductions of IL-5 did 
not reach significance. Furthermore, BAL eotaxin levels were highly variable between 
individual mice receiving CD4 cells from IL-10 -/- mice (Fig. 4.16). Thus, reduced airway 
infiltration following CD4 cell transfer from chronically infected donors, may require IL-10 from 
donor cells. IL-10 in the BAL fluid of recipient mice, following airway challenge, was 
unchanged, with the exception of mice receiving CD4 cells from infected wild type donors, 
contrary to previous data (Fig. 4.12). However, due to the heterogeneity of the CD4 
population, further analysis is required to identify specific populations within this 
compartment. 
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Fig 4.15 Total and eosinophil airway infiltration following CD4 or CD4 transfer from chronically 
infected lL-10 or WT donors. Uninfected allergen-sensitised mice were given 4x10 6 CD4 or CD4 cells 
from infected IL-10 or WT donors, 7 days before i.t. airway challenge. 24 hours later, BAL cell infiltrates 
were collected and differentially counted. Data are shown from individual mice responding to allergen 
challenge, with arithmetic mean points shown in solid boxes. P values were calculated using a Mann Whitney 
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Fig. 4.17 IgE antibody profile following adoptive transfer with CD4 or CD4-
cells from chronically infected IL-10 or WT donors. Allergen-specific serum 
IgE and total IgE titres, measured by ELISA with isotype-specific monoclonal 
antibodies, from allergen sensitised mice receiving 4x106 CD4 or CD4 cells from 
infected IL- 10 - or WT donors, 7 days before i.t. airway challenge. Data are shown 
from individual mice responding to allergen challenge, with arithmetic mean points 
shown in solid boxes. This experiment was conducted twice. 
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Allergen-specific IgE was not significantly altered, but slightly reduced as a result of 
transferring CD4 or CD4 cells from chronically infected IL-10' or wild type donors (Fig. 
4.17A). Allergen-sensitised mice receiving CD4 cells from wild-type and IL-10" donors, 
however, had slightly reduced total IgE levels, although not significantly (Fig. 4.17B). 
One important property of cells generated in IL-10 deficient mice, which is often overlooked, 
is that these cells are not simply deficient in IL-b, but have most likely developed 
compensatory functions to overcome this deficiency. For example, one consequence of 
knocking out IL-10 is the emergence of a stronger IFN-y response (Fig. 4.14A), which may 
influence IgE production, or more importantly, may confound observations of reduced airway 
eosinophilia. The use of genetically modified animals must therefore be interpreted with some 
degree of caution. 
From these studies, however, it appears that CD4 cells from chronically infected donors 
harbour a potent population of cells capable of reducing allergen-induced airway 
inflammation, supported by greater reductions of airway eosinophils and BAL IL-5 and eotaxin 
levels. Furthermore, the regulatory function of these cells does not appear to require IL-10. 
Following these observations, further discrimination within the CD4 compartment was carried 
out. 
4.2.5 Transfer of protection with CD4 CD25 T cells 
To directly test whether infection induces Treg cells with a CD25 phenotype and to track the 
active cellular population within the CD4 compartment, MLNC from chronically-infected mice 
were separated into CD4CD25 and CD4CD25 enriched populations (Fig. 4.18). Briefly, 
CD4 cells were negatively selected, using streptavidin coated microbeads and biotinylated; 
anti-CDIIb, anti-CD8a, anti-MHC class II and anti-IgK, followed by positive selection of 
CD25 cells using anti-CD25 microbeads. 
Building on previous observations, we decided to transfer the number of CD4CD25 cells 
contained within 1x107 unseparated MLNC. Thus, 3x10 5 CD4CD25 and CD4CD25 cells 
were transferred, using an identical schedule as used for MLNC, CD4 and CD4 cell 
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Fig. 4.18. CD4*CD25*  and CD4CD25 isolation from MLN of chronically infected mice. MLNC were 
removed from chronically infected mice. CD4 cells were negatively selected, using streptavidin coated 
microbeads and biotinylated anti-CD! lb. anti-CD8a, anti-MHC class II and anti-Igic. Cells labelled with 
microbeads were retained in a magnetic column, allowing CD4 cells to pass. CD25 cells from the CD4 
pool were positively selected with anti-CD25 microbeads. Cell purities were determined with fluorescently 
labelled monoclonal antibodies CD4-APC and CD25-PE and were acquired on a FACScalibur using 
Cellquest software and analysed using Flowjo. This experiment was conducted three times. 
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Fig 4.19 Total and eosinophil airway infiltration following CD4CD25 or CD4CD25 transfer from 
chronically infected donors. Uninfected allergen-sensitised mice were given 3x10 5 CD4CD25 or CD4CD25 
cells from infected donors, 7 days before it. airway challenge. 24 hours later, BAL cell infiltrates were collected 
and differentially counted. Data are shown from individual mice responding to allergen challenge, with 
arithmetic mean points shown in solid boxes. P values were calculated using a Mann Whitney test. This 
experiment was conducted three times. 
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Fig. 4.20. BAL cytokines following CD4CD25 or CD4vCD25  transfer from chronically-infected 
donors. BAL was fluid recovered from uninfected allergen-sensitised BALB/c (A) and C57B1J6 (B) 
mice given 3x105 CD40CD25 or CD4 0CD25' cells from infected donors, 7 days before i.t. airway 
challenge. BAL fluid was assayed for cytokines and eotaxin, measured by ELISA. Data are shown 
from individual mice responding to allergen challenge, with arithmetic mean points shown in solid 
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Fig. 4.21. BAL fluid IL-13 and IL-13Ra2 levels following CD4CD25 or CD4CD25 transfer from 
chronically infected donors. BAL was fluid recovered from uninfected allergen-sensitised BALB/c (A) and 
C57B1J6 (B) mice given 3x107 CD4CD25' or CD4CD25' cells from infected donors. 7 days before it, airway 
challenge. IL - 13 and IL-13Rcz2 was measured by ELISA. Data are shown from individual mice responding to 
allergen challenge, with arithmetic mean points shown in solid boxes. P values were calculated using a Mann-
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Fig. 4.22 igE antibody profile following CIWCD25 or CD4CD25 transfer from chronically infected donors. 
Allergen-specific serum lgE and total IgE titres, measured by ELISA with IgE-specific monoclonal antibodies, 
from uninfected allergen-sensitised mice given 3x105 CD4CD25 or CD4CD25 cells from infected donors. 7 days 
before it, airway challenge. Data are shown from individual mice responding to allergen challenge, with arithmetic 
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Fig. 4.23. Changes in the CD4CD25 compartment of Lungs and TLN following transfer of CD4CD25 and 
CD4CD25' from NILN of chronically infected mice. TLN and Lung cells were isolated from uninfected allergen-
sensitised mice given 3x10 CD4'CD25 or CD4'CD25 cells from infected donors. 7 days before it. airway challenge. 
Cells were labelled with fluorescently labelled monoclonal antibodies CD4-APC and CD25-PE and were acquired on a 
FACScalibur using Cellquest software and analysed using Flowjo. Data are presented as CD4 cells co-expressing CD25 
from individual mice responding to allergen challenge, with arithmetic mean points shown in solid boxes. This 
experiment was conducted three times. 
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In both BALB/c mice sensitized to OVA and C57BU6 sensitized to Der p1, the most puissant 
reduction of total cellular infiltration (Fig. 4.19), was observed with the transfer of CD4CD25 
cells. Moreover, airway eosinophilia was significantly reduced (BALB/c, P<0.02 and C57BL/6, 
P<0.02), following CD4CD25 transfer. Evidence was also found that the CD4CD25 
population can also contribute to abatement of allergic reactivity, but not as consistently as 
CD4CD25 cells. These data argue that the CD4CD25 phenotype T cell population, at 
least, can mediate suppression of cellular airway infiltration in both strains of mice. 
CD4CD25 cells from chronically-infected mice potently suppressed BAL IL-5, eotaxin, IL-10 
and IFN-y in OVA-sensitised BALB/c mice (Fig. 4.20A). C57BLi6 mice receiving CD4CD25 
cells from infected donors also showed dramatic reductions of BAL IL-5, eotaxin and IFN-y 
although significance was not achieved with IL-5 reduction (P<0.057)(Fig. 4.20B). CD4CD25 
cells also reduced BAL cytokine secretions in OVA-sensitised BALB/c and Der pi-sensitised 
C57BL/6 recipients, although not quite as powerfully. 
Interestingly, following transfer into allergen sensitised recipients and airway challenge, IL-13, 
measured by ELISA, was elevated in several mice, although significance was not achieved 
(Fig. 4.21). Elevated IL-13 in BAL fluid would be predicted to exacerbate pathology and 
heighten airway reactivity to allergic stimulus, unless IL-13 was dysfunctional or bound to a 
decoy receptor. These observations prompted us to measure IL-13Ra2, an IL-13 decoy 
receptor found in chronic inflammatory settings (Mentink-Kane, M. M. et al. 2004). IL-13Ra2 
levels were slightly elevated in C57BLJ6 mice receiving CD4CD25 cells (Fig. 4.21), relative 
to sensitised mice, with lower IL-13 levels. Although not significantly elevated, this may be 
physiologically relevant. Serum IgE levels were unchanged following CD4CD25 or 
CD4CD25 cell transfer into allergen sensitised recipients (Fig. 4.22). 
As we had supplemented allergen-sensitive mice with CD4CD25 (Treg) cells, we decided to 
screen TLN and lung tissue for any shifts in CD4CD25 or CD4CD25 populations in these 
two locations. The percentage of CD4 cells co-expressing CD25 in the thoracic lymph nodes 
or lung were unchanged (Fig. 4.23), suggesting that the balance between effector regulatory 
cells had not been significantly disrupted, if in fact CD25 expression alone is a reliable marker 
for the regulatory population in vivo. 
Accompanying reduced cellular influx and suppressed BAL cytokine secretiors with 
CD4CD25 cell transfer from chronically infected to allergen-sensitised recipients; goblet cell 
hyperplasia and mucous plugging were also reduced. 
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Alcian blue periodic acid-Schiff (AB-PAS) staining of paraffin-embedded lung sections 
revealed a dense layer of mucin containing goblet cells lining the bronchioles of OVA-
challenged and Der p1 challenged mice (Fig. 4.24A, B). Mice receiving CD4CD25 cells from 
infected donors had significantly fewer goblet cells lining the bronchioles (Fig. 4.24A, B and 
4.25, P<0.05) following OVA or Der p1 challenge. However statistical differences were not 
achieved in Der p1 challenged mice, due to sample numbers. AB-PAS staining of lung 
sections taken from mice receiving CD4CD25 cells revealed a reduction in goblet cells in 
some OVA-challenged mice, however, scoring was variable, with some mice showing 
increased staining (Fig. 4.2413 and Fig. 4.25). 
In summary, CD4CD25 cells generated in the MLN of mice chronically infected with 
H.polygyrus are at least one population that can transfer the protective effects of infection into 
allergen-sensitised recipients. Throughout this series of adoptive transfer experiments, a 
consistent reduction of BAL fluid IL-5 and eotaxin secretions has closely mirrored airway 
eosinophilia. Thus, a mechanism involved in the suppression of these eosinophil associated 
mediators, presumably at their conception from Th2 cells, could underpin the observed 
protection from airway eosinophilia. 
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Fig. 4.24 Reduced pathology following transfer of CD4CD25 cells from MLN of chronically infected mice. 
Formalin-fixed lung tissue from uninfected allergen-sensitised BALB/c (A) and C57BL16 (B) mice given 3x10 5 
CD4CD25 or CD4CD25 cells from infected donors. 7 days before i.t. airway challenge were analysed in 5 jm 
sections stained with Alcian Blue - Periodic Acid Schiff (AB-PAS) for mucin-producing goblet cell numbers. This 
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Fig. 4.25 Goblet cell accumulation following transfer of CD4CD25 cells from MLN of chronically 
infected mice. Enumeration of goblet cells, stained with Alcian Blue - Periodic Acid Schiff (AB-PAS) from 
uninfected allergen-sensitised mice given 3x10 5 CD4CD25 or CD4CD25 cells from infected donors, 7 
days before i.t. airway challenge. Data from individual mice responding to allergen challenge, with 
arithmetic mean points shown in solid boxes from a mean score from 3 representative lung sections per 
mouse. P values were calculated using a Mann-Whitney test. This experiment was conducted once. 
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4.3 Discussion 
This chapter follows and builds on observations made in chapter 3, and aimed to dissect the 
mechanism behind helminth-induced suppression of airway inflammation. To address this we 
established an adoptive transfer system with MLNC from infected mice. This allowed us to 
demonstrate that down-regulation is mediated by T cells primarily those with a CD4CD25 
phenotype, which has emerged as a major Treg population (Sakaguchi, S. et al. 2001; 
Shevach, E. M. 2002). However, several distinct regulatory phenotypes of Treg cells have 
been proposed, although clear divisions of lineage or function remain elusive. uTh3  cells, 
primarily acting through TGF-, are most closely associated with the gut mucosal 
environment, while "Tr" cells are thought to suppress airway allergy through IL-10 (Weiner, 
H. L. 2001; Akbari, 0. et al. 2003). Interestingly, the H. poiygyrus-elicited Tregs are generated 
in the "Th3" environment but manifest their function in the "Tr" environment. Moreover, 
despite the prominence of IL-10 production by H. polygyrus-exposed T cells, their ability to 
suppress airway allergy does not appear to be mediated by IL-10, as MLNC from infected IL-
10' mice can mediate suppression, and suppression is intact in animals given anti-IL-10R 
antibodies. 
CD4CD25 T cells are generally associated with self-reactive regulatory cells, which prevent 
autoimmune reactivities (Sakaguchi, S. et al. 2001; Shevach, E. M. 2002). Hence, the 
expansion of CD4CD25 cell-mediated regulatory activity in infection raises the issue of the 
origin and antigen specificity of these cells (Mills, K. H. 2004). Are there pre-existing "Natural" 
Treg phenotype cells which expand in response to infection, or do regulatory cells arise from 
naive ThO precursors which adopt the "Adaptive" Treg behaviour? As with other instances of 
Treg responses to pathogens (Belkaid, Y. et al. 2002; McGuirk, P. et al. 2002), these 
questions have yet to be resolved. However, it does appear that the CD4CD25 T cells are 
not allergen-specific as suppression takes effect within 7 days of transfer from an allergen-
naive donor: therefore protection from allergy can take place without a requirement for 
allergen-specific Tregs. 
Infectious tolerance is one possible explanation for the suppression of allergy in this system, 
with the expansion of a host allergen-specific regulatory population in recipient animals. The 
transfer of regulatory capacity from donor regulatory cell, to host naïve cell, has previously 
been shown in nasal tolerance studies (Unger, W. W. et al. 2003). Additionally, this model of 
allergic airway inflammation is dependent upon allergen-specific T cells, lending to a T cell-to-
T cell interaction. Direct T cell-to-T cell or T cell-to-DC interaction involving Notch (Hoyne, G. 
F. et al. 2001), CTLA-4 (Vasu, C. et al. 2004), PD-1, BTLA (Watanabe, N. et al. 2003) and 
surface bound TGF-P all warrant further investigation. 
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The transfer model also allows us to exclude changes in antibody production as major 
mechanism for suppression of allergy. For example, the production of allergen-specific-IgE is 
comparable in mice receiving naïve or infected MLNC, which show respectively normal and 
suppressed allergic reactions. Moreover, there is no rise in polyclonal IgE in recipients of 
infected CD4 T cells, arguing that changes in either absolute allergen-specific IgE (or in the 
ratio of non-specific to specific lgE) are not responsible for the diminution of allergic 
responses in infected animals. A similar conclusion was drawn from measurements.of 
specific and total IgE in atopic and non-atopic humans harbouring chronic schistosome 
infections (van den Biggelaar, A. H. et al. 2000). 
Unexpectedly, CD4 cells from chronically infected C57BL16 mice also displayed protective or 
suppressive properties in vivo, protecting Der p1-sensitive mice from airway inflammation. 
Sub-populations within this heterogeneous compartment are addressed in the following 
chapters. 
In summary, this chapter has identified modifications within the mesenteric lymph nodes of 
chronically infected mice, including a higher percentage of cells co-expressing CD25, CDI03, 
GITR, CTLA-4 and surface bound TGF-P with significant amounts of IL-10 measured by 
intracellular staining and ELISA. Future work characterising the kinetics, function and 
segregation of defined Treg populations within the MLN, Peyers patches and intra-epithelial 
layers during infection, are warranted. Additionally, a key question is whether these Treg 
populations derive from ThO or natural CD4CD25 cells, or are induced by H.polygyrus 
secreted products, such as IMF (Telford, G. et at. 1998 (helminth)), as seen in schistosome 
infections (van der Kleij, D. et al. 2002). Are Treg populations found within the MLN of 
H.polygyrus infected mice H.polygyrus specific? Furthermore, do these cells function alone or 
in collaboration with dendritic cells or .B cells to elicit their affair with T cells? Many questions 
remain relating to the generation of Treg populations during infection. 
Adoptive transfer of MLNC from chronically infected, but not naïve, mice protected allergen-
sensitive recipients from airway inflammation after allergen challenge. These experiments set 
the stage for more focused adoptive transfer experiments, excluding the requirement for 
exogenous parasite antigen and allowed us to focus on specific populations. MLN CD4 cells 
from infected mice emerged as the most potent sub-population, capable of transferring 
protection. Furthermore, CD4 cells from infected C57BL/6 donors can transfer protection 
independent of IL-b. CD4 cells, also, from infected C57BLJ6 donors can transfer protection. 
However, the requirement for IL-10 is less clear in this heterogeneous division of MLNC. 
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Finally, CD4CD25 cells from infected C57BL/6 or BALB/c donors surfaced as a 
predominant population capable of suppressing airway inflammation and pathology in 
allergen-sensitive mice. CD4CD25 cells could also transfer protection, although this 
population was more variable. 
Finally, if the findings of these studies are generally applicable, in the human context as well 
as the murine, then the effects of helmirith infection must be considered on a broader stage. 
First, Treg induction is likely to be a major plank for parasite survival, and interference with 
the regulatory network may provide an immunological cure for helminth infestation in 
developing countries. Secondly, however, it is incumbent to learn how helminths may activate 
Treg functions and to translate such knowledge for the development of new therapeutics to 
combat the ever-increasing allergy epidemic worldwide. 
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Chapter 5 Suppression of Allergy with CD4 cells from Mice 
Chronically Infected with H.Dolyayrus. 
5.1 	Introduction. 
The results presented in chapter 4 raised the possibility that non-CD4 cells participate in the 
process of immunological interference during helminth infection. Non-CD4 cells may be 
capable of regulating T cell effector function or development either by direct interaction with T 
cells in an antigen-presenting manner or by indirect influence, for example, via cytokine 
mediators. In this chapter, these possibilities are examined with respect to DCs and B cells 
respectively. 
Most DC studies with helminths have addressed initial antigen encounter and the Th2 
polarisation (Balic, A. et al. 2004). During chronic helminth infections, with constant antigen 
exposure, one study has reported reduced APC capacity with attenuated CD4 T cell 
responses (Semnani, R. T. et al. 2003). Signals during helminth infections may promote a 
regulatory environment, such as in the example of lysophosphatidylserine (lyso-PS), a lipid 
fraction derived from schistosomes, which stimulates DCs and converts naïve T cells into IL-
10-secreting T cells (van der Kleij, D. et al. 2002). DCs exposed to IL-10 in vitro adopt a 
plasmacytoid morphology with low CD11c expression and high CD45RB expression; they 
then themselves secrete high levels of IL-10 and can induce tolerance through Ag-specific 
TO cells (Wakkach, A. et al. 2003). Presumably, if parasite exposed DCs conditioned in 
environments of high IL-10 were transferred, within the CD4 fraction, they may posses 
inhibitory signals, increased IDO activity (Mellor, A. L. et al. 2004) or tolerance-inducing 
properties, capable of inhibiting allergen-specific T-cell proliferation or inducing Treg cells, as 
seen with lyso-PS. 
During chronic helminth infection, under the influence of IL-4, macrophages adopt an 
'alternative' phenotype associated with reduced APC capacity (Flores Villanueva, P. 0. et al. 
1994; Loke, P. et al. 2000; Rodriguez-Sosa, M. et al. 2002). Alternatively-activated 
macrophages are distinguishable from classically-activated macrophages by high levels of 
arginase and variable Yml and FIZZ secretions (Nair, M. G. et al. 2003). 
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There is also considerable data pertaining to how CD8 T cells are integrated into a protective 
response with regard to viral challenge (Wong, P. and Pamer, E. G. 2003). What is less well 
understood is how CD8 T cells function in the context of chronic helminth infections. 
Increased numbers of activated CD8 cells have been reported in blood samples from 
chronically infected patients (Kalinkovich, A. et al. 1998). The ability of CD8 cells to suppress 
CD4 cell proliferation during helminth infection or following exposure to helminth products 
(Kizaki, T. et al. 1993; Pedras-Vasconcelos, J. A. and Pearce, E. J. 1996) may also be 
transferable. CD8 cell derived IFN-y can reduce allergen-specific CD4 proliferation 
(Marsland, B. J. et al. 2004), outlining a potential association of helminth derived CD8 cells 
and protection from allergy. 
Despite B cells making up to 45% of secondary lymphoid organs, they have received 
relatively little attention with regard to immune regulation. T and B cell interactions, with two-
way signals, are integral to the establishment of adaptive immune responses; therefore the 
manipulation of B cells as well as T cells by helminth products could alter the final direction of 
effector responses. B cells can also operate as long-term APCs dictating and directing T cell 
development via 137-1 and 137-2 / CD28 interactions. 
S.mansoni infection of either [tMT mice (Ferru, I. et al. 1998) or JHD mice (Hernandez, H. J. 
et al. 1997), both of which are deficient in B cells, induces a polarised ThI response with 
increased IFN-y and IL-12 from soluble egg antigen stimulated (SEA) T cells, compared to the 
characteristic Th2 response seen in infected WI mice. Furthermore, S.mansoni infection of 
tMT mice display increased fibrosis, indicating a requirement for B cells to limit pathology 
(Ferru, I. et al. 1998). In vitro treatment of B cells with N.brasiliensis adult worm homogenate, 
significantly suppressed B cell proliferation, acting via accessory cells, such as macrophages 
(Ehigiator, H. N. et al. 2000), demonstrating again that B cells are important regulators of 
pathology and that B cell function can be directly modulated during helminth infection. 
A regulatory role for B cells has been well established in models of autoimmune disease 
(Wolf, S. D. et al. 1996; Mizoguchi, E. et al. 2000) and intestinal inflammation (Mizoguchi, A. 
et al. 2002). Regulatory function in these settings could be related to B cell secretion of IL-10 
(Mizoguchi, A. et al. 2002) or TGF- (Kehrl, J. H. et al. 1986; Parekh, V. V. et al. 2003) or 
interestingly, indirectly by the recruitment of Treg cells (Bystry, R. S. et al. 2001). 
Thus, B cells are a possible active population in the transfer of protection against allergy. This 
possibility is also supported by B cells accounting for the majority of CD4 cells within the 
mesenteric lymph nodes, their secretion of immunoregulatory cytokines secretions, and 
finally, their ability to recruit Treg cells via chemokine gradients. 
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Unexpected results obtained in Chapter 4 revealed that the CD4 compartment, within the 
mesenteric lymph nodes of chronically infected C571BL/6 mice, when transferred into allergen 
sensitive mice, were capable of suppressing cellular influx and airway eosinophilia. 
Deciphering components of the CD4 compartment with the capacity to inhibit allergen 
induced airway inflammation took a bilateral approach, based on the following questions; 
firstly, what are the cellular populations within the CD4 compartment, that we had previously 
transferred, which could mediate protection? i.e. does this observation fit into any known 
model or is this novel. Secondly, during helminth infections, what phenotype do non-CD4 
populations adopt? And, could they provide inhibitor signals preventing allergen induced 
airway inflammation? 
We hypothesised that APCs (in the first instance, B cells or DCs) from chronically infected 
donors were mediating this protection. We tested this hypothesis, by firstly identifying these 
and other cellular components of the CD4 compartment, during the chronic stages of 
infection. Using the adoptive transfer model, we could ask the following specific questions: 
Can B cells or DCs from chronically infected mice protect Der pI-sensitised recipient mice 
from Der p1-induced airway inflammation? 
What is the phenotype of B cells or DCs during infection? 
Do these cells act directly to suppress Der p1-specific responses, or induce a host 
regulatory response? 
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5.2 Results 
5.2.1 CD4 cells from chronically infected wild type or lL-10 
mice, but not naïve mice, can transfer protection from 
allergic airway inflammation. 
To confirm previous observations described in chapter 4, we investigated CD4 cells from 
C57BL/6 mice and analysed their regulatory potential. CD4 cells were depleted (greater than 
99%) from uninfected wild-type (naïve), 28-day infected wild-type and 28 day infected IL-10  
deficient mice (Fig. 5.1). The CD4 depleted fractions were transferred into the tail vein of Der 
p1 sensitive recipient mice, 7 days before the first of two airway challenges, using the 
adoptive transfer model previously established (Model 2.7 described in Materials and 
Methods). 
Reassuringly, the CD4 compartment from naïve mice had no effect on total cellular influx or 
airway eosinophilia, compared to allergen-sensitised mice (Fig. 5.2). CD4 cells from infected 
wild-type and from infected IL-10 donors, however, significantly suppressed total cellular 
influx and eosinophilia in BAL cell recovery (Fig. 5.2, P<0.05), confirming earlier observations. 
Reduced airway eosinophilia is most likely a result of reduced BAL fluid IL-5 and eotaxin, 
observed in mice receiving CD4 cells from wild type infected donors, in most cases 
irrespective of IL-10 competence (Fig. 5.3). Interestingly, mice receiving CD4 cells from IL-
10-deficient donors had varying amounts of IFN-y in BAIL fluid exudates. A caveat of using IL-
10 deficient mice, is that they are not only deficient in IL-b, but often have dysregulated, 
cytokine responses, particularly increased IFN-y production, alongside any other 
compensatory functions adopted. IFN-y has been shown to suppress airway allergy (Cohn, L. 
et al. 1999) and thus could present a significant confounding effect, which may be responsible 
for the suppression of airway inflammation following transfer of cells from IL-10 deficient mice. 
Neither total IgE nor Der p1-specific IgE levels were altered following cell transfer of CD4 
cells from infected donors, irrespective of IL-10 competence (Fig. 5.4). 
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Fig. 5.1. CD4 depletion. MLNC from naïve, infected wild type or infected IL-10 were incubated with anti -CD4-labelled 
microbeads and separated over a magnetic column. Labelled CD4 cells, retained on the column, were discarded while unlabelled CD4 
cells, which passed over the magnetic column, were collected and washed. CD4 cells were stained with either fluorescently labelled 
anti-CD4 mAb, or a matched isotype control. Cells were acquired on a FACScalibur using Cellquest software, and analysed using 
Flowjo. Data are expressed as a percentage of CD4 cells, relative to the isotype control. This experiment has been conducted twice. 
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Fig 5.2 Reduced airway cellular infiltrations following CD4 transfer from chronically infected wild type and IL- 
10 donors. Uninfected allergen-sensitised mice were given 4x 10' CD4 cells from naïve, chronically infected wild 
type or IL-10 donors, 7 days before two localised intra-tracheal (it.) airway allergen challenge (D:D). 24 hours after 
airway challenge (Day 32), BAL cell infiltrates in response to Der p1 airway challenge were collected and differentially 
counted. Data presented are individual animals with arithmetic mean bars. P values were calculated using a Mann 
Whitney test. This experiment has been conducted twice. 
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Fig. 5.3. BAL fluid cytokines following adoptive transfer of CD4 cells. BAL fluid recovered from allergen sensitised mice 
given 4x10 CD4 cells from naïve (N). chronically infected wild type (WT-1) or IL- 10 - (IL-l0-I) donors, 7 days before two 
localised intra-tracheal (i.t.) airway allergen challenge (D:D). Cytokines and eotaxin were measured by ELISA. Data are 
shown from individual mice responding to allergen challenge, with arithmetic mean points shown in solid boxes. P values 
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Fig. 5.4 Antibody isotype profile. Serum was collected from allergen sensitised mice given 4x10 6 CD4- cells from naive 
(N), chronically infected wild type (WT-I) or IL-10 (lL-lO-I) donors, 7 days before two localised intra-tracheal (i.t.) 
airway allergen challenges (D:D). One day following the final airway challenge allergen-specific IgE titres. in IgG-
depleted serum and polyclonal (total) IgE levels in the same serum samples were measured by capture ELISA. Data are 
shown from individual mice responding to allergen challenge, with arithmetic mean points shown in solid boxes. P values 
were calculated using a Mann-Whitney test. This experiment has been conducted twice. 
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5.2.2 Composition of the C134- compartment. 
We investigated CD4 cells from C57BL/6 mice and analysed the composition of non-CD4 
within the MLN. MLNC were isolated from naïve or chronically infected mice and stained with 
fluorescently labelled monoclonal antibodies to identify B cells (anti-CDI9), DC5 (anti-
CD1 1 c), CD8 cells (anti-CD8a), NKT cells (DX5 (anti-CD49b)), macrophages (anti-F4180) and 
yö T cells (anti-'y mTCR) (Fig. 5.5, Fig. 5.6). In almost all non-CD4 cell types identified, there 
was at least a two-fold increase following infection with H.polygyrus. A reduction in CD4 cells 
(Fig. 4.3, in the previous chapter) presumably accommodates this increase. 
5.2.3 Adoptive transfer of B cells and DCs from chronically 
infected donors. 
Two cellular populations were then chosen for further investigation, namely CD19 B cells 
and CD1 1c DCs. B cells and DCs were isolated from MLN of chronically-infected mice based 
on cell surface expression of the pan-B cell marker (CD19) or pan-DC marker (CD1Ic) using 
anti-CD19 or anti-CD1 ic monoclonal microbeads, respectively. Labelled cells were positively 
selected using magnetic MACS columns (Fig. 5.5). Numbers of cells transferred for each 
subset were those which would be present with 1x10 7 unfractionated MLNC. Thus, 4.5x10 6 B 
cells and 3.5x105  DCs were adoptively transferred into the tail vein of Der p1 sensitive mice. 
Remarkably, both B cells and DCs from chronically-infected mice significantly reduced airway 
infiltration (P<0.03) and eosinophilia (P<0.03) following Der p1 challenge (Fig. 5.7). This 
result may reflect the extent to which H.polygyrus interferes with both innate and adaptive 
immune responses within the host. 
IL-5, the cytokine responsible for mobilisation and maturation of eosinophils and eotaxin, the 
chemokine responsible for local recruitment of eosinophils, were both significantly reduced in 
the BAL fluid of mice receiving either DCs (P<0.03) or B cells (P<0.05) from chronically 
infected donors, providing an explanation for reduced eosinophilia (Fig. 5.8). Characteristic 
ThI (IFNy) and Th2 (IL-4) cytokines, along with IL-10 and IL-6 in BAL fluid were unchanged 
following cell transfer (Fig. 5.8). With all of the adoptive transfer experiments, including these 
with B cell and DCs (Fig. 5.9), the production of both total IgE and allergen specific IgE 
remains unaltered, possibly due to the short period from cell transfer to the end of the 
experiment. 
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Fig. 5.5. CD19 and CD11c purification. MLNC from infected mice were incubated with anti-CD19 or anti-CDI Ic-labelled 
microbeads and separated over a magnetic column. Labelled cells, retained on the column, were collected and washed. CD19 
or CD! lc cells were stained with either fluorescently labelled anti-CD19 or anti-CD1 ic mAb, respectively, or a matched 
isotype control. Cells were acquired on a FACScalibur using Cellquest software, and analysed using Flowjo Data are expressed 
as a percentage of purified cells, relative to the isotype control. This experiment has been conducted twice. 
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Fig. 5.6. CD4 composition. The percentage of CD8'. CD49b' (DXS), F4180' and ybTCR cells in the CD4 compartment of 
naïve and chronically infected mice was calculated using fluorescently labelled mAb, specific for the respective markers. Cells 
were acquired on a FACScalibur using Cellquest software, and analysed using Flowjo. Data are expressed as a percentage of 
fluorescently labelled cells, relative to the isotype control. This experiment has been conducted once. 
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Fig 5.7 Total cell and airway eosinophil infiltration. 
Uninfected allergen-sensitised mice were given 4.5x 106 
CD19 or 3.5x iO CDI lc cells from chronically infected 
donors. BAL cell infiltrates were collected I day following 
airway challenge. Data presented are individual animals 
with arithmetic mean bars. P values were calculated using 
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Fig. 5.9 Antibody isotype profile. Serum from allergen-
sensitised mice given 4.5xlO 5 CD19 or 3.5x 10-' CD1lc 
cells from chronically infected donors. One day following 
the final airway challenge allergen-specific IgE titres, in 
IgG-depleted serum and polyclonal (total) IgE levels in 
the same serum samples were measured by capture 
ELISA. Data are shown from individual mice, with 
arithmetic mean points shown in solid boxes. This 
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Fig. 5.8. BAL fluid cytokines following adoptive transfer of CD11c or CD19 cells. BAL fluid was recovered from 
allergen-sensitised mice given 4.5xl06 CDI9 or 3.5x iO CDIIc cells from chronically infected donors. BAL 
cytokines and eotaxin were measured by ELISA. Data are shown from individual mice responding to allergen 
challenge, with arithmetic mean points shown in solid boxes. P values were calculated using a Mann-Whitney test. 
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Fig. 5.10 MLNC responses at day 28. TLN cells were isolated from allergen-sensitised mice given 4.5xlY CD19 
or 3.5x105  CDllc cells from chronically infected donors, one day after the final airway challenge. Cells were re-
stimulated in vitro with IOtg!ml Der p1 (Der p1), l.tg/ml Concanavalin A (ConA) or unstimulated (-). Proliferation 
(A) was measured by 1 3H1 incorporation and expressed as mean counts per minute (CPM). Culture supernatants were 
collected 54 hours after stimulation with cytokine secretions measured by ELISA (B). Data are shown from triplicate 
wells from individual mice, with arithmetic mean points shown in solid boxes. P values were calculated using a 
Mann Whitney test This experiment has been conducted once. 
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One possible outcome from the transfer of B cells from chronically infected mice with highly 
elevated IgE secretions, was that recipient mice would be swamped with polyclonal or 
H.polygyrus-specific IgE. This was not the case, arguing that suppression of allergy could not 
be attributed to saturation of FcR on mast cells and basophils by non-specific IgE. 
Der p1-specific T-cell proliferation was not altered within the draining lymph nodes 
(mediastinal and thoracic) following cell transfer, however higher background levels were 
seen in cells from mice receiving either B cells or DCs (Fig. 5.10A). Der p1-specific IL-4 
release was unchanged following cell transfer, although antigen induced IFN-y was elevated 
in mice receiving CD19 B cells, marginally failing to reach significance. Importantly and more 
profoundly, Der p1-induced IL-10 release was significantly elevated in local draining lymph 
node re-stimulations, following B cell or DC transfer, compared to allergic mice alone (Fig. 
5.10B, P<0.03). Whether the elevated IL-10 is produced by donor cells or recipient cells has 
yet to be unravelled. 
The elevation of IFN-y was unexpectedly observed following the transfer of both CD4 cells 
from IL-IC deficient mice (Fig. 5.3) and CD19 B cells from wild-type mice (Fig. 5.10). These 
findings raise the possible involvement of BAL IFN-y or TLN-derived IFN-y in suppression of 
IL-5 production in a manner which does not alter IL-4. This question has yet to be explored in 
this setting. 
5.2.4 Critical threshold of donor cells required for protection. 
To address the potency of B cells and DC5 from chronically-infected donors, we transferred 
substantially lower cell numbers, 1.25x10 5 CD194 B cells, 4.5x10 4 CD11c DC, into Der p1-
sensitive recipients. Purified CD19 B cells and enriched CD11c DCs (Fig. 5.11) were 
isolated and transferred as previously described. 
The transfer of 1.25x10 5 CD19 B cells suppressed total cell infiltration and eosinophilia, with 
results similar to those seen previously with 4.5x10 6 cells; however, significance was not 
achieved with reduced airway eosinophilia due to a large variation within the allergen-
sensitised only mice (Fig. 5.12). The transfer of 4.5x10 4 CD11c DCs, however, had no effect, 
with similar airway infiltration as allergen-sensitised mice only. 
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Fig. 5.11. CD19 and CDh1c cell purification. 
Purification of CD19 cells and enrichment of CD! lc 
from MLN of infected mice with anti-CDI9 or anti-
CDI Ic-labelled microbeads separated over a magnetic 
column. Populations were analysed with either 
fluorescently labelled anti-CDI9 or anti-CDI Ic mAb, 
respectively, or a matched isotype control and 
expressed as a percentage of purified cells, relative to 
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Fig 5.12 Total cell and airway eosinophil infiltration. 
Uninfected allergen-sensitised mice were given 1.25xIO CD19 
B cells or 4.5xlO' CDI 1c DC from chronically-infected 
donors. BAL cell infiltrates were collected and differentially 
counted 1 day following airway challenge. Data presented are 
from individual animals with arithmetic means show as solid 
boxes. P values were calculated using a Mann Whitney test. 
This experiment has been conducted once. 
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Fig. 5.13. Cytokines were assayed following 
adoptive transfer of CD11c or CD19cells. (A) 
BAL fluid and sera (B) were recovered from 
allergen-sensitised mice given 1.25x10 5 CD19 B 
cells. 4.55xlO CDIIc DC from chronically 
infected donors. BAL and serum cytokines and 
BAL eotaxin were measured by ELISA. Data are 
shown from individual mice responding to 
allergen challenge, with arithmetic mean points 
shown in solid boxes. P values were calculated 
using a Mann-Whitney test. This experiment has 
been conducted once. 
145 
Chapter 5. CD4 Cell-mediated Suppression of Allergy 
4 
E 
3 . 	 - 	 - 












Naïve 	0:0 	0:0 	0:0 
CD11c CD19 
Fig. 5.14 IgE Antibody profile. Serum from allergen-sensitised mice given 1.25x I CD19 B cells or4.5x104 CD  Ic' 
DCs from chronically -infected donors. One day following the final airway challenge, allergen-specific IgE levels, in 
IgG-depleted serum and polyclonal (total) IgE levels in the same serum samples were measured by capture ELISA. Data 
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Fig. 5.15. Shifts in the CD4CD25 population within the BAL. BAL cells were recovered from uninfected allergen-sensitised 
mice given 1.25xl0 5 CD19 B cells or 4.5x I0 CDllc' DCs from chronically-infected donors, 7 days before i.t. airway challenge. 
Cells were fluorescently labelled with monoclonal antibodies CD4-APC and CD25-PE. Cells were acquired on a FACScalibur using 
Cellquest software, and analysed using Flowjo. Data are presented as the percentage of total BAL cells from individual mice 
responding to allergen challenge, with arithmetic mean points shown in bars. Representative plots are shown with I mouse from a 
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CD19 
Fig. 5.16 Intracellular cytokine staining for 
IL-10 and IFN-y in CD19 cells, 28 days post 
infection. MLNC were stimulated with PMA / 
ionomycin before staining using fluorescently 
labelled monoclonal antibodies (CDI 9-FITC 
and FE-labelled anti-IL-10 or PE-anti- IFN-y). 
Cells were first stained for surface CD19, 
before fixing and permeabilising. Cells were 
then stained for intracellular cytokines. 
Preliminary Data are presented as the 
percentage of CDl9(cytokine)' cells within the 
MLN from individual mice. This experiment has 
been conducted once. 



















B220'TGF- 	18.9 ± 1.6 	26.4 ± 1.7 
B220'TGF-r 0.7 ± 0.03 2.93 ± 1.2 
Fig. 5.17. Surface bound TGF-P on B220 cells. MLN cells were removed from chronically-infected mice 
and stained for B220 and surface bound TGF-, using fluorescently labelled monoclonal antibodies anu-13220 
FITC and biotinylated-anti-TGF- P with streptavidin QR. Cells were acquired on a FACScalibur using 
Cellquest software, and analysed using Flowjo. Data are presented as mean percentage of MLNC ± SD with a 
representative FACS plot from a group of 4. This experiment has been conducted twice. 
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IL-5 and eotaxin levels correlated with reduced eosinôphilia following the transfer of 1.25x10 5 
CD19 B cells from infected donors. Furthermore, no change in IL-5 or eotaxin was observed 
following 4.5x104  CD11c DC transfer, reinforcing the association between BAL IL-5 and 
eotaxin levels and airway eosinophilia (Fig. 5.13A). Significantly, serum IL-5 was also 
reduced in mice receiving 1.25x105 CD19 B cells from chronically-infected donors, 
suggesting a systemic suppression of IL-5 (Fig. 5.13B, P<0.05). IgE levels were again 
unaltered following cell transfer (Fig. 5.14). 
From the previous experiment, mice receiving 4.5x10 6 CD19 B cells from chronically infected 
donors secreted significantly more IL-10 following in vitro Der p1 stimulation of TLN (Fig. 
5.I0B, P<0.03). We therefore decided to analyse TLN of mice receiving 1.25x10 5 CD19 B 
cells from infected donors, hypothesising that increased IL-10 may promote Treg 
development. Indeed, mice receiving CD19 B cells had more CD4CD25 and CD4CD25 
cells in the TLN (Fig. 5.15). 
These findings raise important questions. Can parasite-induced IL-10 from transferred cells 
promote Der p1-specific-CD4CD25 cell development, following B cell transfer? 
Alternatively, are other mechanisms associated with the introduction of B cells from 
chronically-infected donors, promoting CD4CD25 cell development? Moreover, is the source 
of IL-10 donor B cells or host CD4CD25 T cells? These issues all require further 
investigation. 
One caveat here, before addressing the involvement of CD4CD25 cells, is the widespread 
expression of CD25, encompassing activated T and B cells, macrophages and dendritic cells 
(Dr. Matthew Taylor, personal communication). Thus, the elevated CD4CD25 cell population 
is likely to include activated B cells and macrophages. 
5.2.5 B cell phenotypes from chronically infected mice. 
The Pan-B-cell markers, CDI9 and B220, were used interchangeably for optimal 
differentiation with regard to secondary staining. B cells, however, are a heterogeneous 
population. We therefore decided to analyse B cell-derived cytokine secretions and B cell 
subsets within the B cell compartment. Chronically infected mice do not secrete more IL-10 or 
IFN-y, compared to CD19 B cells from naïve mice (Fig. 5.16), suggesting that donor B cells 
are not the source of IL-10 or IFN-y seen in thoracic lymph node cultures following B cell 
transfer and airway challenge (Fig. 5.10). 
148 
Chapter 5. CD4 Cell-mediated Suppression of Allergy 
Therefore, elevated IL-10 in recipient mice may be produced by 'transformed' host Th2 cells 
or CD4CD25 cells. Furthermore, if B cells do not secrete significant amounts of IL-b, what 
is the mechanism by which B cells from chronically infected donors regulate airway 
inflammation in recipient mice? 
Further analysis of B cells from the MLN of infected mice, revealed an almost 6-fold increase 
in B220TGF-13 4 cells, compared to naïve B220 cells (Fig. 5.17). Anti-B220 was used to 
fluorescently label B cells instead of CD19, to obtain a stronger signal, for clearer 
discrimination between B cells and non-B cells. With this population, we sought to identify 
whether Bi or B2 subsets are individually responsible for regulating airway inflammation. 
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Fig. 5.18 B cell phenotypes. B! and B2 B cell phenotypes were analysed in total MLNC (MLNC) pre-
and post(CD19* sorted) CDI9 purification. Cells were co-stained with biotinylated anti-CD5 / 
streptavidin PE and anti-B220-PcP. Cells were acquired on a FACScalibur using Cellquest software, and 
analysed using Flowjo. B I cells with an intermediate CD5 and low B220 profile (circle) and B2 cells with 
a B220 high. CD5 negative profile (box) are marked. This experiment has been conducted once. 
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Fig. 5.19 CD23 (FcERIL) expression on B cells from chronically-Infected mice. LU23 expression was 
determined in MLNC (MLNC) and CD19 purified (CD19 sorted) cells from naïve and chronically 
infected MLN. Cells were stained with anti-CD23-PE and were acquired on a FACScalibur using 
Cellquest software, and analysed using Flowjo. (A) Data is presented with isotype (red line-left panels) 
with CD23 expression (blue line-left panels). (B) CD23 expression on CD19 purified cells is displayed to 
compare naïve (red line) and injected (blue) CD23 expression. This experiment has been conducted once. 
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The Bi and B2 subsets differ in many ways 81 cells, the dominant B cell phenotype in the 
peritoneal cavity and (to date) a rare population in lymph nodes, can be characterised by low 
B220 expression and intermediate CD5 expression (Fagarasan, S. et al. 2000). Conventional 
B cells, B2 cells, express high levels of B220 and low levels of CD5, distinguishable from BI 
cells. 
IL-10 secretion has been closely associated with B1 cells (O'Garra, A. and Howard, M. 1992). 
Repeated anti-IL-10 treatment significantly ablates BI cell numbers (Ishida, H. et al. 1993), 
suggesting that IL-1 0 is required for survival or the generation of Bi cells. Furthermore, IL-lO 
secretion by Bi cells endow these cells with regulatory potential. BI cells from mice exposed 
to the phosphorylcholine-containing glycoprotein of Acanthocheilonema viteae, ES-62, 
present a highly activated and proliferative phenotype with significant spontaneous and anti-
1gM stimulated IL-10 secretion (Wilson, E. H. et al. 2003). Thus, the Bi subset is likely to be 
associated with IL-10 in this system. 
MLN cells expressing B220 and CD5 were fluorescently labelled to identify the proportion of 
- B1-and-132-Bcell subsets -The proportionofBtcellsThi thMLNdidôthirè1richronically 
infected mice (7.55%) compared to naïve mice (7.64%). The percentage of B2 cells in the 
MLN, however, was slightly reduced following infection (naIve-52% compared to infected-
46.4%) (Fig. 5.18). Following CDI9 selection, using anti-CD19 microbeads and magnetic 
columns, the majority of cells remaining (representing the cells which were transferred in the 
adoptive transfer experiment) were conventional B2 cells, irrespective of infection status. 
Thus, similar proportions of B1 and B2 cells were transferred in the sorted CD19 population. 
5.2.6 Elevated CD23 expression on B cells from chronically-
infected mice. 
MLNC and sorted CD19 cells were also assessed for expression of CD23, the low affinity 
- IgE receptor, FcERll, associated with the regulation of IgE (Yu, P. et al. 1994; Cho, S. W. et 
al. 1997). CD23 is expressed as a membrane-bound protein, but is cleaved releasing the 
majority of the protein as a soluble receptor (sCD23) (Cho, S. W. et al. 1997). 
Interestingly, there are more CD19 CD23h19h  cells in MLNC from infected, compared to naïve 
CD19 sorted cells (Fig. 5.19B). In addition, the expression of CD23 was almost an order of 
magnitude higher in intensity, indicating appreciably more CD23 expression and presumably 
more sCD23 release in chronically-infected mice. 
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Fig. 5.20. CD19 cell purification. 
Purification of CDI9' cells from MLN of 
naive, infected wild type and infected IL-10 
mice with anti-CD19 labelled microbeads 
separated over a magnetic column. Populations 
were analysed with fluorescently labelled anti-
CDI9 and a matched isotype control and 
expressed as a percentage of purified cells, 
relative to the isotype control. This experiment 
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chronically-infected wild-type or 
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infiltrates were collected and 
differentially counted 1 day following 
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mean bars. P values were calculated 
using a Mann Whitney test. This 
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Fig. 5.22. BAL fluid cytokines following adoptive transfer of CD19 cells. BAL fluid was recovered from 
allergen-sensitised mice given 4.5xlO' CD19 B cells, from naïve, chronically-infected wild-type or infected IL-10 
donors. BAL cytokines and eotaxin were measured by ELISA. Data are shown from individual mice responding to 
allergen challenge, with arithmetic mean points shown in solid boxes. P values were calculated using a Mann-
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Fig. 5.23 Antibody isotype profile. Serum from allergen-sensitised mice given 4.5x 106  CD19 B cells, from 
naive, chronically-infected wild-type or infected IL-10 donors. One day following the final airway challenge, 
allergen-specific IgE titres, in IgG-depleted serum and polyclonal (total) IgE levels in the same serum samples 
were measured by capture ELISA. Data are shown from individual mice, with arithmetic mean points shown in 
solid boxes. This experiment has been conducted once. 
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The down regulation of IgE by CD23 has been shown in vivo and in co-culture studies using 
CD23 transgenic mice. CD23 deficient mice consistently produced less IgE following a dose 
response antigen I alum regimen (Cho, S. W. et al. 1997). Furthermore, co-culture studies 
with CD23 transgenic cells identified a dose dependant decrease of lgE production from wild 
type B cells and significant reductions of B cell proliferation and differentiation to secretory 
plasma cells I the presence of CD23 over-expressing cells. 
Thus, CD19 cells from infected mice, which differ from CD19 cells from naive mice in their 
ability to inhibit airway inflammation, with elevated CD23 expression and possibly most 
importantly, surface bound TGF-f3, both of which may be important features involved in B cell 
regulation of allergy. 
5.2.7 B cell derived IL-10 is not required to regulate airway 
inflammation. 
To conclusively address the role of donor CD19'Bcell derived IL-b, we infected wild-type 
and IL-10 deficient mice with H.polygyrus and recovered CD19 cells from the mesenteric 
lymph nodes 28 days later. CD19 cells were purified from naïve, infected wild-type and 
infected IL-la deficient mice (Fig. 5.20), with 4.5x10 6 cells transferred, as previously 
described, into the tail vein of Der p1 sensitised recipient mice. Mice were challenged seven 
days later, with BAL fluid recovered one day after airway challenge. 
A lack of IL-10 from donor B cells did not compromise their suppressive capability, with 
significantly reduced total cell (P<0.02) and airway eosinophilia (P<0.04) following transfer 
and airway challenge (Fig. 5.21), compared to naïve CD19 transfer. These data indicate that 
donor cell derived IL-IC, whether from CD4 (Fig. 4.15), CD4 (Fig. 5.2) or CD19 cells (Fig. 
5.20) is not required for suppression of airway inflammation. This observation is not 
surprising, in light of reduced allergy in infected of IL-10-deficient mice, implying that other 
mechanisms are responsible for down modulating effector functions. 
BAL IL-4 was unaltered following CD19 cell transfer, with IFN-y scarcely detectable. IL-5 
and eotaxin, however, mirrored suppressed eosinophilia, with abated levels following CD19 
cell transfer from infected wild-type or infected IL-10 mice (Fig. 5.22). BAL fluid IL-10 was 
also reduced following the transfer of B cells from infected wild-type donors, only. Importantly, 
B cells from chronically infected donors did not change total or Der p1 specific-IgE measured 
in the sera of allergen challenged mice (Fig. 5.23). 
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5.3 Discussion 
Allergen-induced airway inflammation and eosinophilia, in murine models, requires a 
proficient CD4 Th2 response secreting IL-4, IL-5 and IL-13, resulting in-mobilisation and 
recruitment of eosinophils into local tissues along eotaxin gradients. Mast cell degranulation 
and the release of pro-inflammatory mediators, recruitS additional Th2 cells and Th2 
cytokines, propagating airway eosinophilia in local tissues with ever-greater vigour. To elicit 
such a response, antigen presenting cells (airway DC5) must deliver allergen-MHC 
complexes to T cells with appropriate co-stimulation. Interference with DC-T cell interactions 
can significantly disrupt the allergic cascade. Chapter 3 and chapter 4 set the focus on the 
regulation of T cell mediated airway inflammation by other T cell subsets, with a proposed 
mechanism involving the regulation of Th2 cells by CD4CD25 Treg cells from helminth 
infected donors. This chapter moves firmly away from T-cell mediated regulation of,Th2 cells 
and presents a non-T cell mediated mechanism of helminth regulation of airway allergy. 
In summary, this chapter demonstrates that CD4 cells from chronically-infected wild-type and 
lL-10 donors are capable of inhibiting Der p1 induced airway inflammation, with ablated 
BAL_fluid-IL-5-and,-in thecaseoLwildtypeJnfecteddonor_celIs, eotaxin._Doesdonor_cell-_ 
derived IL-10 directly interfere with eotaxin production? Unaltered eotaxin in the BAL fluid of 
mice receiving cells from chronically-infected IL-10 donors were still protected from airway 
eosinophilia, possibly due to depressed IL-5 levels. Dissecting CD4 populations on cell 
surface markers revealed an increase of B cells, DCs, CD8, NKT cells (DX5), macrophages 
(F4I80) and yÔTCR T cells following chronic infection with H.polygyrus. This chapter initially 
focussed on CD19 B cells and CD11c DCs from infected mice, revealing suppressive 
activity in both of these compartments. CD19 B cells consistently inhibited serum and BAL 
fluid IL-5 and eotaxin secretions, with increased Der p1 induced IL-10 and IFN-y release in 
TLN cultures. In addition, mice receiving CD19 B cells from chronically-infected donors had 
more CD4CD25 cells in the airways. Furthermore, CD19 B cells from lL10+  mice were 
capable of inhibiting Der p1 induced airway inflammation, with comparable potency as CD19 
B cells from IL-10 competent donors, conclusively eliminating the requirement for donor-
derived IL-10 in either generation or function of regulatory B cells. A focussed analysis of 
CD19 B cells from chronically-infected mice revealed no change in IL-10 or IFN-y secretion, 
measured by intracellular cytokine staining. However, surface bound TGF-P was elevated in 
CD19 B cells from infected mice. Additionally, CD19 B cells from infected mice had higher 
expression of CD23, the low affinity FcERII, with no shift in the 131:132 sub type populations. 
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B cells are generally regarded as Ig-producing units, with a second-rate antigen presentation 
role far behind DCs, and as a secondary source of cytokines compared to T cells. However, 
their importance in regulating inflammatory responses has recently been highlighted 
(Buendia, A. J. et al. 2002). Initial antigen presentation is indeed most efficiently carried out 
by APCs belonging to the DC type, with antigen presentation by B cells occurring at later 
times, possibly during the late stages of infection. Focussing on the effector T cell response 
elicited, initial antigen stimulation and differentiation induced by DCs favours a full-bodied 
response (Reis e Sousa, C. 2001), whilst the later B cell induced response may not be as 
potent, for good reason, and may favour the promotion of memory T cells or the induction of 
T-cell responses that can 'regulate' the full-bodied thrust induced by the earlier DCs. Beyond 
the T-cell, some B cell subsets can directly dampen responses through cytokine secretions 
(Mizoguchi, A. et al. 2002). Evidence for this latter hypothesis comes in many forms. 
Firstly, the removal of B cells does not alter the initial onset or priming of immune effector 
responses, as for example in EAE (Wolf, S. D. et at. 1996) with efficient antigen presentation 
by DCs. However the severity of, and especially the recovery from, disease in EAE is 
significantly delayed, or even abolished, with the removal of B cells (Wolf, S. D. et al. 1996). 
This supports a model of late-stage B cell-related moderation of inflammation. A lack of down-
modulation has also been observed in CD4 T cell-mediated, S.mansoni egg-induced fibrosis, 
with significantly more collagen deposition observed in B cell-deficient mice (Ferru, I. et at. 
1998). A lack of immune regulation in these mice was also associated with a Thi splenocyte 
response, suggesting that B cell regulation may be responsible for the observed Th2 I IL-10  
response seen in wild-type mice. Likewise, B cell deficient mice infected with the obligate 
intracellular bacterium, Chiamydophila abortus, do not manage to control inflammatory 
responses, with fatal outcome following significantly increased INF-'y, TNF-a and IL-6 and 
reduced TGF-13 in the serum (Buendia, A. J. et at. 2002). These studies re-enforce the 
importance of B cells in regulating excessive inflammatory responses, possibly via immuno-
regulatory cytokines IL-10 and TGF-. 
Evidence of B cell-derived IL-10 has previously been shown (O'Garra, A. and Howard, M. 
1992). Depletion of IL-10 with continuous anti-IL-10 treatment ablated Bi cells, suggesting a 
dependence on IL-10 (Ishida, H. et al. 1993). Intestinal inflammation models, in a similar 
locale as H.po!ygyrus infections, have uncovered IL-10-producing B cells in the MLN during 
the chronic stages of inflammation, with the capacity to down-regulate inflammatory cascades 
without altering polarised T cell responses (Mizoguchi, A. et al. 2002). If these observations 
resemble helminth infections of the intestinal tract with comparative MLNC responses, then 
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similar B cell subsets may be generated, also capable of down-modulating inflammatory 
cascades in the respiratory tract. 
In further studies using a spontaneous chronic colitis model, Mizoguchi and colleagues 
(Mizoguchi, E. et al. 2000) were able to show that the regulatory role of B cells required CD40 
and 137-1 (CD86) for successful resolution of inflammation, associated with a reduction in 
pathogenic CD4 I cells. Thus a cell contact model could also operate, with B cells from the 
MLN of mice chronically infected with H.po!ygyrus interacting directly with Der p1-specific T 
cells. The observation of surface-bound TGF-P on CD19 B cells from H.polygyrus infected 
mice may support such a model. In addition, B cells from the MLN of H.polygyrus infected 
mice may express Fas ligand (FasL), as seen in mice chronically infected with S.mansoni 
(Lundy, S. K. and Boros, D. L. 2002). FasL expressing B cells from S.mansoni-infected mice 
induce apoptosis of SEA-specific CD4 T cells, providing another potential mechanism of B 
cell regulation, via cell contact, which could operate to regulate Der p1-specific T cells. 
Finally, if B cells themselves are not directly responsible for the regulation of airway 
inflammation observed in the transfer experiments, then they may di do so inrectly by 
recruitment. CCL4 secreted by activated B cells and LIPS-activated bone-marrow derived DCs 
actively recruit CD4CD25 Treg cells, capable of controlling the production of auto-antibodies 
(Bystry, R. S. et al. 2001). Thus, whether acting in a cell-cell contact manner, or via regulatory 
cytokine secretions, B cells have a firm place in regulating inflammatory responses. 
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ChaDter 6— H.,polygyrus Infection and EAE 
6.1 	Introduction. 
Most autoimmune diseases arise from inappropriate activation of type 1 immune responses. 
A prediction from the original hygiene hypothesis is that the rise of Th2 allergic diseases 
would be mirrored by a complementary reduction in Thi activity and therefore of the 
incidence of Thi associated diseases. However, this is not the case. In fact, autoimmunity, 
such as type 1 diabetes (IDDM) (2000), multiple sclerosis (MS) (Rosati, G. et al. 1988) and 
coeliac disease (CD) (Farrokhyar, F. et al. 2001) are increasing in a manner similar to allergic 
disorders (Stene, L. C. and Nafstad, P. 2001). Most significantly, allergy and autoimmunity 
can coincide in the same individual and indeed children with CD or RA have a higher 
incidence of asthma (Kero, J. et al. 2001; Simpson, C. R. et al. 2002). 
Allergic and autoimmune diseases can both be considered as immune disorders or 
dysregulated diseases. A common risk factor, in which environmental factors including the 
changing force of infections, could be at play. Such views have helped develop the hygiene 
hypothesis into a more regulatory model. This model is in some ways counter to the 
prevailing paradigm of autoimmune disease being precipitated by infectious agents, although 
specific instances of molecular mimicry between host and parasite are well established 
(Mandrell, R. E. et a1 1992; Harvey, H. A. et al. 2001; Moran, A. P. and Prendergast, M. M. 
2001). However, there are also reports of reduced exposure to mycobacteria and measles 
correlating with a higher incidence of multiple sclerosis (Andersen, E. et al. 1981) with day 
care centres providing suitable environments for 'protective' infections (McKinney, P. A. et al. 
2000). 
The hypothesis that a chronic H. polygyrus infection expands regulatory populations that can 
control inflammatory events extends to support a role for H.polygyrus induced regulatory 
populations with the capacity to control autoimmune diseases. 
To test our hypothesis we used the murine model of multiple sclerosis (MS), Experimental 
Autoimmune Encephalomyelitis (EAE). The course of EAE consists of an induction and 
effector phase. The induction phase involves the priming of MOG (Myelin oligodendrocyte 
glycoprotein)(355) specific CD4 Thi lymphocytes producing IFN-y, IL-2, TNF-a and 
lymphotoxin. The effector phase consists of the migration of MOG-specific T cells to the CNS 
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and across the blood brain barrier, the activation and influx of mononuclear phagocytes into 
the CNS parenchyma and the demyelination of CNS axonal tracts leading to paralysis. 
Progression of disease can be monitored and assessed using a clinical score based on tail, 
hind limb and front limb paralysis. EAE thus provides a powerful model to study immune 
regulation of CD4 cells and pathogenesis. 
Using the EAE model, we asked several questions; 
Can a chronic helminth infection suppress CNS inflammation and the manifestation of 
EAE? 
Is protection from EAE mediated by cellular regulation? 
Is the mechanism responsible for protection immune deviation or immune 
suppression? 
We hypothesised that adoptive transfer of cells from the MLN of chronically infected mice 
could suppress the clinical manifestations and disease progression in uninfected MOG (35-55) 
immunised mice. 
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6.2 Results 
The immunomodulatory capacity of intestinal helminths, in particular H.polygyrus, has 
systemic effects and can modify responses to other infectious (Dehiawi, M. S. et al. 1987) 
and non-infectious agents (Bashir, M. E. et al. 2002). To determine whether cells recruited to 
the MLN of H.polygyrus chronically infected mice could alter the disease course of EAE, 
lxi 0 MLNC from naïve or chronically-infected C57BL16 donors were transferred, via the tail 
vain, into uninfected recipient C57BL/6 mice, one day after MOG (p35-55)  immunization (Model 
2.8. Described in materials and methods). The following day (day 3) nice were given a 
second intraperitoneal injection of pertussis toxin in PBS and assessment of disease state, 
measured by clinical score, was undertaken from day 7 until day 30. 
6.2.1 MLNC from chronically infected donors exacerbate,' rather 
than protect, from EAE. 
-Adoptive -transfer -of- ixi 07—M LNG from-chronicallyinfected -donorshad-no-effectonihe 
induction of EAE; however, the effector stage and disease severity was exacerbated with 
higher maximal clinical score with delayed recovery from day 15 onwards (Fig. 6.1A, C). 
Mortality rates were also higher in mice receiving cells from infected donors. Thus, contrary to 
our initial hypothesis, cells from infected donors exacerbated the effector phase of EAE. This 
was an unexpected result, contrasting sharply with the protection from allergic airway 
inflammation cells of this type demonstrated. It is possible that helminth-induced regulatory 
populations may be tuned to regulate Th2-associated inflammatory responses and not ThI-
mediated responses. Alternatively, a mixed population within the MLNC may obstruct 
regulatory populations. 
Why and how cells from Th2 polarised, chronically infected mice exacerbate Thi-associated 
EAE was intriguing. For a clearer analysis of the recovery phase, we removed mortalities 
from all groups (Fig. 6.1 B). With mortalities removed, no differences between experimental 
groups were observed. 
To further our understanding of the cellular responses in chronic helminth infections, we 
applied the same logic used in previous studies using the allergy model, and divided the 
MLNC into CD4 and CD4 compartments. 
160 




8 1012141618202224262530 	8 1012141618202224262830 
Days post immunisation 	 Days post immunisation 
- EkE 
— EAE / Naïve MLNC 
EAE/INFMLNC 
Donor Cells fl Incidence Mortality 	Day of onset Maximal Clincal Recovery 
(%) 1%) (,,,ean +1. sO) score (n,.an .,. so) Rate (%) 
Control 10 100 0 10.2±1.62 4.1t1.00 10 
Nave-MLNC 10 100 20 12.2±1.54 4.3±1.34 10 
Infected-MLNC 10 100 40 11.3±1.64 4.7±1.25 10 
Fig. 6.1 Disease course of EAE following adoptive transfer of MLNC from naïve or chronically infected donors. 
Uninfected, MOG immunised mice were given lx iO MLNC from naive or chronically-infected donors. (A) EAE 
burden was monitored and presented as a clinical score. Mortalities were removed (B) to asses the recovery phase. A 
disease profile (C) highlights disease course features. Data presented is the arithmetic mean from 10 animals per group. 
P values were calculated using a Mann Whitney test. This experiment has been conducted once. 
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Fig. 6.2. Isolation of CD4' and CD4 cells from MLN of chronically infected mice. MLNC from chronically-infected 
C57BL/6 mice were incubated with anti -CD4-labelled microbeads and separated over a magnetic column. Labelled 
CD4 cells, retained on the column, and unlabelled C134 cells, which passed over the magnetic column, were collected 
and washed. Samples of separated populations were stained with either fluorescently-labelled anti-CD4 mAb, or a 
matched isotype control. Cells were acquired on a FACScalibur using Cellquest software and analysed using Flowjo 
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6.2.2 CD4 and CD4 cells from chronically infected mice display a 
characteristic Th2 phenotype with IL-4, IL-6 and IL-10. 
MLNC from chronically infected C57BL/6 mice were separated into CD4 or CD4 
compartments using CD4 microbeads (Miltenyi Biotech) (Fig. 6.2). In vitro re-stimulation of 
CD4 cells from H.polygyrus infected mice displayed H.po!ygyrus-specific proliferation and 
the secretion of ILA, IL-6 and IL-10 (Fig. 6.3A, Fig. 6.313). The CD4 compartment proliferated 
only in response to mitogen stimulation with IL-6 and lEN-? secretions. The CD4 population 
requires alternative methods of stimulation to gain insight into cytokirie profiles and 
responsiveness. 
6.2.3 CD4 cells from chronically infected mice delay the onset of 
EAE, whilst CD4 cells delay the onset and reduce the 
severity of disease. 
CD4 or CD4 cells from chronically infected mice were adoptively transferred intravenously 
into MOG (p3555) immunised recipients with clinical scoring conducted using a single blind 
regime from day 7 post-immunisation. 
MOG (p35-55) immunised mice receiving CD4 cells had a delayed onset of disease, with 
significance achieved in one of the two experiments shown (Fig. 6.4A, B, P<0.01). CD4 cell 
transfer reduced the incidence, mortality and maximal clinical score with an increased 
recovery rate (Fig. 6.4A-Exp.1, B). However, a second experiment did not obtain such 
sweeping protection following CD4 cell transfer. Onset of disease and mortality was reduced. 
However other parameters were unchanged, compared to MOG (p35.55)  immunised mice 
alone. 
Significantly, MOG (p355-55)  immunised mice receiving CD4 cells from helm inth-infected donors 
had greater levels of protection from EAE than MOG (p355)  immunised mice receiving CD4 
cells (P<0.01). The Incidence of EAE in MOG (p355-55)  immunised mice receiving CD4 cells 
was consistently reduced, by up to 30%, with significantly reduced disease progression and 
maximal clinical score (Fig. 6.4A, B). 
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Fig. 6.3 CD4° and CD4 MLNC responses at day 
2$. MLNC separated into CD4 and CD4 cells 
were re-stimulated in vitro with lOtg/ml 
H.polygyrus antigen (Hp), I Rg/ml Concanavalin A 
(ConA) or media alone (-). Proliferation (A) was 
measured by [ 3H)-thymidine incorporation and 
expressed as mean counts per minute (CPM). 
Culture supernatants were collected 54 hours after 
stimulation with cytokine secretions measured by 
ELISA (B). Cytokine data are shown from triplicate 
wells from 5 mice. P values were calculated using a 








Day of onset 
(mean +1. SD) 
Maximal Clincal score Recovery 
(mean  - 10 100 10 10.1±3.4 3.8±1.3 	 40 
EXP1 CD4+ 10 90 0 11.1±1.9 2.9±1.3 50 
CD4- 9 89 11.1 10.9±1.6 3.0±1.7 	 77.7 
- 9 100 10 10.3±0.7 3.0±0.3 62.5 
EXP2 CD4+ 8 100 0 12.6±2.3 2.9±1.7 	 37.5 
CD4- 10 70 0 11.1±1.0 2.1±1.5 85.7 
Fig 6.4 Disease course of EAE, following CD4 and CD4 cell transfer from chronically infected donors. 
Uninfected. MOO sensitised mice were given 4xl0 6 CD4 or CD4 from chronically infected donors. (A) EAE was 
monitored and presented as a clinical score. Two independent experiments are shown with 8-10 mice per group in each 
experiment. A disease profile (B) highlights disease course features from each experiment. Data presented is the 
arithmetic mean from 8-10 animals per group ± SEM. P values were calculated using a Mann Whitney Lest. This 
experiment has been conducted twice. 
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The recovery rate (percentage of mice that recovered from disease) following acute disease 
was increased in one of two experiments following CD4 cell transfer, whilst CD4 cells 
consistently improved recovery by 37.7% and 23.2% from two separate experiments, 
compared to MOG-immunised mice only (Fig. 6.48). 
These data indicate that adoptive transfer of CD4 or CD4 cells from the MLN of mice 
chronically infected with H.polygyrus can delay the onset of disease, possibly by interference 
with the induction phase, can decrease the severity and maximal clinical score and 
significantly reduce disease progression. Most importantly, cells from infected mice enhance 
recovery from EAE. 
Why a mixed MLNC population exacerbates disease, whilst compartmentalised populations, 
provide a degree of protection from EAE is puzzling. Confirmation of this result is required 
with further experiments. Possibly MLNC contain populations counteract each other whilst 
together, but act in a protective manner when separated. For example, the CD4 
compartment, containing CD4CD25 regulatory T cells may preferentially interact with DCs, 
B cells and effector T cells within the MLNC population. Following separation, regulatory cells 
may interact with host DC5, B cells and MOG-specific-T cells. In a similar manner, CD4 cells, 
when depleted of CD4 T cells, may be able to interact with host MOG-specific-T cells, 
suppressing their action. 
6.2.4 Cells from chronically infected donors modulate systemic 
and local cytokine secretions in MOG (p355) immunised 
recipients. 
Immune deviation towards a T112 profile, inhibiting pro-EAE Thi responses, was proposed in 
S.mansoni egg-induced-protection from EAE (Sewell, D. et al. 2003). To appreciate the role 
of cytokines in this model, splenocytes and local draining lymph node (inguinal and popliteal) 
cells were isolated at the end of the experiment (7 weeks post-immunisation) and stimulated 
in vitro with H.polygyrus antigen, MOG (p355) peptide or Con A. [3H]-thymidine incorporation 
was used to asses MOG-specific proliferation and culture supernatants were collected for 
cytokine secretion profiles. 
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Mice receiving CD4 or CD4 cells from chronically-infected donors had a higher level of 
background proliferation, making it difficult to interpret changes in MOG-specific responses 
(Fig. 6.5A). MOG-specific proliferation was higher in mice receiving CD4 cells, however 
proliferation was unchanged with respect to unstimulated cells from the same animals. 
Elevated MOG-specific proliferation is contrary to the expectation that regulatory donor cells 
would suppress proliferation. These data , however, do indicate that cellular responsiveness 
is intact in mice receiving cells from chronically infected donors. 
Surprisingly, MOG-specific IL-4 secretions (123.0 ± 41.9 pg/mI) were detected in splenocyte 
culture supernatants from MOG-immunized mice. However both IL-4 and IFN-y were 
increased in mice receiving CD4, but not CD4 cells, .although significance was not achieved 
(Fig. 6.513). Thus, it appears that immune deviation may not be responsible for the observed 
protection from EAE following cell transfer. Lymphocyte-derived IL-6 is essential for the 
induction and clinical manifestations of EAE (Okuda, Y. et al. 1999), yet IL-6 is also involved 
in Th2 differentiation (Diehl, S. and Rincon, M. 2002), suggesting a dose-dependent or site-
specific function of this pleiotropic cytokine. 
IL-6 secretions were measured in splenocyte cultures following cell transfer. Mice showing 
reduced clinical outcome, following CD4 cell transfer, had significantly elevated systemic 
MOG-induced IL-6 (43.3 ± 11.3 ng/mI compared to 22.6 ± 9.7 ng/ml, P<0.001, Student's t-
test) compared to MOG-immunised mice. However, elevated constitutive IL-6 secretions 
make interpretation difficult. 
Most importantly and most significantly, systemic IL-la was considerably elevated in mice 
receiving CD4 or CD4 cells from chronically infected donors (128.3 ± 75.5 pg/mI (mice 
receiving CD4 cells (P<0.005)) and 143.7 ± 91.9 pg/ml (mice receiving C134 cells 
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Fig. 6.5 Splenocyte responses from mice receiving CD4° or CD4 cells from chronically infected donors. Splenocytes 
were re-stimulated in vitro with I0.tg/ml H.polygyrus antigen (Hp), 4tg/ml of MOG <. lgIml Concanavalin A 
(ConA) or media alone (-). Proliferation (A) was measured by ('HI-thymidine incorporation and expressed as mean counts 
per minute (CPM). Culture supernatants were collected 54 hours after stimulation with cytokine secretions measured by 
ELISA (B). Cytokine data are shown from triplicate wells from 10 mice from EXP.l. P values were calculated using a 
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Fig. 6.6. Inguinal and popliteal lymph node responses from mice receiving CD4< or CD4 cells from chronically 
infected donors. Lymph node cells were re-stimulated in vitro with 10ig/ml H.polygyrus antigen (Hp), 4.tg/ml of MOO 
1ig/ml Concanavalin A (ConA) or medium alone (-). Proliferation (A) was measured by 1 3H1-thymidine 
incorporation and expressed as mean counts per minute (CPM). Culture supernatants were collected 54 hours after 
stimulation with cytokine secretions measured by ELISA (B). Cytokine data are shown from triplicate wells from 10 mice 
from EXP. I in Fig 6.4. P values were calculated using a Mann Whitney test. This experiment has been conducted once. 
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Events within the spleen give useful indications of systemic responses, especially important 
when transferring donor cells intravenously and immunising systemically. However, to obtain 
measurements relating to modifications in EAE and, in particular, CNS inflammation, 
responses in the local draining lymph nodes and tissue at the site of inflammation may 
provide a clearer picture. 
Inguinal and popliteal lymph nodes were recovered from mice 35 days post-immunisation, 34 
days after adoptive cell transfer. In vitro re-stimulation revealed significantly elevated MOG-
specific proliferation, following CD4 (P<0.001) or CD4 (P<0.001) cell transfer from infected 
donors (Fig. 6.6A) however background proliferation was again elevated, making 
interpretation difficult. H.polygyrus specific proliferation was  observed in local lymph nodes, 
suggesting that either donor cells, or descendants of them, migrated to active lymph nodes. 
Elevated MOG-specific IFN-y was observed in mice receiving CD4 or CD4 cells (Fig. 6.613). 
However, constitutive IL-4 and IL-10 were elevated following CD4 cell transfer also, 
indicating a heightened Thi and Th2 response in local and systemic lymph nodes, correlating 
with elevated proliferation. 
We screened the spleen and lymph nodes for changes in the CD4CD25 compartment, 
which may be associated with elevated IL-b. Despite a significant reduction of CD4 cells in 
the spleens of mice receiving CD4 cells from infected donors, there was no change in the 
percentage of CD4CD25 cells in the spleen or local draining lymph nodes (Fig. 6.7, 
P<O.05). 
The progression of EAE is mediated by CD4 T-cells and although antibodies are not 
principally involved in initiation and disease severity, we decided to measure total serum IgE, 
due to the observed protection mediated by CD4 cells from IgE rich infected mice. 
Interestingly, although not significant, total IgE was elevated in mice receiving either CD4 or 
CD4 cells (Fig. 6.8). 
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Fig. 6.7 Shifts in the CD4CD25 population within the Spleen and Lymph nodes. Splenocytes and lymph 
node cells were labelled with fluorescently labelled monoclonal antibodies CD4-APC and CD25-PE. Cells 
were acquired on a FACScalibur using Cellquest software and analysed using Flowjo software. Data are 
presented as the percentage of total spleen or lymph node cells (A) or as a percentage of the CD4 population 
(B) from individual mice, with arithmetic means shown as bars. P values were calculated using a Mann 




Naive 	EAE 	EAE 	EAE 
CD4 	CD4 
Fig. 6.8 lgE Antibody response following CD4 or CD4 cell transfer into MOG-immunised mice. Sera 
were isolated from uninfected MOG-immunised mice with or without CD4 or C134 cell transfer. Polyclonal 
(total) lgE levels were measured by capture ELISA. Data are shown from individual mice, with arithmetic 
mean points shown in solid boxes. This experiment has been conducted once. 
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6.2.5 Analysis at the peak of disease 
The above immunological data describe events measured at day 35, 34 days after 
immunisation and approximately 20 days after the peak of disease. This time point, although 
useful for building a picture of lasting events, may be more useful when taken together with 
measurements at the peak of disease. Therefore, MOG-immunised mice with or without CD4 
or CD4 cell transfer from infected donors were sacrificed at the peak of disease, day 14. 
CD4 or CD4 cells from chronically-infected donors were purified and transferred into MOG-
immunised recipients, as above. Interestingly, in this experiment, mice receiving CD4 cells 
from infected donors were completely protected from all measurable signs of paralysis (Fig. 
6.9). Mice receiving CD4 cells had reduced maximal clinical scores. However, incidence and 
onset of disease were not different from MOG-immunised mice alone (Fig. 6.9). 
During the peak of disease, cytokine and proliferative responses in the spleen (Fig. 6.10) and 
local draining lymph node (Fig. 6.11) cultures did not differ between treatment groups. 
Similarly, there was no difference in total CD4 cells, however, the percentage of CD4CD25 
cells in the spleen of mice receiving CD4 cells from infected donors was slightly reduced 
(Fig. 6.12). 
Proliferation in the local draining lymph nodes was higher in mice receiving CD4 and CD4 
cells from infected donors, (Fig. 6.11), again indicating that T-cell proliferation and 
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Fig 6.9 Disease course of EAE, 
following CD4° and CD4 cell 
transfer from chronically infected 
donors. Uninfected, MOGçc, 
sensitised mice were given 4xlO t 
CD4 or CD4 cells from 
chronically-infected donors. (A) 
EAE burden was monitored and 
presented as a clinical score, from 5 
mice per group. (B) Disease profile 
highlights disease course features. 
Data presented are the arithmetic 
means from 5 animals per group ± 
SEM. P values were calculated using 
a Mann Whitney test. This 
experiment has been conducted 
once. 
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Fig. 6.10 Splenocyte responses at 
the peak of disease from mice 
receiving CD4° or CD4- cells from 
chronically infected donors. 
Splenocytes re-stimulated in vitro 
with I0og/ml H.polvgvrus antigen 
(Hp). 44g/ml of MOG (MOG). 
I .tg/ml Concanavalin A (ConA) or 
medium alone (-). Proliferation (A) 
was measured by ['HI-thymidine 
incorporation and expressed as mean 
counts per minute (CPM). Culture 
supernatants were collected 54 hours 
after stimulation with cytokine 
secretions measured by ELISA (B). 
Cytokine data are shown from 
triplicate wells from IC) mice from 
EXP.1. in Fig. 6.4. P values were 
calculated using a Mann Whitney 
test. This experiment has been 
conducted once. 
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Fig. 6.11 Inguinal and popliteal lymph node responses at the peak of disease from mice receiving 
CD4° or CD4 cells from chronically infected donors. Lymph node cells were re-stimulated in vitro 
with l0.tg/mI H.polvgvrus antigen (Hp). 4sg/ml of MOG 1.0-151  (MOG). lp.g/ml Concanavalin A (ConA) 
or medium alone (-). (A) Proliferation was measured by 1 3 H1-thymidine incorporation and expressed as 
mean counts per minute (CPM). (B) Culture supernatants were collected 54 hours after stimulation with 
cytokinc secretions measured by ELISA. Cytokine data are shown from triplicate wells from 5 mice. P 
values were calculated using a Mann Whitney test. This experiment has been conducted once. 
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Fig. 6.12 Shifts in the CD4CD25 population within the spleen and lymph nodes at the peak of disease. 
Splenocytes and lymph node cells were labelled with fluorescently labelled monoclonal antibodies CD4-APC 
and CD25-PE. Cells were acquired on a FACScalibur using Cellquest software and analysed using Flowjo 
software. Data are presented as the percentage of total spleen or lymph node cells (A) or as a percentage of the 
C134 population (B) from individual mice, with arithmetic mean bars shown in bars. P values were calculated 
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Fig. 6.13 Accumulation of CD4 cells in the CNS. The CNS was removed and homogenised with 
lymphocytes collected following density gradient centrifugation. Cells were labelled with fluorescently labelled 
monoclonal antibodies CD4-APC and were acquired on a FACScalibur using Cellquest software and analysed 
using flowjo software Data are presented as the percentage of CD4 cells recovered from individual mice, with 
arithmetic mean bars shown. P values were calculated using a Mann Whitney test. This experiment has been 
conducted once. 
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Fig. 6.14 Intracellular cytokine expression of CNS lymphocytes during the peak of disease. CNS 
lymphocytes were isolated from MOG-immunised mice given CD4 or CD4 cells from chronically infected 
donors. Intracellular cytokine expression following 12 hours of PMA/lonomycin stimulation was determined 
on a FACScalibur using Cellquest software and analysed using Flowjo software. Cells were first stained for 
surface CD4, before fixing and permeabilising. Fixed cells were stained for intracellular cytokines. Data is 
presented as the percentage of CD4' cytokine cells recovered. One representative mouse (left panels) or 5 
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Fig. 6.15 IgE response in MOG immunised mice at the peak of disease following CD4 
or CD4 cell transfer. Serum was collected from uninfected MOG immunised mice with or 
without CD4 or CD4  cell transfer. Polyclona] (total) IgE levels were measured by capture 
ELISA. Data are shown from individual mice, with arithmetic mean points shown in solid 
boxes. This experiment has been conducted once. 
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At the peak of disease, the central nervous system (CNS) was removed and homogenised 
with lymphocytes recovered by density gradient centrifugation. The percentage of CD4 cells 
in the CNS was unchanged following the transfer of CD4 cells from infected donors, 
compared to MOG-immunised mice alone (Fig. 6.13). However, transfer of CD4 cells from 
infected donors, completely ablated CD4 cell influx into the CNS, accounting for reduced 
paralysis and observable clinical disease. 
Re-stimulation of infiltrating lymphocytes, recovered from the CNS of MOG-immunised mice, 
revealed that almost half of all CD4 cells (CD4 cells 9 4%, CD44iFN-y 1.84%) produced 
significant amounts of IFN-y (Fig. 6.14, P<0.008). Adoptive transfer of CD4 cells from 
infected mice did not change this percentage of CD4 lFN-y cells. No lymphocytes were 
recovered from mice receiving CD4 cells from infected donors (Fig. 6.12). Intracellular IL-10 
cells were not found in any group of mice, suggesting that lymphocytes that migrated to the 
site of inflammation do not secrete IL-b, or that staining for intracellular IL-10 was sub-
optimal. Thus, at the site of inflammation, the observed protection from EAE following CD4 
cell transfer can be explained by reduced infiltrating cells, resulting in diminished IFN-y cells. 
Interestingly, CD4 cells transferred from infected donors induced a significant increase in 
total IgE levels (Fig. 6.15, P<0.008), similar to observations at day 35 (Fig. 6.8). 
Thus, a cellular population generated during a chronic helminth infection can protect from 
EAE, with most activity within the CD4 compartment. Protection from EAE accompanies 
elevated MOG-specific-IL-10 and IL-6 from splenocyte cultures, with increased IL-4 and IFN-y 
secretions within local lymph nodes. During the peak of disease, there were no significant 
changes in cytokine secretions. However, a complete inhibition of CD4 cell accumulation in 
the CNS was observed in MOG-immunised mice, following the transfer of CD4 cells from 
infected donors. 
We next asked whether IL-b, from donor CD4 cells was required to control EAE. From the 
earlier work in chapter 5, we uncovered a population of B cells that could protect mice from 
allergen induced airway inflammation, independent of IL-b. 
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6.2.6 CDC cells from infected mice can protect MOG-immunised 
mice from EAE, independent of IL-10. 
We started our line of investigation by transferring a similar number of CD4 cells from naïve, 
chronically-infected wild-type or chronically-infected lL-10 donors. CD4 cells were first 
depleted from MLN, using anti-CD4-microbeads and magnetic columns (Fig. 6.16), before 
adoptively transferring 4x1 06  CD4 cells into the tail vein of MOG-immunised mice. 
CD4 cells from naïve donors had no effect on the onset of disease. However, the recovery 
phase was delayed, resulting in a significant exacerbation of disease. CD4 cells from 
infected IL-10-1- mice significantly reduced maximal clinical score and disease (Fig. 6.17, 
P<0.01). More profound protection was achieved with CD4 cells from infected WT mice. 
Thus, IL-10 from the CD4 donor compartment does not appear to be essential for the 
observed reduction of disease, but may contribute to the strength of the effect. 
In vitro splenocyte cultures from MOG immunised mice receiving cells from naïve, WT-
infected or IL-10-/- infected mice responded equally to MOG (3555)  with comparable 
proliferation (Fig. 6.18A). Mice receiving CD4 cells from infected lL-10 mice, secreted less 
IL-4 and IFN-y, marginally failing to reach significance, with a contrasting increase of MOG (35 
55) -specific IL-10 (Fig. 6.1813). CD4 cells from infected wild type mice reduced IFN-y 
secretion in MOG (3555)  —immunised mice. However, this was accompanied with significantly 
elevated IL-6 and IL-1 0 following MOG (3555) re-stimulation (Fig. 6.1813, P<0.05). 
Within the local draining lymph nodes, the same pattern was evident, with greater differences 
than the spleen. MOG (355)-specific IL-10 was again significantly enhanced following cell 
transfer from infected donors; irrespective of donor IL-10 competence (P<0.008). MOG-
specific IFN-y and IL-6 was reduced following C04 cell transfer from wild type donors (Fig. 
6.19B), explaining the reduced disease and clinical score observed in these mice. Removing 
IL-10 from donor cells similarly reduced MOG-specific IFN-y and IL-6, indicating that 
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Fig. 6.16. Depletion of CD4 cells 
from MLN of naïve, chronically 
infected wild type and IL.10 mice. 
MLNC from naïve, chronically 
infected wild type or IL-10 mice 
were incubated with anti-CD4-
labelled microbeads and separated 
over a magnetic column. Labelled 
CD4 cells, retained on the column 
were discarded, and unlabelled CD4 
cells, which passed over the magnetic 
column, were collected and washed. 
CD4 depleted populations were 
stained with either fluorescently 
labelled anti-CD4 mAb, or a matched 
isotype control. Cells were acquired 
on a FACScalibur using Cellquest 
software and analysed using Flowjo 
software. Data are expressed as a 
percentage of CD4 cells, relative to 
the isotype control. 
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Days post immunisation 
I Donor Cells fl Incidence Mortality Day of onset Maximal Clincal score Recovery 
I (%) (%) (mean +1- SDI (mean +1. SD) Rate (%) 
- 5 100 0 9.4±0.9 3.8±1.3 20 
NAIVE 5 100 10 8.8±0.5 4.6±0.9 0 
C134- WT 5 100 0 11.8±3.1 2.0±07 20 
CD4- IL-lOKO 5 100 0 9,2±1.1 3.0±1.0 20 
Fig 6.17 Disease course of EAE, following CD4 transfer from naïve, chronically infected wild type or IL-
10 donors. Uninfected, MOO (35.55) immunised mice were given 4xl0 6 CD4 cells from naïve, chronically 
infected wild type or IL-10 donors. (A) EAE burden was monitored and presented as a clinical score. A 
disease profile (B) highlights disease course features. Data presented is the arithmetic mean from 5 animals per 
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Fig. 6.18 Splenocyte responses from MOG-immunised mice receiving 
CD4 cells from naïve, chronically infected wild type or chronically 
infected 1L-10 donors. Splenocytes re-stimulated in vitro with 
1Qg/ml H.polvgvrus antigen (Hp). 4g/ml of MOG (6.S5)  (MOG). 
1sg/ml Concanavalin A (ConA) or unstimulated (-). Proliferation (A) 
was measured by [ 3H1-thymidine incorporation and expressed as mean 
Counts per minute (CPM). Culture supernatants were collected 54 hours 
after stimulation with cytokine secretions measured by ELISA (B). 
Cytokine data are shown from triplicate wells from 10 mice from EXP.l. 
P values were calculated using a Mann Whitney test. This experiment 
has been conducted once. 
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Fig. 6.19 Inguinal and popliteal lymph node responses from MOG-
immunised mice receiving CD4 cells from naïve, chronically infected 
wild type or chronically infected IL-10 donors. Lymph nodes re-
stimulated in vitro with 1O.sg/ml H.polygyrus antigen (Hp), 4sg/ml of MOO 
05551 (MOO). ltg/ml Concanavalin A (ConA) or unstimulated ( - ). 
Proliferation (A) was measured by 1 3 H1-thymidine incorporation and 
expressed as mean counts per minute (CPM). Culture supernatants were 
collected 54 hours after stimulation with cytokine secretions measured by 
ELISA (B). Cytokine data are shown from triplicate wells from 10 mice from 
EXP.l. P values were calculated using a Mann Whitney test. This experiment 
has been conducted once. 
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Thus, in summary, CD4 cells from chronically-infected donors can significantly protect MOG-
immunised mice from disease progression associated with CNS inflammation, demyelination 
and paralysis (P<0.001). An emerging trend of reduced MOG-specific IFN-y and IL-6 and 
increased MOG-specific IL-10 in local lymph nodes appears to correlate with disease state. 
Moreover, this protection is independent of donor IL-b, although recipient IL-10 may remain 
an important component of the protective pathway. 
6.2.7 CD194  cells from chronically infected donors protect MOG-
immunised mice from the progression and severity of EAE. 
The emergence of the CD4 population from chronically infected mice with the capacity to 
reduce the severity of EAE mirrored similar findings with this mixed population in the allergy 
model (Chapter 5). However, the CD4 compartment is highly heterogeneous in its cellular 
composition. To determine whether a B cell population could be responsible for protecting 
MOG-immunised mice from EAE, as was found fro Der pi-sensitised mice and airway 
inflammation, we isolated CD19 cells from naïve (WT-NaIve) wild-type infected (WT-INF) 
and IL-10-4- infected (lL-10-lNF) mice (Fig. 6.20). CD19 cells were isolated from 
chronically-infected donors with 4.5x106  cells transferred into MOG-immunised recipients in 
parallel experiments with Der pi-sensitised recipient mice, described in Chapter 5, Fig. 5.20-
5.23. 
MOG-immunised mice receiving CD19 cells from naïve donors had a similar onset of 
disease, compared to MOG-immunised alone, however, paralysis progressed quicker and 
reached a higher maximal clinical score (Fig 6.21A, B). Despite these alterations in disease 
dynamics, the recovery from disease was unaltered in recipients of naïve B cells with overall 
EAE not significantly different from MOG-immunised alone. CD19 cells from infected wild-
type mice, however, considerably reduced EAE, with a lower incidence, slightly delayed onset 
and significantly reduced maximal clinical score (P<0.004) (Fig. 6.21). Removal of IL-10 from 
the donor compartment did not compromise the protective effect of CD19 cells from 
chronically-infected donors, but may have enhanced the protective effect, with a variably 
delayed onset and similar reduced maximal clinical score and a further improved recovery 
rate (Fig. 6.21A, B). 
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Fig. 5.20 and 6.20. CD19 cell 
purification. Purification of CD19 
cells from MLN of naïve, infected 
wild-type and infected IL-10 mice 
with anti-CD 19 labelled microbeads 
separated over a magnetic column. 
Populations were analysed with 
fluorescently labelled anti-CDI9 
and a matched isotype control and 
expressed as a percentage of 
purified cells, relative to the isotype 
control. This experiment has been 
conducted once. 
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Days post immunatcn 
Donor Cells fl Incidence Mortality Day of onset Maximal Clincal score Recovery 
(%) (¼) (mean +I- SD) (mean +1- SD) Rate (%) 
- 5 100 0 12.0±1.4 3.0±1.4 0 
NAIVE 5 100 0 11.4±1.5 3.6±0.5 0 
CD19± WI 5 80 0 12.3±2.8 1.6±1.1 40 
CD19+ IL-10KO 5 100 0 13.8±4.7 1.6±0.9 100 
Fig. 6.21 Disease course of EAE, following CD19 transfer from naïve, chronically infected wild type or 
IL-10 donors. Uninfected, MOG (35-55) immunised mice were given 4.5xl06 CD19 cells from naïve, 
chronically-infected wild-type or IL-10 donors. (A) EAE was monitored and presented as a clinical score. A 
disease profile (B) highlights disease course features. Data presented is the arithmetic mean from 5 animals per 
group. P values were calculated using a Mann Whitney test. This experiment has been conducted once. 
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Splenocyte proliferation in response to MOG (3555)  was unaltered following the transfer of 
CD19 cells from naïve or chronically infected donors, compared to MOG-immunised mice 
alone (Fig. 6.22A). Cellular responsiveness, was increased following the transfer of CD19 
cells from chronically infected lL-10 donors. CD19 cells from chronically infected wild type 
and lL-10 mice (Fig. 6.2213), reduced MOG-specific IL-6 and IFN-y. Irrespective of donor IL-
10 competence, MOG-specific IL-4 and IL-10 secretion by splenocytes was increased 
following transfer from infected donors. 
Local lymph node proliferation was considerably reduced following the transfer of CD19 cells 
from chronically infected lL-10, but not wild type donors (Fig. 6.23A), suggesting that a lack 
of IL-10 may have rendered CD19 cells more potent. Furthermore, MOG-immunised mice 
receiving CD19 cells from chronically infected lL-bO donors had less MOG-specific IL-4, 
IFN-y and IL-6 secretions, compared to MOG-immunised alone. CD19 cells from infected 
wild type mice suppressed MOG-specific IL-6 and IFN-'j with increased MOG-specific IL-10  
(Fig. 6.23B). 
Thus, a deficiency of IL-10 from the donor CD19 cells, resulting in reduced cytokine 
secretions from lymph node cells, suggests that donor IL-10 may promote or encourage the 
induction of MOG-specific IL-4 and a Th2 polarisation. Alternatively donor IL-10 may adopt a 
regulatory role suppressing Thb responses. 
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Fig. 6.22 Splenocyte responses from MOG-immunised mice receiving 
CD19 cells from naïve, chronically infected wild type or chronically 
infected IL-1O donors. Splenocytes re-stimulated in vitro with 
lOigIml H.polvgvrus antigen (Hp). 4.tg/ml of MOO (MOG), 
lsg/ml Concanavalin A (ConA) or unstimulated (-). Proliferation (A) 
was measured by 1 3H1-thymidine incorporation and expressed as mean 
counts per minute (CPM). Culture supernatants were collected 54 hours 
after stimulation with cytokine secretions measured by ELISA (B). 
Cytokine data are shown from triplicate wells from 5 mice. P values were 
calculated using a Mann Whitney test. This experiment has been 
conducted once. 
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Fig. 6.23 Inguinal and popliteal lymph node responses from MOG-
immunised mice receiving CD19 cells from naïve, chronically 
infected wild type or chronically infected LL-1O donors. Lymph 
nodes re-stimulated in vitro with l0ig/ml H.po!ygyrus antigen (Hp). 
4tg/ml of MOG (MOG). 1ig/ml Concanavalin A (ConA) or 
unstimulated (-). Proliferation (A) was measured by 1 3H1-thymidine 
incorporation and expressed as mean counts per minute (CPM). Culture 
supernatants were collected 54 hours after stimulation with cytokine 
secretions measured by ELISA (B). Cytokine data are shown from 
triplicate wells from 5 mice. P values were calculated using a Mann 
Whitney test. This experiment has been conducted once. 
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6.3 Discussion 
The relative aseptic lifestyle in developed regions of the world may be the underlying cause of 
rising immunopathologies caused by exogenous and self-antigens. With autoimmune disease 
prevalence (Rosati, G. et al. 1988; 2000; Farrokhyar, F. et al. 2001) increasing in a similar 
manner to allergies, and both disorders coinciding in the same individuals (Kero, J. et al. 
2001; Stene, L. C. and Nafstad, P. 2001; Simpson, C. R. et at. 2002), a common origin may 
exist. A unifying feature of both allergies and autoimmune disorders is the tack of control of 
host responses, resulting in immunopathology. Thus, despite representing opposing branches 
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Box. 6.1. Schematic Effector vs. Regulatory balance. Excessive immune regulation, 
inhibits the development of effector responses (represented, due north). A lack of 
immune regulation (represented, due south) allows effector response, whether they are 
type 1 or type 2, to uncontrollably propagate with increased risk of immunopathology. 
Autoimmune disorders (South West) result from deficient regulation of a Thl 
response, with allergies (South east) due to deficient regulation of Th2 responses. 
Notably, ThI and Th2 responses can co-exist and do not represent poles of a spectrum. 
Thus, the importance of regulatory populations in autoimmune, as well as allergic, disorders 
gave us the opportunity to test our hypothesis that chronic helminth infections expand 
regulatory networks, restoring peripheral regulation and preventing excessive inflammation. 
There is significant evidence of helm inth-related protection from autoimmune disorders such 
as experimental autoimmune encephalomyelitis (EAE) (Sewell, D. L. et at. 2002), non-obese 
diabetic (NOD) mice (Cooke, A. et al. 1999; Bach, J. F. 2002; Zaccone, P. et at. 2003), the 
trinitrobenzesulphonic acid (TNBS) model of Crohn's disease (Elliott, D. E. et at. 2003), 
H.pylori induced gastritis and gastric atrophy (Fox, J. G. et al. 2000) and the spontaneous 
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development of severe colitis in IL-10 KO mice (Berg, D. J. et al. 1996). However, most of 
these studies, using concurrent infection or parasite eggs to modulate disease, do not identify 
a cellular population or mechanism, other than a correlating increased or decreased specific 
cytokine secretions and disease state. 
Is there a common mechanism of helm inth-related protection against auto-immunity? As 
mentioned earlier, a Th2 polarisation (Elliott, D. E. et al. 2003) appears in the majority of 
reports of helminth infection and autoimmunity. However, a regulatory environment with IL-10 
and TGF-P may accompany immune deviation, as suggested in H.polygynis-related 
protection from gastritis (Fox, J. G. et al. 2000). 
We therefore tested the hypothesis that helminth infections expand a regulatory population 
capable of controlling both allergic and autoimmune disorders. Our first approach with whole 
MLNC from chronically infected donors found an exacerbation of EAE which might have led 
to rejection of the hypothesis. However it was possible that Th2 effector cells may synergise 
with Thi cells to exacerbate inflammation, as seen in allergy models, in which adoptive 
transfer of both Thi and Th2 cells leads to significantly enhanced lung inflammation (Hansen, 
G. et al. 1999). Experiments were therefore performed on separated CD4 and CD4 cells 
from the MLNC of chronically infected mice, in which it was shown that a population of 
regulatory cells was harboured within the CD4 compartment. Is there an inhibitory effect of 
CD4 cells on the regulatory function of CD4 cells? One such mechanism may involve the 
association of cells recruited together interacting with one another. Thus, the separation of 
cells may encourage donor CD4 cells to interact with recipient cells. For example donor 
antigen presenting cells, such as dendritic cells or B cells, generated during H.polygyrus 
infection, may interact with recipient pathogenic T-cells, providing inhibitory signals or 
inducing apoptosis. 
The regulation of autoimmunity by Treg cells has been extensively studied, with the goal of 
developing antigen-specific Treg cells to control autoimmune immunopathology (Kohm, A. P. 
et al. 2002; von Herrath, M. G. and Harrison, L. C. 2003). This research strategy has 
focussed attention on antigen presenting cells as potential Treg inducers, illustrated by the 
expansion of Treg cells in vivo following the transfer of TNFa and auto-antigen peptide-
treated DCs (Menges, M. et al. 2002). Therefore, within the CD4 compartment of cells 
generated during a chronic H.polygyrus infection, where TNFa is certainly expressed (Fig. 
4.2), APCs are present which could induce auto-antigen-specific Treg cells in recipient mice, 
explaining the reduced EAE. Such APCs would include both B cells and DCs. 
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Evidence of B cell involvement with autoimmune disorders has previously been reported. 
Firstly, the removal of B cells does not alter the initial onset or priming of EAE (Wolf, S. D. et 
al. 1996), with presumably efficient antigen presentation by Ms. However the severity, and 
especially the recovery, of disease in EAE is significantly delayed following the removal of B 
cells (Wolf, S. D. et al. 1996). Supporting this, Fillatreau and colleagues (Fillatreau, S. et al. 
2002) recently described a model involving B cell derived IL-10 as an essential component in 
the recovery phase of EAE, without which recovery was significantly delayed. 
As described in chapter 5, Intestinal inflammation models, resembling a similar location as a 
H.polygyrus infection but with an immunological profile similar to EAE, have also uncovered 
IL-10 producing B cells (requiring CD40 and 137-1 interactions during the chronic stages of 
inflammation) with the capacity to down regulate inflammation (Mizoguchi, A. et al. 2002) 
(Mizoguchi, E. et al. 2000). In addition, Fas ligand (FasL) expression on B cells as seen in 
mice chronically infected with S.mansoni (Lundy, S. K. and Boros, D. L. 2002) may provide a 
direct model, with deletion of pathogenic T cells following adoptive transfer. 
The heterogeneous population in the CD4 compartment demanded some cell fractionation to 
tease out a potential mechanism. We therefore isolated CD19 cells from naïve and 
chronically infected donors, with and without the ability to produce IL-b, asking specifically if 
CD19 cells could protect from EAE and if so, if they required IL-b. 
The observations here, that CD4 and purified CD19 cells from chronically infected donors, 
irrespective of IL-10 capabilities, can significantly protect MOG-immunised mice from disease 
progression, begin to shed light on potential mechanisms. Elliot and colleagues have 
observed similar regulatory capacity - of MLN cells from IL-10 -4- mice chronically infected with 
H.polygyrus (Elliott, D. E. et al. 2004). In their studies, transferred MLNC protecting from 
colitis expressed Fox p3, associated with Treg cells, supporting an IL-10 independent 
regulatory function of cells from the MLNs of infected mice. 
Notably, CD19 cells from chronically infected IL-10 donors may be more potent than 
CD19 cells from IL-10 competent mice, suggesting that immunological compensation may 
have exaggerated other functions, such as TGF-P secretion. The regulatory role of TGF-P in 
EAE has been extensively studied. The simple neutralisation of TGF-3 can convert otherwise 
resistant Brown Norway rats to the clinical manifestations of EAE following immunisation with 
myelin basic protein (Cautain, B. et al. 2001). Furthermore, the induction of TGF-P secreting 
cells, following oral feeding of plant derived lipids (Harbige, L. S. et al. 2000) or cholera toxin 
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B subunits (Sun, J. B. et al. 2000) can reduce the severity of EAE, through the inhibition of 
dendritic cell activation and chemokine expression. Of particular relevance, mesenteric lymph 
node cells from donor mice given myelin basic protein (MBP) conjugated to cholera toxin B 
sub units (CTB), could transfer protection from EAE in recipient mice (Sun, J. B. et al. 2000). 
Thus, a model of TGF-3-secreting cells regulating EAE can be proposed with a unifying 
mechanism transferable to the regulation of Der p1 induced airway inflammation. Indeed, 
such a mechanism has been proposed by Thorbecke and colleagues (Thorbecke, G. J. et al. 
2000), with T-cells transfected to produce TGF-P capable of suppressing both Thi cell 
mediated EAE and Th2 mediated allergic airway inflammation. 
Throughout the studies described in this chapter, the greatest protection from EAE coincided 
with reduced IL-6 and IFN-y. It is known that the pathogenesis of EAE is associated with 
increased secretion of IL-6 and IFN-y, and an accumulation IFN-y producing cells in the CNS. 
In addition, IL-6 has been implicated as an essential component of EAE (Okuda, Y. et al. 
1999), while the dependence on IFN-'y is less clear. Both of these cytokines are, however, 
pliant to the regulatory effects of TGF-3 (Holter, W. et al. 1994) (Walia, B. et al. 2003), thus 
providing a plausible hypothesis that TGF-3-secreting B cells protect from EAE through 
inhibition of IL-6 and IFN-y. 
In summary, in this chapter we have demonstrated that CD19 cells derived from the 
mesenteric lymph nodes of mice chronically infected with H.polygyrus, can significantly 
protect MOG-immunised mice from EAE. Taken together with the previous chapter, B cells 
generated during helminth infection can regulate inflammatory responses, limiting 
immunopathology, and may represent a population of antigen presenting cells that could be 
manipulated to regulate immunopathologies in an antigen-specific manner. Further studies 
with B cells generated during helminth infection, pulsed with allergen or auto-antigens could 
address the therapeutic potential of B cells in regulating allergic and autoimmune disorders. 
The key question is, however, if B cells regulate in a non-specific manner, whether they do so 
through release of immunoregulatory cytokines, or by the induction of regulatory cells through 
some facet of their function as APCs. 
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ChaDter 7—Trafficking of donor cells in vivo. 
7.1 	Introduction 
Homeostasis of the immune system requires compartmentalisation of naIve, effector and 
memory lymphocytes. To this end numerous cellular chemokine receptors and endothelial 
adhesion molecules synchronize in a multi-step process of lymphocyte extravasation into and 
out of tissues. During inflammation adhesion molecules, such as E- and P-selectin, ICAM-1 
and VCAM-1 on the endothelium of inflamed tissue, are upregulated. Cellular adhesion 
molecules (CAM) are largely controlled by cytokines, signalling through NF-KB pathways 
(Meager, A. 1999). Furthermore, cytokines not only upregulate CAM expression, but also 
cellular chemokine receptors. Chemokine receptor expression may in turn facilitate the 
recruitment of Thi or Th2 lymphocytes to sites of inflammation. For example, in vitro studies 
have associated the expression of CCR5 and CXCR3 with Thi cells, while.CCR3, CCR4, 
CCR8 and CXCR4 expression is biased towards Th2 cells (Hamann, A. and Syrbe, U. 2000; 
Sallusto, F. et al. 2000). The synchrony of CAM expression, chemokine secretion and 
receptor expression assist in generating only the desired immune response in the tissue, 
providing another level of immune regulation. 
AD 
During a primary H.polygyrus infection a rapid accumulation of B cells (Parker, S. J. and 
lnchley, C. J. 1990) and T-cells (Svetic, A. et al. 1993; Morimoto, M. et al. 2004) is observed 
in the MLN and surrounding encysted larvae. As described in chapter 3, the T-cell response 
to H.polygyrus antigen in the MLN is polarised towards a Th2 phenotype, with elevated IL-4, 
IL-5, IL-b, and IL-13. This cytokine milieu has been coupled with the induction of VCAM-1 
and late expression of E-selectin on endothelial cells, recruiting and propagating a Th2 
response in the local tissues (Meager, A. 1999). Thus, in accordance with this model, 
lymphocytes recruited into the MLN and local tissues during a H.polygyrus infection could 
express a specific chemokine receptor profile, specifically recruiting effector Th2 cells and 
other cells with an analogous receptor profile, regulated by cytokines and CAM expression on 
the local endothelium. 
A detailed analysis of chemokine receptor expression on CD4CD25 T cells and CD19TGF-
B cells, recruited to the site and MLN of H.polygyrus infected mice, would facilitate our 
understanding of the dynamics and possible origin of regulatory cells during infection. 
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The modulation of allergen-induced airway inflammation and the delayed onset and severity 
of disease in the EAE model following the transfer of cells from chronically infected mice, 
have established the regulatory capacity of MLNC during infection. CD4CD25 T-cells and 
CD19 B cells recruited to the MLN of chronically-infected mice appear to employ regulatory 
properties or inhibitory signals which, upon transfer into an unrelated immunological arena, 
retain their regulatory function. However, it is unclear where and how these regulatory 
functions are applied in the recipient mouse. Questions pertaining to the origin, function and 
mechanism of regulatory cells are unanswered. Assessing the location of these cells in the 
adoptive transfer models may help in some of these areas. 
Building on the studies described in this thesis, our objective here was to explore a 
mechanism of how CD4CD25 T-cells and CD19 B cells from chronically infected donors 
regulate allergy and / or autoimmunity following adoptive transfer. Firstly, it is unclear what 
fate the transferred cells undergo in the MOG-immunised or Der pi-sensitised recipient. 
Can donor cells migrate to inflammatory sites? 
Do donor cells expand in recipient mice and regulate inflammation? 
Do donor cells transfer regulatory capacity to recipient cells, converting host cells 
into antigen specific regulators? 
Using elegant transfer experiments with congenic markers to track the transferred cells, 
Unger and colleagues (Unger, W. W. et al. 2003) describe the transfer of regulatory capacity 
from CD4CD25 cells to naïve recipient CD4 cells. Furthermore, suppression of both Thi 
and Th2 responses, irrespective of initial Thl/Th2 skewing, and antigen-specific suppression 
was revealed, advancing our understanding of Treg capabilities. A lack of regulatory function 
in the CD4 compartment with regard to EAE in our studies may suggest that the initial 
cytokine environment may be important. For example, polarisation and differentiation into Thi 
or Th2 cells is irreversible following 4 cell divisions (Grogan, J. L. et al. 2001). 
Is the same model applicable to Treg cells? With a polarised Th2-suppressing-Treg, 
generated to specifically regulate Th2 responses, and vice versa for Thi responses? 
Potentially, CD4CD25 T-cells generated during a H.po!ygyrus infection in a polarised Th2 
environment may be professional Th2 suppressors (as seen in the Th2 associated allergy 
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model) and may not regulate a Thi mediated autoimmune disease. Studies of Treg function 
under cytokine polarising conditions could unravel these questions. 
We set out to address the fate of the donor cells in the recipient mice using the allotypic Ly5 
system. C57BL/6-Ly5.1 and C57BL/6-Ly5.2 mice express different allotypes of the CD45 
(Ly5) antigen, allowing us to distinguish, with mAb, the location of donor cells in recipient 
mice. 
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7.2 Results 
7.2.1 The Allotypic Ly5 system. 
The allotypic Ly5 system, using C57BL/6-Ly5.1 and C57BL/6-Ly5.2 mice expressing different 
allotypes of the CD45 (Ly5) antigen, allowed donor cells to be identified in recipient mice 
without pre-treating cells with dyes or interfering with immune function. Before in vivo tracking 
experiments were conducted, we confirmed expression of CD45.1 on C57BL/6-Ly5.1 cells 
and tested reagents for the ability to distinguish between allotypes using flow cytometry. 
CD4 and CD4 MLNC from naïve C57BL/6-Ly5.1 mice were purified and fluorescently 
labelled with monoclonal antibodies, anti-CD4, anti-CD45.1 and anti-CD45.2 (Fig. 7.1). Both 
purified CD4 and CD4 populations expressed CD45.1 and did not cross-react with CD45.2 
(Fig. 7.1). Mixing MLNC from C57BL/6-Ly5.1 and C57BL/6-Ly5.2 mice in vitro, before 
labelling with anti-CD4, anti-CD45.1 and anti-CD45.2 allowed us to carry out a proof-of-
principle experiment, testing the ability to discriminate CD45.1 from CD45.2 expression (Fig. 
7.2). Interestingly, cells co-expressing CD45.1 and CD45.2 were seen, which may represent 
the interaction of cells and may pose as a potential problem when deciphering donor and 
recipient cells in transfer experiments. 
7.2.2 Trafficking of donOr cells in Allergen-Induced Airway 
Inflammation. 
C57BL/6-Ly5.1 donor mice were chronically infected with H.polygyrus. MLNC were isolated 
and separated into CD4 and CD4 compartments, and 4x10 6 CD4Ly5.1 or CD4Ly5.1 
transferred intravenously into Der pi-sensitised C57BL16 Ly5.2 mice 7 days before airway 
challenge. Following Der p1 airway challenge, mice receiving CD4Ly5.1 (P<0.008) and 
CD4Ly5.1 (P<0.05) had fewer total airway infiltrates (Fig. 7.3A) and airway eosinophils (Fig. 
7.313). BAL fluid IL-5 and eotaxin (Fig. 7.3C) mirrored reductions in eosinophils without 
altering total IgE levels (Fig. 7.30). Thus, as reported earlier in chapter 4, both CD4 and 
CD4 cells from donor mice, can significantly inhibit Der p1-induced airway inflammation. 
Having established the robust suppression of airway allergy with donor cells we sought to 
identify the location of the donor Ly5. 1 + cells, one day after airway challenge, a total of 11 
days after transfer. 
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Fig. 7.1. Isolation of Ly5.1CD4 and Ly5.PCD4 cells from MLN of C57BL/6-Ly5.1 mice. MLNC from C57BL/6-Ly5.1 mice 
ere incubated with anti -CD4-Iabelled microbeads and separated over a magnetic column. Labelled CD4 cells (A), retained on the 
column, and unlabelled C134 cells (B), which passed over the magnetic column, were collected and washed. Samples of separated 
populations were stained with fluorescently labelled anti-CD4 and anti-CD45.l(Ly5. I) or anti-CD4 and anti-CD45.2 mAb, or a 
matched isotype control (left panel). Cells were acquired on a FACScalibur using Celiquest software and analysed using Flowjo. Data 
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Fig. 7.2. Mixing C57BL/6-Ly5.1 and C57BL/6 MLN cells. MLNC from C57BL/6-Ly5.1 and C57BL/6 mice were collected and 
washed. Cells were mixed and stained with fluorescently labelled anti-CD4 and anti -CD45.l(Ly5.1) and anti-CD45.2 rnAb, or a 
matched isotype control. Cells were acquired on a FACScalibur using Celiquest software and analysed using Flowjo. This experiment 
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Fig 7.3 Reduced airway allergy following the transfer of CD4 and CD4 cells from chronically 
infected donors. Uninfected allergen-sensitised C57BL/6 mice were given 4x10 6 CD4' or CD4 cells from 
infected C57BL/6-Ly5. I donors. 7 days before two localised intra-tracheal (it.) airway allergen challenges 
(D:D). 24 hours after airway challenge (Day 32), BAL cell infiltrates in response to Der p1 were collected 
(A) and differentially counted (B). BAL fluid cytokines were measured by ELISA (C) with polyclonal 
(total) IgE levels measured by capture ELISA in serum samples (D). Data presented are individual animals 
with mean bars. P values were calculated using a Mann Whitney test. This experiment has been conducted 
three times. 
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Following allergen provocation, lung tissue (Fig. 7.4A), thoracic lymph nodes (Fig. 7.413), MLN 
(Fig. 7.4C), spleen (Fig. 7.5A) and popliteal lymph nodes (Fig. 7.513) were removed from 
recipient mice, with single cell suspensions prepared and stained for donor cell markers, 
CD4Ly5.1 and CD4Ly5.1. Significant numbers of CD4Ly5.1 and CD4Ly5.1cells could 
be found in the local draining lymph nodes (Fig. 7.48, P<0.008), comprising of 0.42±0.18% 
and 0.39±0.07% of the CD4 and CD4 population, respectively. Similarly, 0.18±0.10% and 
0.30±0.14% of lung CD4 and CD4 cells were Ly5.1 (Fig. 7.4A). These data suggest that 
donor cells from chronically infected mice migrate to sites of inflammation and either directly 
suppress host cell responses or conscript host cells towards a regulatory phenotype. 
However, CD4Ly5.1 and CD4Ly5.1 could also be found in the MLN (Fig. 7.4C) of recipient 
mice, which may not be surprising as this is the organ of origin from donor mice. MLN-
derived-CD4 and CD47 cells may have homing receptors associated with mucosal 
associated lymphoid tissue, trafficking to gut associated lymphoid tissue (GALT) as well as 
bronchus associated lymphoid tissue (BALT). However, to distinguish homing from 
dissemination we analysed spleen and popliteal lymph nodes, distal lymph nodes unrelated to 
airway challenge. Similar numbers of CD4Ly5.1 and CD4Ly5.1 could be found in these 
lymphoid organs also (Fig. 7.4D, E), suggesting that donor CD4'Ly5.1 and CD4Ly5.1 + cells 
disseminate throughout recipient mice and do not home, specifically, to sites of inflammation. 
7.2.3 Donor cell migration during a steady state and during 
inflammation. 
To distinguish allergen-induced migration from undirected dissemination, Der pi-sensitised 
recipient C57BL/6-Ly5.2 mice were given 4x10 6 CD4Ly5.1 and CD4iy5.1 donor cells and 
either left unchallenged or given 2 airway challenges. Thus, with and without allergen-induced 
airway inflammatory we could compare preferential migration versus dissemination. 
Firstly, total airway infiltration (Fig. 7.5A) and airway eosinophilia was ablated (Fig. 7.58) 
following the transfer of donor CD4Ly5.1 and CD4Ly5.1 cells into Der p1 sensitised mice, 
following airway challenge. As expected, airway inflammation was not observed without 
airway challenge, irrespective of cell transfer. BAL fluid IL-5 and eotaxin paralleled airway 
eosinophilia (Fig. 7.5C) with elevated levels in allergic mice and reduced levels in mice 
receiving cells form infected donors. Without airway challenge, IL-5 and eotaxin levels were 
comparable to naïve levels. 
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Fig.7.4. Tracking donor CD4Ly5.1* and CD4Ly5.1 cells in Lung (A), TLN (B) and MIN (C). 
Organs were removed one day after airway challenge with single cell suspensions stained with 
fluorescently labelled anti-CD4 and anti-CD45. 1 (Ly5. 1) mAb's. Cells were acquired on a 
FACScalibur using Cellquest software and analysed using Flowjo. Data presented represents individual 
mice and arithmetic mean bars, with representative FACS plots. P values were calculated using a 
Mann Whitney test. This experiment has been conducted once. 
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Fig.7.4. Tracking donor CD4Ly5.1+ and CD4Ly5.1 cells in Spleen (D) and Popliteal 
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once. 
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Fig 7.5. Reduced Airway Allergy following the Transfer of CD4 and CI)4 - cells from Chronically infected donors. 
Uninfected allergen-sensitised C57BL16 mice were given 4x106 CD4 or CD4- cells from infected C57BU6-Ly5.1 
donors, with or without two localised intra-tracheal (i.t.) airway allergen challenges (D:D or D:-. respectively). 24 hours 
after airway challenge (Day 32). BAL cell infiltrates in response to Der p1 were collected (A) and differentially counted 
(B). HAL fluid cytokines were measured by ELISA (C) with polyclonal (total) IgE levels measured by capture ELISA in 
serum samples (D). Data presented are individual animals with mean bars. P values were calculated using a Mann 
Whitney test. This experiment has been conducted once. 
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Total lgE levels did not change significantly, following cell transfer with or without airway 
challenge (Fig. 7.51D). Thus, in summary, airway allergy was suppressed following the transfer 
of CD4Ly5.1 and CD4Ly5.1 cells from infected donors, as mentioned above and in 
chapter 4. Airway inflammation was not present without airway allergen challenge, allowing 
us to dissect the migration of donor cells with and without airway inflammation. 
Analysis of BAL cell recoveries revealed an accumulation of donor CD4Ly5.1 and 
CD4Ly5.1 cells (Fig. 7.6A), compared to un-challenged mice, indicating that a population of 
donor cells migrate to sites of inflammation. However, irrespective of airway challenge, donor 
CD4Ly5.1 and CD4Ly5.1 cells were found in the lung (Fig. 7.6B) and TLN (Fig. 7.6C) at 
similar percentages to un-challenged. mice. CD4Ly5.1 and CD4iy5.1 donor cells were 
also found in the MLN (Fig. 7.61D) and spleen (Fig. 7.6E), with significantly more CD4Ly5.1 
cells found in the MLN, spleen and TLN of un-challenged mice (P<0.008). Thus, it appears 
that donor CD4Ly5.1 and CD4Ly5.1' cells disseminate throughout the .recipient mouse. 
Upon airway challenge a fraction, or possibly a subset, of CD4Ly5.1 + cells migrate to the 
airways, reducing the number of CD4Ly5.1 cells found in other organs. Further studies with 
intra-dermal allergen challenge at alternative sites would confirm this observation of 
preferential migration to inflammatory sites. Unfortunately, the recovery of donor cells from 
recipient mice in these experiments was too low to phenotype donor cells further than CD4 
orCD4. 
7.2.4 Trafficking of Donor Cells in EAE. 
To further address the migration of donor cells during inflammation, we tracked the donor 
CD4Ly5.1 and CD4Ly5.1 cells in MOG-immunised mice following disease. CD4 and 
CD4cells were isolated from chronically-infected C57BL/6-Ly5.1 mice with 4x10 6 cells 
transferred into the.tail vein of MOG-immunised C57BL/6-Ly5.2 mice. Clinical scores were 
monitored from day 7 until day 30 post immunisation (Fig. 7.7), with analysis of local lymph 
nodes (inguinal and popliteal) and spleen cells at day 35. Transfer of 4x10 6 CD4Ly5.1 and 
CD4Ly5.1 cells from chronically infected donors significantly reduced paralysis and maximal 
clinical score (Fig. 7.7, P<0.02). 
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and TLN (C). Organs were removed from airway challenged mice (D:D) and un-
challenged mice (D:-) with single cell suspensions stained with fluorescently labelled anti-
CD4 and anti-CD45.1 (Ly5.1) mAb's. Stained cells were acquired on a FACScalibur using 
Cellquest software and analysed using Flowjo. Data presented represents individual mice 
and arithmetic mean bars. P values were calculated using a Mann Whitney test. This 
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Cellquest software and analysed using Flowjo. Data presented represents individual mice and arithmetic mean bars. P 
values were calculated using a Mann Whitney test. This experiment has been conducted once. 
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Fig 7.7. Disease course of EAE, following Ly5.1CD4 and Ly5.1CD4 cell transfer from chronically infected 
donors. Uninfected, MOG (35-55) immunised C57BL/6 mice were given 4x10 C' Ly5.1CD4 or Ly5.1CD4 from 
chronically infected donors. (A) EAE burden was monitored and presented as a clinical score, from two 
independent experiments with 8-10 mice per group in each experiment. A disease profile (B) highlights disease 
course features from each experiment. Data presented is the arithmetic mean from 8-10 animals per group ± SEM. 
P values were calculated using a Mann Whitney test. This experiment has been conducted twice. 
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At day 35, 34 days after adoptive transfer, significant numbers of donor Ly5.1CD4 (Fig. 7.8, 
P<0.05) and Ly5.1CD4 (Fig. 7.9, P<0.05) cells could be found in the spleen and local lymph 
nodes, suggesting that donor cells are firstly in a suitable location to influence the 
development of EAE, and secondly that either the donor cells or derivatives of the donor cells 
are still present. Donor Ly5.1CD4 or Ly5.1CD4 cells were not found in the CNS at the mid-
point of disease. 
Taken together, donor CD4 or CD4 cells can disseminate throughout the recipient mouse 
and reside in distal lymph nodes, such as the thoracic lymph nodes and popliteal lymph 
nodes during a steady state. Upon immune challenge and inflammation, donor CD4 and 
CD4 cells can be found in the tissue or site of inflammation, 11 days after transfer. 
Furthermore, original donor cells, or derivatives of, can reside in local lymph nodes for at least 
34 days after transfer; illustrating the potential longevity of donor cells. 
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Fig 7.8. Tracking donor CD4Ly5.1 cells in Spleen and lymph nodes following EAE. Uninfected, MOG (35-55) 
immunised C57B1J6 mice were given 4xlO' Ly5.1CD4 or Ly5.1CD4 from chronically infected donors. On day 
35, spleen and lymph nodes were removed with single cell suspensions stained with fluorescently labelled anti-CD4 
and anti-CD45. I (Ly5. 1) mAbs. Stained cells were acquired on a FACScalibur using Cellquest software and analysed 
using Flowjo. Data presented represents individual mice and arithmetic mean bars, with representative FACS plots. P 
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Fig 7.9. Tracking donor CD4Ly5.1 cells in Spleen and lymph nodes following EAE. Uninfected, MOG (35-55) 
immunised C57BL16 mice were given 4x106 Ly5.1CD4 or Ly5.1CD4 from chronically infected donors. On day 
35, spleen and lymph nodes were removed with single cell suspensions stained with fluorescently labelled anti-CD4 
and anti-CD45.1 (Ly5.1) inAbs. Stained cells were acquired on a FACScalibur using Celiquest software and analysed 
using Flowjo. Data presented represents individual mice and arithmetic mean bars, with representative FACS plots. P 
values were calculated using the Mann Whitney test. This experiment has been conducted once. 
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7.3 Discussion 
In this chapter the fate of donor cells following adoptive transfer from chronically infected 
C57BL/6-Ly5.1 mice into Der p1 sensitised- or MOG-immunised-1357BL/6-Ly5.2 recipients 
has been followed. Donor cells have the capacity to disseminate throughout the recipient host 
and reside within secondary lymphoid organs for up to 5 weeks. Furthermore, donor cells 
were found in sites of airway inflammation and local lymph nodes as well as in the local lymph 
nodes associated with CNS inflammation. These observations allow us to propose two 
models of donor cell and host cell interactions within local lymph nodes, modulating the 
ensuing immune response. We have previously observed the secretion of IL-10 as well as 
elevated levels of surface-bound TGF-3 within the CD4 and CD19 populations. Donor cells 
of these phenotypes could directly modulate host T-cells or APCs. Alternatively, direct cell-to-
cell interaction via Notch (Hoyne, G. F. et al. 2001), CTLA-4 (Grohmann, U. et al. 2002) or 
PD-1 (Watanabe, N. et al. 2003) molecules on donor cells, may be involved following donor 
cell migration to local draining lymph nodes. 
Regulatory cytokines could also operate indirectly, for example by modulating NF-KB 
signalling in APCs (Bhattacharyya, S. et al. 2004), APC stimulatory function (McBride, J. M et 
al. 2002) and promoting the induction of tolerance to allergen or auto-antigen (Steinbrink, K. 
et al. 1997). More relevant to these studies, IL-10 can directly inhibit IL-5 secretion from Th2 
CD4 cells (Zuany-Amorim, C. et al. 1996) or IFN-y from Thi cells (Fiorentinb, D. F. et al. 
1991), providing a suitable model of indirect donor and host cell interaction in both allergy and 
autoimmunity. 
The observation of donor cells in all lymphoid organs that we looked at may support a homing 
selection model. Briefly, this model suggests that the acquisition of adhesion and signalling 
molecules following activation is random, producing a pool of homing phenotypes (Davenport, 
M. P. et al. 2000). This stochastic model appears rather wasteful, although the selection of 
cells expressing the optimal 'post codes' arriving at the desired tissue may be a process for 
the clonal expansion of specialised cells, such as effector or regulatory cells. The 
observations made in our studies supports such a model with preferential homing of a unique 
subpopulation of donor cells, expressing the desired molecular 'post code'. Analysis of cells 
recovered in the lymph nodes, tissues and airspaces in the allergy model may expose unique 
populations. 
204 
Chapter 7. Trafficking of donor cells in vivo 
An alternative indirect mechanism may operate in which donor cells conscript host cells into a 
regulatory phenotype, in a form of infectious tolerance. Recent reports of human CD4CD25 
cells converting naïve cells into IL-10-producing Tn -type Treg cells supports such a model 
(Dieckmann, D. et al. 2002). Similarly, as mentioned above, CD4CD25 cells induced in an 
oral tolerance model can convert naïve CD4 cells into regulatory cells, in an antigen-specific 
manner (Unger, W. W. et al. 2003). This is an attractive model, given the very low numbers of 
donor cells found in the local lymph nodes (thoraci in the case of allergy and 
inguinal/popliteal in the case of EAE). Recent reports of APCs and in particular B cells, 
secreting chemokines, which attract Treg cells (Bystry, R. S. et al. 2001), and the 
identification of chemokine receptors on Treg cells (lellem, A. et al. 2001), may also support 
this model. This again argues that future analysis of chemokine receptors on H.polygyrus-
induced Treg cells should be a high priority. 
Analysis of host Ly5.2 cells in local lymph nodes following transfer of Ly5.1 cells, and 
assessing the suppressive capacity of the host population, could address the occurrence of 
infectious tolerance in this system. Several questions arise: 
Can CD4CD25 cells from H.polygyrus-infected mice convert naïve CD4 cells into 
regulators, supporting an infectious tolerance model? 
Can Treg cells from a H.polygyrus infection induce hyporesponsiveness to a third party 
antigen, as may occur in the models of helrninth regulation of allergy and autoimmunity. 
Can CD19 cells present antigen in a manner that induces antigen-specific tolerance? 
These, and other questions, remain unanswered, hopefully not for too long. The adoptive 
transfer system with allotype-marked cells provides an appropriate experimental model to 
address some of these questions. 
In summary, this chapter has identified the presence of donor cells in recipient Der p1-
sensitised or MOG-immunised mice. Donor cells appear to disseminate throughout recipient 
mice, during both steady state and inflammatory phases, possibly supporting a homing 
'selection' model. In addition, following airway challenge donor cells are found at the site of 
allergen provocation, suggesting preferential recruitment of a subpopulation of cells with the 
capacity to regulate overzealous inflammation. Finally, donor cells can persist for at least 34 
days in recipient mice, possibly supporting the therapeutic use of 'memory' or resting 
regulatory cells (Fisson, S. et al. 2003). 
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Chapter 8. General Discussion 
8.1 	Introduction 
Human epidemiological studies, both observational and post-therapy, support an inverse 
association between chronic helminth infections and allergic responsiveness (reviewed by 
(Yazdanbakhsh, M.- et al. 2001)). This thesis supports these observations with experimental 
data and provides evidence of helm inth-induced regulatory responses restraining both allergic 
and autoimmu ne associated inflammation. 
Using experimental murine models, this thesis aimed to dissect the relationship between 
chronic helminthiasis and allergic reactivity. We hypothesised that immunological events 
invoked during helminth infections and allergic reactivity interact with the net effect of either a 
'restored' or expanded regulatory population, suppressing allergic, and indeed other 
inflammatory responses. To address this aim and test our hypothesis, we used a model of 
chronic helminthiasis, the natural murine gastrointestinal nematode Heligmosomoides 
polygyrus, in two allergen-induced models of airway inflammation, using the experimental 
allergen, OVA, and the natural house dust mite aero-allergen, Der p1. These models allowed 
us to observe modifications in cellular recruitment, cytokine and chemokine expression, and 
airway pathology in the presence of a chronic helminth infection with two mouse strains and 
two allergens. 
A chronic primary infection with H.polygyrus elicited an authoritative type 2 response, with 
T112 lymphocytes found throughout the infected host, and elevated IgE and IgGi serum 
antibodies. Our major observation that a chronic T112-dominated H.polygyrus infection can 
suppress Th2 dependent airway allergy (Fig. 8.1), whether measured by the inflammatory 
infiltrate in BAL fluid, by pen-bronchial and pen-vascular inflammation or by mast cell activity, 
supports our hypothesis that helminth infections down-regulate allergic reactivity through the 
action of suppressive populations, rather than by altering the Thl / T112 balance. Th2 effector 
cytokines in the BAL fluid (IL-5 and IL-13) and the chemokine eotaxin, were secreted at lower 
levels, while IFN-y and IL-4 were unchanged, suggesting that allergen-specific Th2 cells are 
indeed modulated. In addition, the observation of H.polygyrus-reactive T cells in the lungs 
and local draining lymph nodes of chronically-infected mice and the reversibility of 
suppression of airway inflammation following depletion of CD25 cells, provided a 
mechanistic hypothesis for us to test. 
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Fig. 8.1 Suppression of Allergen-Induced Airway Inflammation with a 
concurrent chronic Helig,nosomoi4es polygyrus infection. 
Our primary observations support other work with H.polygyrus, demonstrating reduced allergy 
to food antigens (Bashir, M. E. et al. 2002), the inhibition of ongoing colitis (Elliott, D. E. et al. 
2004) and the suppression of Helicobacter pylon-induced gastritis (Fox, J. G. et al. 2000). 
The immunomodulatory capacity of H.polygyrus infection thus encompasses a remarkable 
range of immunopathologies. 
IL-10 dependent suppression of peanut-specific IgE production by I-!.polygyrus has also been 
reported (Bashir, M. E. et al. 2002), with similar effects found in Strongyloides stercoralis 
infection (Wang, C. C. et al. 2001). Our study does not however, indicate that modulation of 
allergen-specific IgE occurs, perhaps due to the infection protocols used here. The 
suppression of airway inflammation in pre-sensitised mice with a subsequent chronic 
H.polygyrus infection did, however, reduce Der p1-specific IgE, suggesting that the timing of 
infection can indeed influence allergen sensitisation. Further studies of helm inth-regulated IgE 
are required, in light of recent reports and theories of B cell survival (Aalberse, R. C. and 
Platts-Mills, T. A. 2004) and differential IgE and lgG4 production (Jeannin, P. et al. 1998). 
Our initial studies also highlight the redundancy of IL-10 in helm inth-induced suppression of 
airway inflammation, suggesting other, possibly multi-faceted, mechanisms of regulation. In 
conjunction with other reports on the suppression of colitis in IL-10 mice following the 
transfer of MLN from H.polygyrus infected IL-10-1- mice (Elliott, D. E. et al. 2004), IL-10 can 
be conclusively eliminated as an essential player in this system. An IL-10-independent 
mechanism involving immune deviation, with the reduction of IFN-y and heightened IL-13 
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secretion is one likely explanation for these observations (Fox, J. G. et al. 2000; Elliott, D. E. 
et al. 2004). However, in addition to immune deviation towards a Th2 response, these authors 
also report elevated expression of Fox p3, the transcription factor defining Treg activity, within 
the MLN of H.polygyrus infected mice. Hence the possibility of immune suppression is not 
excluded by previously published studies. 
Our initial work uncovered and supported the phenomenon of helminth protection from allergy 
and other inflammatory conditions. To dissect mechanisms operating during concurrent 
infection and allergy, and to test our initial hypothesis, we developed an adoptive cell transfer 
model to isolate cellular compartments capable of transferring protection from allergy. Using 
this model, a logical progression of purified cellular populations and subpopulations were 
transferred from chronically infected donors into uninfected allergen-sensitised recipients. 
This method allowed us to pursue active cell subsets within the MLN of chronically infected 
mice and revealed several candidate populations; T cells expressing CD4 and the alpha chain 
of the IL-2R, CD25; CD19 B cells; and CD11c dendritic cells, all emerged as puissant 
populations capable of transferring protection from allergy to allergen-sensitive recipients 
(Fig. 8.2). Thus, at least at the cellular level, we had identified three populations with potent 
regulatory properties, capable of suppressing airway allergy. 
Before proposing and dissecting potential mechanisms, we must appreciate that this model of 
allergen induced airway inflammation, with intraperitoneal allergen sensitisations in alum 
adjuvant over a 28-day period, is mediated by allergen-specific Th2 cells. Removing CD4 
cells (Gavett, S. H. et al. 1994), blocking IL-4 (Brusselle, G. G. et al. 1994) or disrupting 
GATA-3 or STAT-6 (Tomkinson, A. et al. 1999; Zhang, D. H. et al. 1999) all inhibit the 
development of allergen-induced airway inflammation. Furthermore, the allergic airway 
inflammatory response can be induced with the transfer of CD4 T cell receptor-transgenic 
Th2, but not Thl, cells (Cohn, L. et al. 1998), firmly establishing this model as a Th2 mediated 
model of airway inflammation. 
Thus, Th2 cell development from initial DC-allergen encounter, migration to thoracic lymph 
nodes and presentation to naïve T cells, as well as re-activation of allergen-specific Th2 cells 
and egression to the airways, represent a series of crucial events culminating in the allergic 
cascade (Fig. 8.3). Interference at any point with this series of events will limit the degree of 
airway inflammation observed, providing many possible mechanisms by which cells or 
mediators generated during a helminth infection would provide protection from allergy. We 
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hypothesise that the three identified cellular populations, CD4CD25 T cells, CD19 B cells 
and CDI lc dendritic cells from helm inth-infected mice disrupt this series of crucial events 
reducing the intensity of allergen-induced inflammation. 
Fig. 8.2 Suppression of Allergen Induced Airway Inflammation with cellular 
populations isolated from chronically infected donors and transferred into an 
allergen sensitised recipient mice. 
8.2 Helminth-induced CD4CD25 Treg 
The generation, origin and detailed phenotype of CD4CD25 cells in the MLNC of 
H.polygyrus-infected mice are currently being investigated in our laboratory. This thesis 
uncovered several regulatory populations and focuses on in vivo functionality of these cells 
with sufficient phenotypic data to propose possible mechanisms. 
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As mentioned in chapter 4, Treg cells generated inthe MLN, serving the intestinal mucosal 
surfaces, have been characteristically described as Th3 cells, while Treg cells in the 
respiratory mucosal environment are generally TO cells. However there is considerable 
overlap between these populations. 
For example, Th3 cells, initially described in oral tolerance models (Chen, Y. et at. 1994; 
Inobe, J. et al. 1998) secrete TGF-3 (Weiner, H. L. 2001) and stimulate IgA production (lnobe, 
J. et at. 1998), and are capable of suppressing both Thl and Th2 cells (Weiner, H. L. 2001). 
TO cells, secreting IL-10, have been isolated from respiratory associated mucosal sites 
(Cottrez, F. et at. 2000; Akbari, 0. et al. 2001) yet have also been associated with regulating 
gastric colitis by a process of antigen-driven bystander suppression (Groux, H. et at. 1997). 
TO cells can thus control both Thi (Groux, H. et al. 1997) and Th2 responses (Akbari, 0. et 
al. 2001). CD4CD25 cells, in addition to controlling the activation of self reactive I cells 
(Kohm, A. P. et al. 2002), are also essential regulators of intestinal (Lundgren, A. et al. 2003) 
and airway (Karlsson, M. R. et al. 2004) inflammatory responses (Singh, B. et al. 2001). 
CD4CD25 cells can also regulate Thi (Belkaid, Y. et al. 2002) and Th2 (Bellinghausen, I. et 
at. 2003) associated responses. The functional cross-over of these three Treg subtypes, TO, 
Th3 and CD4CD25, with regard to intestinal, or more general, mucosal-associated tissues 
represent the one concrete property of these vaguely defined cells: their ability to suppress 
effector T cells. Our observations are a clear example of this, as CD4CD25 cells, frequently 
defined as 'naturally occurring Treg' cells, are isolated from the 'Th3 location'- (MLN of 
chronically infected mice) but show functionality in the'Trl location'- (in the airway tissues). 
Dysfunctional immune regulation, in particular Treg function in human patients, has been 
linked to allergic manifestations (Bellinghausen, I. et at. 2003; Cavani, A. et al. 2003; Akdis, 
M. et al. 2004; Grindebacke, H. et at. 2004; Ling, E. M. et al. 2004) and autoimmune 
pathologies (Viglietta, V. et al. 2004) highlighting the crucial function of Treg cells in 
controlling inflammatory responses. How could CD4CD25 cells from the MLN of chronically 
infected mice protect allergen-sensitised mice from airway inflammation, following allergen 
provocation? 
We show here that CD4CD25 cells isolated from the MLN of chronically-infected mice, 
where expression of CTLA-4, GITR, CD103, surface bound TGF-P and intracellular. IL-b, are 
all elevated to varying degrees within the CD4 population, can suppress allergen-induced 
airway inflammation. 
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The protocol used here, transferring 3x10 5 CD4CD25 cells from chronically-infected donors 
into the tail vein of allergen-sensitised mice; 7 days before airway challenge, tests the ability ,  
of donor cells to regulate reactivation of allergen-specific cells in the airways. Therefore, at 
this stage in the allergic cascade, donor cells are most likely to act upon events associated 
with Th2 cell function, such as reactivation of Th2 cells by APCs, or subsequent mobilisation 
of effector cells, such as eosinophils. Although the direct interaction of Treg cells and 
eosinophils has not been studied, there is clear down-modulation of IL-5 and eotaxin, 
presumed to be secreted by Th2 populations, in these studies. 
83 Regulatory model 
Allergen-specific immunotherapy (SIT) in humans is able to successfully induce a state of 
non-responsiveness to allergen stimulation, reduced effector cytokine secretion and 
enhanced production of IL-10 and TGF- (Muller, U. et al. 1998; Akdis, C. A. and Blaser, K. 
1999; Pierkes, M. et at. 1999; Bellinghausen, I. et at. 2001). Suppression of allergic reactivity 
by CD4CD25 Treg cells with reduced allergen-specific IL-5, IL-13 and IFN-y from effector I 
cells suggests that T cell function is modulated in human patients (Francis, J. N. et al. 2003; 
Jutel, M. et al. 2003; Gardner, L. M. et al. 2004). Animal studies have moreover shown that 
Treg cells down-regulate allergic airway inflammation (de Lafaille, M. A. et al. 2001(lgE); 
Hadeiba, H. and Locksley, R. M. 2003; Jaffar, Z. et at. 2004) and have identified the active 
involvement of CTLA-4 in down-modulating T cell activation and maintaining lymphocyte 
homeostasis (Hetlings, P. W. et al. 2002; Vasu, C. et at. 2004). 
Extensive screening of cell surface receptors on Treg cells identified 80% of CD4CD25 Ireg 
cells expressing CTLA-4, with only 18% of CD4CD25 effector T cells expressing CTLA-4 
(McHugh, R. S. et al. 2002). We screened MLN cells from chronically infected mice and also 
found up-regulated expression of CTLA-4 on CD4 cells, compared to naïve CD4. The 
interaction of CTLA-4 on T cells with B7 molecules on DCs triggers intracellular signalling 
within DCs and the activation of idoleamine 2,3-dioxygenase (IDO)(Fallarino, F. et al. 2003). 
100 is a rate-limiting tryptophan catabolising enzyme that can inhibit T cell proliferation 
through depletion of local tryptophan levels (Munn, D. H. et at. 1999). 
Thus, a network of elevated CTLA-4 expression on helminth derived CD4CD25 cells, 
interacting with host DCs and increasing IDO activity (Grohmann, U. et al. 2002; Fallarino, F. 
et at. 2003) provides a potential mechanism whereby CD4CD25 cells from infected donors 
could modulate allergen-specific T cell responses (Fig. 8.3). 
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Fig. 8.3. Treg mediated model of Airway Allergy suppression. Potential mechanisms 
of Treg modulation of the allergic cascade, including modulation of allergen 
presentation to Th2 cells, via CTLA-4 and IDO pathways or direct suppression of Th2 
proliferation via TGF-13 secretions. GITR and CD 103, may not act as functional 
suppressor molecules but may modulate the suppressive capacity of Tregs and identify a 
subset of homing Tregs, respectively. The central Treg may be a primary, helminth 
derived CD4CD25' cell or secondary converted Treg with allergen specificity. 
In addition to CTLA-4 and B7 interactions, Toll-like receptor (TLR)-9 ligation can increase 
tryptophan catabolism (Hayashi, T. et al. 2004). Furthermore, increased IDO activity via TLR-
9 ligation has been shown to inhibit airway allergy (Hayashi, T. et al. 2004). Whether 
!-I.polygyrus antigens or secreted molecules harbour any ligands for TLR-9, providing an 
additional means of up-regulating IDO activity has yet to be unravelled. An additional function 
for CTLA-4 may involve competition for B7 molecules on DCs, limiting the activation of 
allergen specific I cells (Fig. 8.3). The involvement of CTLA-4 on CD4CD25 cells and the 
levels of [DO activity in DCs within the thoracic lymph nodes and local tissues could be easily 
tested in future experiments using this model. 
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Glucocorticoid-induced TNFR family-related gene (GITR) expression, like CTLA-4, has been 
identified on CD4CD25 Treg cells (Shimizu, J. et al. 2002). Agonistic antibody treatment, 
against GITR, in co-cultures of CD4CD25(Treg) and CD4CD25 (effector) cells, abrogated 
the suppression of effector cells (McHugh, R. S. et al. 2002; Shimizu, J. et al. 2002; 
Ronchetti, S. et al. 2004). However, the mechanism of GITR as a negative regulator of T cell 
proliferation is unknown. Recent studies have suggested that GITR ligation on CD4CD25 
(effector cells) is required to abrogate suppression and that GITR-L / GITR engagement 
renders Tcells resistant to the suppression of CD4CD25 cells (Stephens, G. L. et al. 2004). 
Therefore, although GITR may not be an effector molecule mediating suppression, GITR 
expression may mediate an immunoregulatory role by reducing the suppressive activity of 
CD4CD25 cells. At present the expression of GITR on CD4 cells derived from the MLN of 
chronically-infected mice, appears to act only as a marker of Treg cells, and may indeed 
abrogate suppression following ligation. Until the function of GITR is unravelled, its potential 
role in the suppression of allergen specific T cells remains intangible. 
Finally, and with particular relevance to MLN CD4CD25 Treg cells, is the discovery of a 
subset of CD4CD25 cells expressing the cLEI37  integrin, CD103. Similar to CTLA-4 and 
GITR, CDI 03 expression is considerably elevated on activated CD4CD25 cells compared 
to activated CD4CD25 cells (McHugh, R. S. et al. 2002). During infection with H.polygyrus, 
we found CD103 expression was significantly elevated on CD4 cells from infected, 
compared to naïve cells. CD103 cells are preferentially located in the interstitial regions of 
the intestinal epithelium, the MLN and Peyer's patches (Banz, A. et al. 2003) with CD103 
expression on CD4CD25 cells possibly representing a location or homing molecule. 
CD4CD25CD103 cells have been shown to suppress the development of IBD (Lehmann, J. 
et al. 2002), although as CD4CD25CDI03 cells are also suppressive in vitro (McHugh, R. 
S. et al. 2002) CDI 03 may be a marker for a particular subgroup of unknown specialised 
function. 
8.4 	Infectious tolerance 
The direct interaction of CD4CD25 cells from infected mice with allergen-specific Th2 cells 
in a contact-dependent manner may only be part of a bigger picture. A more generalised 
model can be envisaged in which the recruitment of host cells into regulatory function through 
a cell-to-cell contact-dependent initiation is coupled with subsequent contact-independent 
suppression of allergen-specifiô Th2 cell proliferation. Several studies have reported this 
phenomenon of conveying suppressor activity to naïve or previously effector T cells, branded 
'infectious tolerance'. 
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Mechanistic models of infectious tolerance propose that activated C134CD25 cells not only 
suppress T cells in a contact-dependent manner via inhibitory receptors and surface-bound 
TGF-, but can convert them into regulatory cells. The newly-converted Treg cells then 
produce inhibitory mediators such as IL-10 or TGF-, blocking the activation of other T cells in 
a contact-independent manner (Jonuleit, H. et al. 2002). In addition to contact-dependent 
enrolment of T cells, secreted TGF-P can convert T cells into suppressive, TGF-13 secreting 
Tregs, which also express Fox p3, reinforcing Treg properties (Chen, W. et al. 2003). In the 
house dust mite (HDM) induced airway inflammation model, Chen and colleagues (Chen, W. 
et al. 2003) demonstrated that these secondary, 'newly recruited' Treg cells secreting TGF-
could suppress HDM-induced airway inflammation. This study supports the proposal that 
peripheral generation of CD4CD25 cells secreting TGF-P provides one functional pathway 
for suppressive activity in airway allergy. Other studies support this work with primary and 
secondary Treg cells expressing Fox p3, confirming the conversion and generation of 
peripheral Tregs (Zheng, S. G. et al. 2004). 
Thus, the hypothesis can be constructed that transferring CD4CD25 cells from chronically-
infected mice has the ability to convert naïve CD4 cells into Treg cells and, on transfer, 
demonstrate infectious tolerance in allergen-sensitised recipients. The observation of 
elevated surface-bound TGF-P in CD4 populations within the MLN of chronically-infected 
mice may support this model (Fig. 8.4). Several further questions arise; firstly, are helminth-
derived CD4CD25 cells responsible for TGF-P secretion? Can helminth-induced Treg cells 
convert naïve CD4 cells into regulatory cells? A series of in vitro experiments with naïve 
CD4 cells, from congenic mice could easily test such events. Finally, is there expansion of 
recipient CD4CD25 cells in allergen-sensitised mice, following the transfer of CD4CD25 
cells from helm inth-infected donors? Again this could be tested using the congenic system. 
The phenotype of primary Tregs, possibly 'natural' CD4CD25 I cells, and secondary Tregs 
could address the issue of Treg heterogeneity. Stassen and colleagues (Stassen, M. et al. 
2004) propose that second generation Tregs, adopting a TO like function with IL-10 secretion 
(Dieckmann, D. et al. 2002) or a Th3 like function with TGF-13 secretions, derive from distinct 
populations of primary Treg compartments, distinguishable by their expression of a4I7  and 
a4i integrins, respectively. These and other phenotypic variations are slowly being 
uncovered, developing a greater understanding of the biology of Treg cells. 
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This model of infectious tolerance accommodates the relatively small number of CD4CD25 
cells observed in peripheral blood, and their poor proliferative capacity. The model also 
provides a possible solution to the confusion of cell-contact dependent and independent 
mechanisms by encompassing both events. Furthermore, it may suggest that antigen-specific 
expansion of primary Treg populations is not necessary as a result of antigen-independent 
suppression by secondary Treg populations, possibly operating in the system presented in 
this thesis with helminth-induced primary and allergen-suppressive secondary Treg 
populations. 
Following adoptive transfer of Tregs into allergen sensitive hosts, we found donor cells 
disseminated throughout the host. Following airway challenge, donor cells could still be found 
throughout the host, with a small proportion migrating to the airways. We have yet to 
phenotype the donor cells found in the airways, however it is enticing to suggest that a 
subgroup of donor Treg cells with the capacity to home to sites of inflammation propagate the 
expansion of host, possibly allergen-specific, Treg populations. Infectious tolerance may be 
self-sufficient with a healthy supply of naïve CD4 cells to be converted by donor Tregs. 
However, once there is recruitment of host CD4CD25 Treg cells, in addition to naïve CD4 
cells a regulatory cascade may be triggered. lellem and colleagues (lellem, A. et al. 2001) 
have identified the chemokine receptors CCR4 and CCR8 on peripheral CD4CD25 cells, 
isolated from human blood, allowing us to dissect the migratory properties of Tregs. The 
chemotactic properties of Tregs in response to the macrophage derived chemokine (MDC, 
CCL22) and thymus and activation-regulated chemokine (TARC, CCL17) was confirmed in 
vitro, suggesting that MDC- and TARC-secreting cells attract Tregs, possibly propagating 
infectious tolerance (Fig. 8.4). This model of Treg mediated suppression of airway allergy is 
finally supported following the observation of increased numbers of CCR4 expressing CD4 
cells found in the airways of patients with airway eosinophilia (Katoh, S. et al. 2003). 
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Fig. 8.4. Multidimensional Infectious tolerance. Helminth derived Treg cells, interacting with activated 
DCs, may recruit naIve. Th2 polarised or Treg cells via MDC and TARC chemotactic gradients. An 
appropriate cytokine environment rich in IL-10 and TGF-P from helminth derived Treg cells, with allergen-
induced activation of DCs, ThO cells may be given allergen-specific Treg properties, capable of suppressing 
allergen-reactive Th2 cells. 
8.5 	Heim inth-induced regulatory B cells 
The suppression of airway inflammation, following the adoptive transfer of either CD1 1c (DC) 
or CD19 (B cells) (Fig. 8.2), implicates a multidimensional network of cellular regulation 
developed, at least, in the chronic stages of helminth infection and possibly throughout 
infection. APCs, and in particular DCs, represent afferent innate cells responsible for the 
generation and re-activation of Thi, Th2 and Treg cells (Reis e Sousa, C. 2001; Yamazaki, S. 
et al. 2003). During the chronic stages of infection DCs may preferentially promote Treg 
populations (Yamazaki, S. et al. 2003) with less emphasis on effector T cell responses. 
During tolerance regimes, DCs secreting IL-10 or TGF-P can induce Treg populations (Akbari, 
0. et al. 2001). The preliminary observation of DCs with functional regulatory potential in our 
system warrants further investigation. In this thesis, however, we did not pursue the 
tolerogenic, or Treg-inducing, properties of DCs from helm inth-infected donors, but rather 
focussed on the fascinating properties of CD19 B cells and their ability to regulate airway 
allergy (Fig. 8.2). In parallel studies using the experimental autoimmune encephalomyelitis 
(EAE) model of multiple sclerosis, we added further evidence of a regulatory role for B cells 
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derived from chronically-infected donors, with the significant reduction of clinical disease 
following adoptive transfer (Fig. 8.5). 
B cells, similar to Treg cells, play important roles in regulating pathogenic inflammatory 
responses (Wolf, S. D. et al. 1996; Ferru, I. et al. 1998; Buendia, A. J. et al. 2002; Mizoguchi, 
A. et al. 2002); (Buendia, A. J. et al. 2002; Fillatreau, S. et al. 2002). However, unfortunately, 
B cell-related regulation has not received as much attention as that of T cells, and it is 
consequently been more difficult to propose a testable functional model. 
How could a purified population of B cells modulate allergen-induced and MOG-induced 
inflammation? As mentioned above, allergen-induced airway inflammation is a T cell-
mediated process. Similarly, the EAE lesion is initiated by CD4 T cells (Lassmariri, H. and 
Ransohoff, R. M. 2004). While EAE and allergy pose as Thi- and Th2-polarised diseases 
respectively, they both develop from exacerbated CD4 cellular responses. These responses 
may be a common factor in allergies and autoimmune disease and perhaps deficient B cell-
mediated regulation is a factor in their increasing prevalence. As with Treg cells, we now ask 
the same question: how could B cells modulate allergen-reactive-Th2 and MOG-reactive-Thi 
cells, and their respective APC partners? 
An attractive model is regulation by B cell-derived IL-10 (O'Garra, A. and Howard, M. 1992), 
as evident in other helminth infections (Velupillai, P. et al. 1997; Mangan, N. E. et al. 2004), 
with the capacity to down regulate inflammatory cascades (Mizoguchi, A. et al. 2002). 
However we show here that IL-10 is not responsible for suppression of either allergen-
induced or MOG-induced inflammation. We cannot totally exclude IL-10 from the picture, 
however, as recipient cell-derived IL-10 may be required for eventual resolution of allergy or 
autoimmunity. In addition, infection of IL-10 deficient mice may promote compensatory 
mechanisms, not operative in the wild-type setting. 
I- 
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Fig. 8.5. Modulation of EAE with cellular populations isolated from a chronically 
infected donor and transferred into MOG immunised recipient mice. 
The discovery of B cell expression of TGF-3 in MLNC of chronically-infected mice may lie at 
the heart of a B cell-mediated mechanism and confirms other reports of B cell-derived TGF-3 
(Kehrl, J. H. et al. 1986). TGF-3 can suppress Thi cell differentiation and proliferation 
(Gorelik, L. et al. 2002) and can block Th2 responses by inhibiting GATA3 expression 
(Gorelik, L. et al. 2000), providing suitable properties to regulate Th2-associated allergy and 
Thi-associated autoimmunity. 
Evidence of TGF-P regulating the clinical developments of EAE has been observed in several 
rodent models. Firstly, EAE can be induced in rodents, otherwise resistant, by neutralising 
TGF-f (Cautain, B. et al. 2001), suggesting that TGF-P is indeed responsible for resistance. 
In addition, TGF-3-secreting cells can reduce the severity of EAE in other murine models 
(Harbige, L. S. et al. 2000; Sun, J. B. et al. 2000). Could B cells from the MLN, regulate CNS 
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inflammation? Oral tolerance studies show that myelin basic protein (MBP) conjugated to 
cholera toxin B subunits (CTB) significantly suppresses EAE, with reductions in leukocyte 
recruitment and Thi cytokines (Sun, J. B. et al. 2000). Accompanying these reductions the 
authors report increased numbers of TGF--secreting lymphocytes in the MLN, which were 
able to transfer protection from EAE, suppressing both Thi and Th2 cytokines. The potential 
for B cells from the MLN of chronically-infected donors, to suppress EAE via TGF-P is 
therefore plausible. 
How could B cells from the MLN of infected donors regulate airway allergy? Presumably, by a 
similar mechanism, involving surface-bound TGF- (Fig. 8.3, 8.5, 8.6)(Kehrl, J. H. et al. 
1986). B cells from IL-10 -4- mice reduced airway allergy to a similar degree as B cells from 
infected wild-type donors, suggesting that donor B cell-derived IL-10 is not required. The 
literature abounds with evidence of depressed airway allergy mediated by TGF--secreting 
cells (Jutel, M. et al. 2003); (Hansen, G. et al. 2000; Terui, T. et al. 2001; Schmidt-Weber, C. 
B. et al. 2002). 
Using a dominant negative TGF-P type II receptor on T cells, Schramm and colleagues 
(Schramm, C. et al. 2003) clearly demonstrate that TGF-P exerts its effects on T cells, with 
exacerbated AHR, IL-13 secretions and NOS expressing cells, following airway challenge of 
mice unable to respond to TGF-P receptor ligation. Thus, B cell-derived TGF-, as with Treg-
derived TGF-13, may operate either to directly suppress effector T cell responses or to convert 
naive cells into suppressive, TGF--secreting Tregs (Chen, W. et al. 2003). Furthermore, B 
cells may recruit Tregs via CCL4 secretions (Bystry, R. S. et al. 2001), with the 
supplementary inhibition of effector cell activation by down regulating MHC class II (Gorelik, 
L. and Flavell, R. A. 2002). 
Taken together, a model of TGF-3 secreting cells, of either Treg or B cell lineage, 
suppressing allergen-specific or MOG-specific effector T cells may be responsible for the 
observed protection from allergy and EAE following adoptive cell transfer from chronically 
infected donors. A similar model was proposed by Thorbecke and colleagues (Thorbecke, G. 
J. et al. 2000). Although donor cell-derived IL-10 is not required, TGF-P from donor cells may 
induce host IL-10 secretion (Kitarti, A. et al. 2000) with a synergistic effect in the recipient host 
(Terui, T. et al. 2001). Conversely, IL-10 can mediate the up-regulation of the TGF-3R2 on 
activated T cells, rendering them more susceptible to the suppressive effects of TGF-
(Cottrez, F. and Groux, H. 2001), supporting a dual role for these regulatory cytokines. The 
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variable susceptibility of Thi and Th2 cells to the suppressive effects of Tregs (Cosmi, L. et 
at. 2004), may therefore be overcome by synergistic effects of IL-10 and TGF-3 (Terui, T. et 
al. 2001). Interestingly, the identification of a human TGF-P homologue, tgh-2, from Brugia 
malay! (Gomez-Escobar, N. et al. 2000) illustrates that parasites might themselves express 
homologues, which bind to host the TGF-R and/or IL-10R, mimicking signalling and directly 
reproducing suppression of effector responses. 
Richard K. Gershon, a pioneer during the first coming of Tregs during the late 1970's and 
early 1980's was reported leaving a session on suppressor I cells, with a feeling of 
wonderment, that... in the face of so much suppression, an immune response could occur at 
at" (Cantor, H. 2004). This is still a pertinent question today; what regulates the regulators? 
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Fig. 8.6. TGF-P mediated model of infectious tolerance. Helminth infected hosts, 
generating significant numbers of Treg and B cells, with surface bound TGF-, could 
propagate the generation of allergen-reactive Tregs or MOG reactive Tregs. capable of 
modulating disease progression. 
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8.6 Hygiene Hypothesis- From one mouse to the human 
population. 
What have we learnt from the adoptive transfer models, and what do they tell us about the 
Hygiene Hypothesis? In this thesis, we have demonstrated that a chronic H.polygyrus 
infection can inhibit the severity of allergen-induced airway inflammation. CD4CD25, CD19 
and CD1 1c cells isolated from the MLN of chronically infected mice, can achieve an 
equivalent level of protection from airway allergy in allergen-sensitised mice, without infection. 
Thus, these cellular 'compartments, and possibly others, may collaborate in a regulatory 
network, suppressing anti-helminth effector responses, and as shown here, prevent the 
progression of airway allergy. In addition, we also demonstrate that CD19 cells from 
helm inth-infected mice can significantly reduce the clinical manifestations of EAE, as well as 
airway allergy, suggesting that a widespread suppression occurs during chronic helminth 
infection. IL-10 was not required to transfer protection from infected donors to allergen-
sensitive or MOG-responsive recipients, eliminatihg donor (but not necessarily recipient) IL-
10 as a possible mediator of protection. CD4 and CD19 cells in the MLN of chronically-
infected donors expressed elevated levels of surface-bound TGF-P and we thus propose a 
model analogous to infectious tolerance, in which regulatory capacity is induced in secondary 
Treg populations, via surface-bound TGF-P. 
Within a chronically infected host, 'natural' Treg cells may convert naïve T cells, via TGF-3, 
into non-specific or secondary allergen-specific Treg cells, suppressing allergen-reactive I 
cell responses. Araujo and colleagues (Araujo, M. I. et al. 2004) recently reported reduced 
allergen reactivity with reduced secretion of Der pl-specifiô IL-4 and IL-5 and elevated Der 
p1-specific IL-10 in S.mansoni-infected asthmatic patients. Following treatment and 
eradication of worm burdens, Der p1-specific IL-10 was reduced, suggesting that S.mansoni 
infection was promoting these responses. Were asthmatic patients protected from allergen 
reactivity by IL-10-secreting allergen-specific Tregs, generated from S.mansoni induced 
Tregs? 
The present rise in allergic and autoimmune diseases may be accounted for by a lack of 
immune regulation (Tsitoura, D. C. et al. 2000; Wills-Karp, M. et al. 2001; Bach, J. F. 2002; 
Umetsu, D. T. et al. 2002; Zuany-Amonim, C. et al. 2002; Akbari, 0. et al. 2003; Herrick, C. A. 
and Bottomly, K. 2003; Jutel, M. et al. 2003; Karlsson, M. R. et al. 2004). Experimentally 
restoring regulatory networks can reduce these diseases, as shown in this thesis. The inverse 
association between helminth infections and allergic reactivity may thus be explained by 
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helm inth-induced regulatory networks, encompassing a multiple cellular compartments 
suppressing allergen reactivity. 
Evolutionarily, allergies may be a consequence of our helminth-infected evolutionary history, 
when helminth infections were more abundant. STAT6 polymorphisms have recently been 
associated with resistance to Ascaris infection in human populations (Peisong, G. et al. 2004) 
with resistant alleles also associated with allergic asthma (Gao, P. S. et al. 2000). Thus, a 
reduction in worm burdens may, in part, account for rising allergy trends. 
A multi-angled approach tackling the global burden of inflammatory conditions and in 
particular allergic asthma could help identify potential therapeutic directions. Several, 
independent approaches- therapeutic, observational in the developed and developing worlds, 
I believe, identify a common mechanism to prevent Th2 associated allergic diseases (Fig. 
8.6). 
Firstly, high dose allergen-specific immunotherapy used to treat allergic patients, generates 
significant populations of allergen-specific regulatory T cells, producing IL-10 and/or TGF-3 
(Muller, U. et al. 1998; Francis, J. N. et al. 2003; Gardner, L. M. et al. 2004; Vissers, J. L. et 
al. 2004). This therapy also induces the secretion of non-inflammatory antibody lgG4 (Akdis, 
C. A. and Blaser, K. 2000), and is proving to be a successful step in treating allergic asthma. 
Secondly, there have been significant observations, predominantly in developed societies, of 
a 'modified' Th2 response following exposure to relatively high levels of cat (fel dl) and dog 
(Can fl and Can f2) allergens. Pioneered by Thomas Platts-Mills and others, reports of 
exposure to domestic cats and dogs providing protecting from allergic diseases and allergen 
sensitisations adds another dimension to the hygiene hypothesis (Hesselmar, B. et al. 1999; 
Roost, H. P. et al. 1999; Ownby, D. R. et al. 2002);(Ownby, D. R. et al. 2002; Perzanowski, 
M. S. et al. 2002; Custovic, A. et al. 2003; Gem, J. E. et al. 2004). Children who do not 
respond to Fel dl with skin prick tests had significant levels of Eel dl-specific-IgG4 (Platts-
Mills, T. et al. 2001) and IL-10 secretions from peripheral T cells (Reefer, A. J. et al. 2004). As 
IgG4 production requires IL-4, similar to IgE, the occurrence of lgG4 and IL-10 without IgE 
has been described as a 'Modified Th2' response (Platts-Mills, T. et al. 2001). Presumably, 
Treg cells may also appear in the modified Th2 response, following the observation of IL-10- 
producing T cells (Reefer, A. J. et al. 2004). 
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Finally, the observation, predominantly in the developing regions of the world and 
experimentally in this thesis, that helminth infections can protect from allergic diseases 
(reviewed by (Yazdanbakhsh, M. et al. 2001)), encompassing Treg cell expansion (Elliott, D. 
E. et al. 2004; Hesse, M. et al. 2004; McKee, A. S. and Pearce, E. J. 2004), IL-10 and TGF-
secretions and the generation of IgG4 antibodies (Maizels, R. M. et al. 1995), further supports 
a regulatory model suppressing allergic disease. 
These three independent approaches have all identified a similar mechanism (Fig. 8.7) with 
consistent observational studies, strong laboratory-based evidence and clinical intervention 
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Fig. 8.7. A regulatory model, encompassing successful allergen immunotherapy (SIT) a modified Th2 
response observed following increased exposure to cat or dog allergen (Allergen") and during 
Helminth infection. All three observations and approaches support a regulatory model and yield successful 
protection from allergic disease, representing a pioneering model in the developing hygiene hypothesis. 
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